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Abstract 
The accelerated emergence of drug resistant bacteria is one of the most serious 
problems in healthcare and the difficulties in finding new antibiotics make it even more 
challenging. To overcome the action of conventional antibiotics bacteria develop 
effective resistance mechanisms including the formation of biofilms. Biofilms are 
bacterial communities of cells embedded in a self-produced polymeric matrix 
commonly found on medical devices such as indwelling catheters. When pathogens 
adopt this mode of growth on the surface, they effectively circumvent host immune 
defences and antibiotic therapy, causing severe and life threatening device-related 
infections.  
To reduce the incidence of biofilm-associated infections different strategies, such as 
often replacement of the device, utilisation of novel materials for its construction and/or 
design of functional coatings have been suggested. Besides the variable efficiency, 
they commonly involve the use of large quantities of antibacterials leading to side 
effects, hypersensitivity, inflammatory responses or emergence of resistance. Thus, 
new paradigms are urgently needed for more efficient and specific approaches to 
prevent and treat biofilm infections.  
This thesis focuses on the development of advanced nanoscale materials and 
coatings for controlling clinically relevant bacterial biofilms and the emergence 
of drug resistance. To this end, acylase and amylase enzymes degrading essential 
for the biofilm growth components, were innovatively combined into hybrid 
nanocoatings to impart antibiofilm functionalities onto indwelling medical devices. 
Alternatively, ultrasound-assisted nanotransformation of antimicrobials was used as a 
tool for enhancing their antibacterial efficacy and overcoming the intrinsic drug resistant 
mechanisms in Gram-negative bacteria. These strategies offer new perspectives for 
prevention and treatment of biofilm infections, limiting the selection and spread of 
antibiotic resistance.  
The first part of the thesis describes the building of enzyme multilayer coatings able 
to interfere with bacterial quorum sensing (QS) and prevent biofilm establishment on 
silicone urinary catheters. This was achieved by alternate deposition of negatively 
charged acylase and oppositely charged polyethylenimine in a Layer-by-Layer (LbL) 
fashion. The acylase-coated catheters degraded the bacterial signalling molecules and 
inhibited the QS process of Gram-negative bacteria. These coatings also significantly 
reduced the biofilm growth on urinary catheters under conditions mimicking the real 
situation in catheterised patients, without affecting the human cells viability.  
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Acylase was further combined with the matrix degrading α-amylase enzyme into 
hybrid multilayer coatings able to interfere simultaneously with bacterial QS signals and 
biofilm integrity. The LbL assembly of both enzymes into hybrid nanocoatings resulted 
in stronger biofilm inhibition as a function of acylase or amylase location in the multi-
layer coating. Hybrid nanocoatings with the QS inhibiting acylase as outermost layer 
reduced the occurrence of single and multi-species biofilms on silicone catheters in 
vitro and in an in vivo animal model.  
The thesis also reports on the efficacy of nanomaterials for prevention and 
eradication of antibiotic resistant biofilms. Multilayer assemblies that contain in their 
structure and release on demand antibacterial polycationic nanospheres (NSs) were 
engineered on silicone surfaces. A polycationic aminocellulose (AC) conjugate was first 
transformed into NSs with enhanced bactericidal activity and then combined with 
hyaluronic acid to build bacteria-responsive layers on silicone material. When 
challenged with bacteria these multilayers disassembled gradually inhibiting both 
planktonic and biofilm modes of bacterial growth.  
The same AC NSs were also covalently immobilised on silicone material using 
epoxy-amine conjugation chemistry. The intact NSs on the silicone material were able 
to inhibit bacterial colonisation and biofilm growth, suggesting the potential of epoxy-
amine curing reaction for generation of stable non-leaching coatings on silicone-based 
medical devices. 
Finally, ultrasound-assisted nanotransformation of clinically relevant antibiotic 
penicillin G was used as a strategy to boost its activity towards Gram-negative bacteria 
and their biofilms. The efficient penetration of the spheres within a Langmuir monolayer 
sustained the theory that NSs are able to cross the membrane and reach the 
periplasmic space in Gram-negative bacteria where they may exert their bactericidal 
activity “unrecognised” as a threat by bacteria. In such conditions it is very likely that 
the selective pressure is reduced and bacteria do not feel the need to defend, 
expressing resistant phenotypes.  
 
 
Keywords: enzymes, Layer-by-Layer coatings, sonochemistry, nanospheres, silicone, 
urinary catheters, quorum quenching, antibacterial activity, biofilm prevention, antibiotic 
resistance  
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For most of the history of microbiology, bacteria have been simply viewed as freely 
suspended single cells often referred as planktonic. However, towards the end of the 
20th century it became clear that bacteria thrive predominantly in surface attached 
communities of cells embedded within self-produced extracellular polymeric matrix 
(EPM) known as biofilms [1].  
Although traditionally regarded as environmental phenomenon, nowadays biofilm 
growth is widely considered one of the major virulence attributes of bacteria and fungi 
that play a pivotal role during the pathogenesis [2, 3]. Biofilm may form on any foreign 
object inserted into the human body as well as in any place in the body where the host 
defence is compromised, such as in the lungs of patients with cystic fibrosis, or in 
chronic wounds with impaired blood supply [4]. When established on sutures, 
catheters, heart valves, implants, and intrauterine devices the biofilms usually cause 
severe chronic infection and subsequent tissue destruction, as well as systemic 
dissemination of the pathogen and dysfunction of the device [5, 6]. Whereas free 
floating bacterial cells can be eradicated by the action of antibacterials and host 
immune responses, the biofilm encased communities of bacteria frequently survive the 
treatment and can cause infection recurrence. In most cases, the treatment of biofilm-
related diseases requires surgical removal of the contaminated device and affected 
areas in combination with intensive antibiotic therapy [7]. However, the innate or 
acquired resistance of bacteria to antimicrobials and immune defence mechanisms 
often impairs the conventional therapy resulting in increased time of hospitalization and 
health care costs, and ultimately in significant mortality and morbidity [8, 9]. Hence, 
instead of treating the consequences, the efforts are currently directed towards the 
development of preventive strategies to reduce the high incidence of device-related 
infections [13]. 
Various physical and chemical methods including flushing, chlorination, and 
ultraviolet (UV) disinfection, have been applied to control bacterial contamination and 
biofilms occurrence on medical devices and equipment [10] [11, 12]. More recently 
antimicrobial coatings with variable efficiency in preventing biofilms, by either killing the 
pathogens or inhibiting bacterial growth and reproduction, have been developed [13-
18]. Despite some promising results, most antibacterial agents eventually increase the 
risk of resistance development.  
Advances in the biofilm research have led to new insights into the mechanisms of 
biofilm establishment that marked an important progress in the development of novel 
strategies to address bacterial biofilm challenge. Enzymatic based approaches have 
been suggested as a valuable alternative to control biofilms. Enzymes have been 
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successfully explored for the inhibition of bacterial virulence and surface adherence as 
well as elimination of clinically relevant biofilms. Whereas the conventional antibiotics 
exert substantial evolutionary stress on bacterial population by targeting different 
intracellular components, the antibiofilm active enzymes use other eradicating 
mechanisms, which reduce the selection for resistance strains. Another very promising 
approach utilises nanotechnology to form highly efficacious nanostructures of currently 
available antimicrobials with enhanced functionality. The assemblies of the molecules 
at nanometer scale have unique properties, differing from those of the free molecules 
and the bulk materials with the same composition. Nano-size transformation of current 
bactericides could be considered a straightforward method to improve the treatment of 
severe infections and viable alternative to reduce the time- and resource-consuming 
screening for new drugs.  
The main goal of this thesis is to develop nanostructured materials for 
prevention and eradication of bacterial biofilms limiting the selection and spread 
of drug resistance. To achieve this, innovative platforms of enzymes and NSs for 
coating of medical devices were designed. Enzymes interfering with bacterial 
cooperative behaviours and essential biofilm adhesives are innovatively integrated into 
multilayer nanocoatings expected to reduce the incidence of catheter-associated 
biofilm infections. Sonochemically engineered NSs of bactericides are proposed as 
novel tools for eradicating medically relevant bacteria. We opted for altering the form 
and enhancing the interaction of existing antibacterials with bacterial cells and biofilms 
to improve the treatment efficiency, instead of screening for new drug entities.  
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2.1 Bacterial Biofilms Formation  
Wherever a suitable surface, moisture and nutrients are available, free floating bacteria 
are likely to exist in the form of complex biofilm structures of cells embedded within the 
self-produced EPM [19, 20]. Bacterial biofilms are not just passive assembly of cells 
attached to a substratum or to each other, but rather structured, coordinated, 
communities with distinct architectures and properties [6, 21]. These sessile bacterial 
communities are ubiquitous in nature and possess the sophisticated ability to rapidly 
adapt and propagate in a wide variety of habitats. While in some case biofilms provide 
significant benefits to the human health forming protective layers on the body tissues 
against pathogenic microorganisms, more and more evidences highlight their role in 
the occurrence of life-threatening infections [22]. During the adaptation to biofilm 
lifestyle hundreds of genes are differentially expressed to introduce changes in 
phenotypic and genotypic pattern, making the population more resistant to currently 
available antimicrobials and host immune system. The significance of biofilms for 
human health has stimulated the efforts to understand the mechanism of biofilm 
formation in order to open a new axis of customizing measures highly effective against 
bacteria and their biofilm forms.   
The formation of microbial biofilms can be described in three main stages - 
attachment, growth (maturation), and detachment. Initially, bacteria attach to a living or 
non-living surface where they proliferate and form a characteristic three dimensional 
structure, the second stage. During the third stage, planktonic cells detach from the 
biofilm, as a result of either cell growth or removal of biofilm aggregates, and colonize 
other sites away from the original site of infection (Figure 2.1) [23]. An important step 
for biofilm establishment on medical devices is the adherence of free ﬂoating cells to 
the so called “surface conditioning layer”. This conditioning layer comprises: 
biomolecules such as proteins (e.g. ﬁbronectin, ﬁbrinogen, and collagen), lipids, 
polysaccharides, and inorganic salts that modify the physical and chemical properties 
of the material and serve as source of nutritive substances and microelements [13]. 
When bacteria approach that layer, they first interact with the biomolecules through 
specific receptors and then irreversibly adhere to the surface [24]. Upon attachment, 
they start to grow and expand, forming small microcolonies of cells of the same species 
or other bacterial species and microorganisms according to the environmental 
parameters. Further changes in genes expression allow cells to replicate and establish 
functional community encased in protective EPM [3]. 
Biofilm EPM comprises variety of compounds including polysaccharides, proteins, 
nucleic acids, uronic acid and humic substances that originate from both the bacteria 
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and surrounding environment [25-27]. Among all, matrix exopolysaccharides (EPS) are 
integral part of the biofilm structure and provide diverse benefits for bacterial 
populations within the mature stage [21]. They assist bacteria to strongly adhere to a 
multitude of different surfaces, provide protection from a wide range of host and 
environmental factors (e.g. immune effectors, antimicrobials, predators), serve as 
reservoirs for nutrient acquisition and help the formation of three-dimensional biofilm 
architecture. Even though being a part of similar microbial communities, it is quite 
possible that under specific environmental conditions bacteria elaborate multiple EPS 
with different structure and functional roles [28, 29]. For example, in a response to 
environmental stressors, e.g. dehydration and osmotic stress, the biofilm forming 
Escherichia coli and Pseudomonas aeruginosa species produce significant amounts of 
colonic acid and alginate, respectively [29-31]. P. aeruginosa also utilise the 
polysaccharides Pel and Psl which are very important for the cells attachment to the 
surface as well as biofilm firmness and stability. However, the regulation and 
expression of alginate, Pel and Psl as well as their functional role in the biofilm 
maturation can vary drastically among the different strains [32]. 
Mature biofilm is often observed as three dimensional, mushroom- or tower-like, 
structure of matrix-enclosed cells organised in accordance with their metabolism and 
aero tolerance [9, 29]. Its architecture is very heterogeneous in space and time, 
containing microcolonies of cells, separated by water channels allowing the transport of 
nutrients, oxygen, and even antimicrobial agents [33]. At the last step of biofilm life 
cycle, bacteria become motile again, disperse from the community to colonise distal 
sites and initiate new biofilm growth (Figure 2.1) [9, 34]. The biofilm dispersion is in 
response to the starvation conditions or overcrowding, which take place because of 
the: i) production of EPM - degrading enzymes, lithic activation of bacteriophages, 
expression of phosphodiesterase and specific signals, and ii) passive detachment of 
biofilm fragments or cells mediated by shear forces, abrasion, human factors and 
predation over bacteria in the biofilm [34]. 
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Figure 2.1 Biofilm growth cycle. Once planktonic bacteria are attached to a surface, the 
secretion of matrix components begins leading to mature biofilm formation. The biofilm growth 
cycle finishes when the bacteria and parts of the biofilm structure are dispersed towards the 
surrounding environment for colonisation of other sites.  
 
2.2 Quorum Sensing in Bacterial Virulence and Biofilm Growth 
There are growing evidences that pathogens are able to switch from free-swimming 
cells to a surface-attached lifestyle by sensing the changes in the environmental 
conditions [35-37]. At certain population density, bacteria sense the presence of other 
bacterial cells in the surrounding and act as multicellular organisms through the QS 
process [38]. QS is a communication process mediated by small diffusible hormone like 
molecules, called autoinducers (AIs). This process differs greatly from microorganism 
to microorganism, depending on the bacterium group (Gram-positive or Gram-
negative), the type of signalling molecules and signal transduction system [38, 39].  
2.2.1 Quorum Sensing in Gram-negative Bacteria  
Gram-negative bacteria use acyl-homoserine lactones (AHLs) whereas Gram-positive 
bacteria utilize peptides or cyclic oligopeptide signals, called autoinducing peptides 
(AIPs), as the primary signalling molecules (Figure 2.2) [40, 41]. AHLs molecules 
consist of homoserine lactone (HL) ring and fatty acid side chain, varying in length (C4 
to C18), saturation, and oxidation at C3 position (Figure 2.2) [42]. They are produced 
by intracellular synthases (LuxI homologues of Vibrio fischeri) through an acylation 
reaction of adenosyl-methionine, which is the source for HL formation, and acyl-acyl 
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carrier protein (ACP), the source of fatty acid AHL side chain. The AHL signals 
accumulate in the surrounding environment and when reach high concentrations (i.e. 
threshold levels) they bind to cognate cytoplasmic transcriptional regulators, which are 
LuxR type proteins, inducing target genes expression (Figure 2.2A) [43]. This results in 
the activation of specific quorum responses (e.g. virulence factors production, biofilm 
formation, bioluminescence and etc.) and positive regulation of the intracellular 
synthetase by the signals which will then provide more AHLs for the expression of QS-
related genes. 
The QS signalling systems in some Gram-negative bacteria are usually more 
complicated than described above. Extensive studies have been carried out to 
understand the QS pathways of pathogenic P. aeruginosa, which exploit four types of 
QS systems associated with the induction of different virulence phenotypes [44]. Two 
of these QS systems, known as las and rhl, are AHL based and use 3-oxo-C12-HSL 
and C4-HSL signals to regulate the production and secretion of various virulence 
factors including elastase, exotoxin A, pyocyanin, and biofilm formation [45, 46]. The 
other systems, named pqs and iqs, use another class of signalling molecules which are 
known as 2-2-heptyl-3-hydroxy-4(1H)-quinolone (PQS) and 2-(2-hydroxyphenyl)-
thiazole-4-carbaldehyde, respectively [47, 48]. All these systems are hierarchically 
arranged, being the las at the top of the QS control. The sophisticated QS circuit in P. 
aeruginosa is extremely adaptable and can respond to distinct environmental stress 
cues, providing high flexibility of its pathogenesis [49]. Despite the complex QS network 
in P. aeruginosa, most pathogenic Gram-negative species possesses a single AI based 
QS system that comprise one type AHL synthase and cognate transcription regulator. 
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Figure 2.2 Quorum sensing in Gram-negative bacteria. A) Bacteria secrete acyl homoserine 
lactones (AHLs, orange circle) that in threshold concentrations penetrate into the cells and 
activate the cognate signal receptor, inducing the QS-regulated production of virulence factors 
and biofilm formation. B) Chemical structure of AHL signalling molecules secreted and detected 
by most Gram-negative bacteria.  
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2.2.2 Quorum Sensing in Gram-positive Bacteria 
Gram-positive bacteria use linear or cyclic AIPs, as the primary means of signalling 
molecules and two component signal transduction systems as the main quorum 
mechanism (Figure 2.3) [62]. AIP signals are synthesised in bacterial cells as 
precursors (pro-AIP) and excreted through specialized membrane-bound AIP 
transporters. During the pro-AIPs transportation through the membrane these 
transporters process the signal in sizes that vary from 5 to 17 amino acids [63, 64]. At 
threshold concentrations, the already mature AIP signals specifically bind to and 
activate two-component histidine kinase receptor located in the cell membrane of 
Gram-positive bacteria. The activation of the histidine kinase then results in 
phosphorylation of cognate response regulator protein, which modulates the target 
genes expression of a wide range of bacterial phenotypes (Figure 2.3) [33]. Several 
AIP based QS signal transduction systems have been well studied such as the 
accessory gene regulator (agr) system of Staphylococcus aureus and agr-like system 
of Enterococcus faecalis. The agr signalling system in S. aureus uses four different 
types of thiolactone-containing peptides, namely AIP I, AIP II, AIP III and AIP IV and 
represent an attractive target for the attenuation of QS regulated virulent behaviours 
(Figure 2.3).  
Besides being able to communicate with members of the same species via AHLs or 
AIPs signals, bacteria may also communicate with members of other species, using 
specific signal molecules, known as AIs-2 [65-67]. These signals are obtained from 4,5-
dihydroxy-2,3-pentanedione, produced by LuxS enzyme and consequently recognized 
by the interspecies LuxP and LsrB receptors found in V. harveyi and Salmonella 
typhimurium, respectively [38]. 
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Figure 2.3 Quorum sensing in Gram-positive bacteria. A) Initially, bacteria synthesize auto-
inducing peptide (AIP) signals as precursors (pro-AIP) in the cells that are further transformed 
into mature AIPs (grey rhomboids) during their transportation through membrane transporters. 
These AIPs then interact with a transmembrane histidine kinase receptor activating the target 
genes expression via autophosphorylation of the cognate transcriptional regulator. B) Chemical 
structure of the AIP signals produced by S. aureus, S. mutants and B. subtilis.  
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2.3 Antibiotic Resistance of Biofilms  
QS-regulated gene expression events in the pathogens have an important role for cells 
organisation into sophisticated communities able to sustain long-term exposure to high 
antibiotic concentrations and therefore cause severe chronic infections [7, 35]. Biofilm 
insusceptibility is multifactorial interplay of physical, physiological and adaptive 
tolerance mechanisms of: i) impaired penetration of antibiotics and antiseptics through 
the biofilm matrix, ii) horizontal gene transfer of resistance plasmids in the extracellular 
deoxyribonucleic acid (eDNA), iii) decreased bacterial growth and increased nutrient 
limitations, and iv) adaptive stress responses and formation of multi-resistant strains 
[70].  
The decreased bactericidal effect of aminoglycoside antibiotics, for instance, have 
been explained with the limited diffusion of positively charged antibiotic molecules due 
to their sequestration by the oppositely charged matrix polysaccharides and eDNA [71, 
72]. Furthermore, environmental gradients of nutrients, metabolites, pH, oxygen and 
slow bacterial growth are thought the reason for resistance to β-lactams penicillin and 
ampicillin, a class of broad-spectrum antibiotics effective only towards dividing bacteria, 
but not very active against the slow or no growing bacteria within the depths of mature 
biofilms [73]. The limited availability of oxygen also allows P. aeruginosa to survive the 
treatment with tobramycin and ciprofloxacin [74]. The juxtaposition of one or more 
species within the EPM is great advantage for the horizontal transmission of resistant 
genes and the increased mutation frequency [75-77]. Bacteria within the community 
easily acquire resistance and may inactivate the antibiotics via the inhibition of cell wall 
synthesis and protein production, alteration of drug targets, and overexpression of 
efflux pumps [77, 78].  
Nevertheless, the existence of small subpopulation of dormant cells, called 
persisters, is considered to elucidate most of the biofilm specific tolerance towards 
antimicrobials [7]. These cells were found in both planktonic and biofilm forms. They 
are not considered resistant mutants, but possess great potential to avoid the killing by 
most of the currently used in practice antibiotics and resume their growth once the 
therapy is withdrawn acting as reservoirs for infection recurrence [29].  
 
2.4 Biofilms in Device-Related Infections  
Microbial biofilms are at the root of many chronic and recurrent infections and their 
formation have been estimated to account for 80 % of all microbial infections currently 
treated in hospitals [79]. A number of diseases including otitis, sepsis, endocarditis, 
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osteomyelitis, prostatitis, recurrent urinary tract infections and tooth decay are 
associated with drug resistant biofilm occurrence (Table 2.1) [9]. These biofilms may be 
composed of single or mixture of bacterial and fungal species which are frequently in a 
continuous interplay to accelerate the persistence of the infection [80, 81]. Gram-
negative P. aeruginosa, E. coli and Klebsiella pneumoniae, Gram-positive streptococci 
and staphylococci, as well as Candida species are among the most commonly 
identified microorganisms in the sever biofilms related diseases (Table 2.1) [23]. For 
instance, the biofilm growth of mucoid, alginate-producing P. aeruginosa strains in the 
lungs of hospitalized patients is the major reason for chronic inflammation and tissue 
damage, associated with multiple complications, long term morbidity, and a high 
mortality rate [82]. The alginate in the EPM of this strain is believed to allow for the 
persistent infection protecting the microcolonies from phagocytosis and antibiotics [83]. 
P. aeruginosa is also frequent pathogen involved in burn wounds, chronic wounds and 
chronic obstructive pulmonary disorder, where it represents a serious problem (Table 
2.1) [82, 84].  
Table 2.1 Medical devices and bioﬁlm-related diseases.  
Organism  Medical Device  Infection 
E. coli 
Urinary catheters, orthopaedic 
devices 
Urinary tract infections, biliary 
tract infections, prostatitis 
E. faecalis 
Urinary catheters, central 
vascular catheters 
Endocarditis, urinary tract 
infections 
P. aeruginosa 
Contact lenses, urinary 
catheters, central vascular 
catheters, orthopaedic devices, 
soft tissue fillers 
Cystic fibrosis, burn wounds, 
chronic wounds 
S. aureus 
Central and peripheral 
vascular catheters, 
arteriovenous shunts, 
prosthesis, breast implants 
Chronic sinusitis, chronic 
wounds burn wounds, trauma 
infection,  
Staphylococcus 
epidermidis 
Urinary catheters, central and 
peripheral vascular catheters, 
prosthesis, soft tissue fillers 
Sepsis, endocarditis 
Proteus mirabilis 
Urinary catheters, orthopaedic 
devices 
Kidney stones, respiratory 
tract, wound infection, urinary 
cystitis 
K .pneumonie 
Urinary catheters, central 
vascular catheters 
Lower biliary tract, wound 
infections 
S. mutans Dental implants  
Dental plaque, gingivitis, dental 
caries, periodontitis 
Candida albicans  
Central venous catheters, 
urinary catheters 
 Bloodstream, urinary tract 
infections 
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An extremely high percentage of planktonic bacterial cells in the healthcare facilities 
are difficult to eradicate by most commonly available antibiotics, but when they grow in 
the structured biofilm communities their eradication is even more challenging [85]. 
Bacterial biofilms are up to 1000 times more resistant to conventional antibiotic 
treatments and host defence mechanisms than their free floating counterparts. The 
increasing incidence of biofilm infections is also considerably related with the progress 
of the modern medicine and the frequent use of implants and indwelling medical 
devices (IDMs) [86, 87].  
Indwelling medical devices such as urinary catheters are utilised to relieve urinary 
retention and urinary incontinence. Bacteria readily colonise catheters surface and 
thereby gain access to human organs or tissues causing severe bloodstream or urinary 
tract infections (UTIs) [5, 11]. Catheter-associated urinary tract infections (CAUTIs) are 
the most frequent health care–associated infection worldwide related with the regular 
and sometimes unnecessary use of indwelling urinary catheters [88, 89]. These 
infections account for over 40 % all nosocomial infections and form 80 % of all UTIs 
currently treated in the hospitals [89-91]. CAUTIs are major health concern that delays 
the patient’s recovery and significantly increase healthcare costs, length of antibiotic 
therapy and risk of resistance development [6, 89].  
The most common urinary catheter in use is the Foley indwelling urethral catheter - a 
soft latex or silicone tube inserted into the human bladder to drain urine [89]. It has 
inﬂatable balloon near the catheter tip which serves to hold the device into the bladder 
over the period of catheterisation (Figure 2.4) [92]. Indwelling catheter systems were 
originally designed for short-term bladder drainage, but nowadays are common in the 
long-term care. The systems can be opened - the urine drains into open collection 
container, and closed - the catheters empties into securely fastened plastic collecting 
bag. Despite the fact that the closed systems are more resistant to bacterial 
contamination and UTIs occurrence, it has been reported that 10 to 50 % of patients 
undergoing short-term catheterisation (0-2 weeks) develop asymptomatic bacteriuria, 
whereas essentially all patients undergoing long-term catheterisation (more than 6 
weeks) will develop symptomatic UTIs [93]. For each day the catheter is in place the 
risk for acquisition of infection in any part of the urinary system, including urethra, 
bladder, ureters, and kidney has been estimated to increase by approximately 10 % 
[94]. 
 
 
  
 15 
 
+ 
 
Figure 2.4 Schematic representation of Foley urinary catheter.  
 
There are several routes for bacteria to enter the body and then establish UTIs in the 
hospitalized patients. At the time of insertion, bacterial microflora from the periurethral 
area of the patients can colonize the catheter tip and consequently access the bladder 
[95]. In most cases, however, bacterial entry occurs through the urethral meatus-
catheter mucoid film formed on the external surface of already placed catheter [96]. 
Besides, failure of the drainage system or contamination of the urine in the collection 
bag will allow bacteria to access the urinary tract [89]. The majority of the identified 
pathogens are from the patient´s own microbial flora, the healthcare personnel or other 
patients, and other sources available in the hospital environment [16]. Special 
emphasis should be put when the CAUTIs is caused by species from the hospital 
settings, that often represent drug-resistant strains complicating significantly the 
treatment [89]. 
Soon after the catheters contamination the individual pathogenic cells change 
phenotypically and initiate biofilm formation [23, 77, 97]. At the beginning these biofilms 
are composed of single species, but longer time of exposure inevitably results in 
multispecies biofilm formation with very dynamic microbiology [98]. Up to five different 
species may be isolated from biofilms of individuals with long-term catheterisation, 
being the Gram-negative rods (P. aeruginosa, E. coli and P. mirabilis) and enterococci 
(especially E. faecalis) the most frequently identified (Table 2.1) [99, 100]. The specific 
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interactions and synergism between the distinct species within the polymicrobial 
biofilms, often results in increased antibiotic resistance and virulence factors production 
[101]. Multispecies biofilm consortium of Gram-negative P. aeruginosa, Pseudomonas 
protegens, and K. pneumonia was shown to resist the treatment with tobramycin and 
sodium dodecyl sulphate, whereas monocultures of these species tolerated the 
antibacterial action of both compounds in different levels [102]. Depending on the 
exerted selective pressures, different microorganisms may even evolve to increase the 
mutual benefit of the consortium and begin to function better together than alone. 
Despite the significance of the polymicorbial biofilms in many human diseases, the 
interspecific bacterial interactions are not well characterized and require profound 
understating in order to develop adequate preventative and treatment strategies.  
By far biofilms that contain crystals in their matrix remain the most problematic 
especially for the patients undergoing long-term catheterisation. There are two main 
types of crystals: i) struvite, which are rectangular in shape build of magnesium 
ammonium phosphate, and ii) apatite that represent microcrystalline structures made of 
a hydroxylated calcium phosphate in which the phosphate groups are replaced by 
carbonate [103]. The driving force behind their formation is the urease-induced 
hydrolysis of urea to ammonium hydroxide, which results in elevated pH of the urine 
followed by precipitation of magnesium and calcium phosphate. The crystals formation 
and accumulation in the biofilm structures frequently lead to encrustation and blockage 
of the urinary catheter [104, 105]. As a result the urine is either retained in the bladder 
or leaks outside the catheter, and if not replaced serious complications, e.g. 
pyelonephritis, septicaemia and endotoxic shock may occur [106]. Many bacterial 
species are capable of producing urease including P. aeruginosa, K. pneumoniae, 
Morganella morganii, some Providencia spp, some strains of Staphylococcus aureus 
and coagulase negative staphylococci, but the most abundant bacterium recovered 
from crystalline biofilms is P. mirabilis [89, 95, 107, 108]. Practically, all types of urinary 
catheters are vulnerable to microbial contamination and biofilm development. The 
eradication of biofilm-embedded cells is very difficult task and therefore, instead of 
treating the consequences, the efforts are currently directed towards the development 
of preventive strategies to reduce the incidence of severe medical device-related 
infections.  
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2.5 Current Strategies for Controlling Bacterial Biofilms  
To reduce the incidence of biofilm-associated infections various strategies, such as 
removal of the contaminated medical device, utilisation of novel materials for device 
construction or surface functionalisation with antibacterial agents, have been 
suggested [14]. Systematic replacement of contaminated IDMs is only a temporary 
solution, as the freshly inserted device provides a new surface for bacteria to adhere 
and establish biofilms [109]. Alternatively, novel silicone materials on which bacteria 
adhere less, have been used for urinary catheters construction. Silicone-based 
materials are not the best decision for limiting the spread and occurrence of infections 
mainly because of the nonspecific protein adsorption on the catheters surface that after 
some time triggers bacterial attachment [110].  
Nowadays, surface functionalisation with broad-spectrum antibacterial agents is a 
very active field of research for developing of materials with variable efficiency against 
biofilms [15, 111, 112]. The substantial evolutionary stress that most antimicrobials 
exert on bacteria ultimately may lead to the emergence of multi-drug resistance 
species. In consequence significant efforts are being made to design novel 
antibacterial surfaces able to resist bacterial colonisation without promoting resistance 
occurrence. Existing antibacterial and antibiofilm materials show different efficiency 
towards single and multi-species biofilms and can be categorized as:  
i) Engineered nano- and micro-topography surfaces that inhibit bacterial 
adhesion [113, 114]. These anti-adhesive coatings aim to counteract the 
conditioning layer formation on the surface, i.e. host proteins adherence, and 
thus repel bacterial cells [13]. Imparting surface characteristics with 
hydrophilic polymers such as hyaluronic acid, heparin, poly(ethylene glycol) 
(PEG) and its derivatives, has been received much attention for the 
development of bacteria repellent surfaces [115-120].  
ii) Surfaces with covalently immobilised antimicrobials that kill bacteria upon 
contact [121]. Cationic macromolecules containing quaternary ammonium 
and phosphonium moieties have been frequently used for functionalisation of 
a wide range of contact-killing surfaces [122, 123]. However, the bactericidal 
effect of these materials can easily be reduced by host biomolecules or 
residues of dead cells, blocking their direct contact with the cells [124]. 
iii) Biocide releasing surfaces. Surfaces leaching antibiotics, metal and metal 
nanoparticles (NPs) have been designed to provide a local and defined 
delivery of the killing agents into the affected zones [125-128]. The major 
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limitation of these antibacterial/antibiofilm leaching materials is their short 
lifetime [129].  
Although some promising results, these approaches suffer from the use of active 
agents which may be associated with side-effects such as cytotoxicity, hypersensibility, 
inflammatory responses or progressively increasing antibiotic resistance emergence 
[130]. Therefore, there is still a need for more efficient and specific control of bacterial 
biofilms and infection establishment relying on innovative strategies that are superior to 
the commonly used in the practice methods. Approaches targeting disruption of 
bacterial QS process and degradation of biofilm matrix components have been 
successfully applied alternative for the prevention and control of drug resistant biofilms 
in vitro and in vivo. In contrast to most commonly used antimicrobials, these anti-
infective agents do not directly affect bacterial survival and thus would not lead to 
selection for resistance. At present the use of nanosized organic particles with high 
bactericidal activity is also of considerable interest for overcoming bacterial resistance 
without significant toxicity. The unique properties of nanostructured materials, e.g. 
small size and large surface area to mass ratio, hold significant promise for improving 
materials functionality towards bacteria in both planktonic and biofilm forms. Taking into 
account the complex interplay of factors involved in drug resistance, combination 
therapies that rely on several antibacterial/antibiofilm agents affecting sequentially or 
simultaneously several structural component of sessile bacterial communities have 
been emerged as a new source of inspiration to design antibiofilm materials and 
coatings.  
Various physical or chemical strategies including self-assembled monolayers, graft 
polymerization, Layer-by-layer (LbL) assembly and covalent attachment have been 
widely used for the modification of numerous surfaces and medical devices. Among all 
the techniques, LbL deposition of active agents allows the design of a wide range of 
sophisticated multifunctional materials and coatings with anti-adhesive and/or bacteria 
killing properties without the need for chemical modification of the surfaces and the use 
of crosslinking agents.  
 
2.6 Layer by Layer assembly: A versatile tool for engineering bacteria resistant 
materials 
LbL assembly of polyelectrolytes is an easy, versatile and cost-effective approach for 
engineering multifunctional antibacterial and antibiofilm coatings on a variety of 
surfaces with different chemistry and geometrical shape [131].This technique is based 
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on the sequential deposition of oppositely charged layers and has been widely used to 
incorporate a broad range of biomacromolecules [132], enzymes [133], drugs [134], 
and NPs [135] in coatings, without causing structural changes that could alter their 
efficacy (Figure 2.5). Several technologies namely immersive, spin, spray, 
electromagnetic, and fluidic, are available to create tailor-made polyelectrolyte-
containing nanocoatings with better characteristics [136]. To date the immersive 
method, which is performed by dipping a charged substrate into an oppositely charged 
aqueous solution of the active agent, is the most widely used for the fabrication of 
multilayer architectures with controllable thickness. In this process, known also as “dip-
coating”, the electrostatic interactions between the building blocks are the main driving 
force, although non-electrostatic interactions such as hydrophobicity, hydrogen bonds, 
Van der Waals forces, charge transfer halogen interactions could be involved as well 
[137]. Depending on the interactions between the molecules, their charge density, pH 
and ionic strength of the solution the multi layering can occur either linearly or 
exponentially [138].  
Linear mode of layers growth is typical for polyelectrolyte pairs such as 
poly(styrenesulfonate)/poly(allylamine hydrochloride) (PSS/PAH) that are able to 
interact strongly. The thickness of these coatings increases linearly and the same 
amount of polyelectrolyte material is added to the growing layers upon each deposition 
cycle. Such multilayers have a stratified architecture with no diffusion of the 
polyelectrolytes within the layers. When the interactions between the oppositely 
charged building blocks are weak, as in the case of hyaluronic acid (HA) and poly(L-
lysine) (HA/PLL), the LbL multilayers grow exponentially. The exponentially growing 
multilayers can adsorb large amount of the polymer, up to hundreds of nanometers per 
deposition cycle, which opens up opportunities for the design of thick films with 
reservoir capacities [137-139]. A key feature in this growth pattern is the diffusion of at 
least one of the two polyelectrolytes “in and out”, leading to the formation of 
interpenetrated structure with high water content [140]. These highly hydrated coatings 
are considered a functional platform for the successful immobilisation of proteins or 
enzymes onto materials and surfaces, without significant loss of their biological 
activities [138, 141]. The biomolecules can be loaded/entrapped within the 
polyelectrolyte layers, or might be an integral part of the coating replacing one of the 
building electrolytes [142]. Moreover, the solutions pH and ionic strength, as well as the 
type of polymer pairs are fundamental for the successful engineering of stable at use 
materials [138]. 
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Figure 2.5 A) Schematic representation of the LbL assembling of oppositely charged 
polyelectrolytes (left). Three major classes of multilayer coatings with antibacterial functionalities 
have been engineered (right): antiadhesive that inhibits the attachment of pathogens, contact-
killing coatings that explore antimicrobial agents on the surface, and biocide-releasing to deliver 
antibacterials and kill bacteria in the supernatant. PEG-poly(ethylene glycol), purple ellipse (live 
cells), red ellipse (dead cells). 
 
A wide variety of materials with a potential to repel and kill pathogens, on contact and 
in close vicinity, could be developed in a LbL fashion (Figure 2.5). The design of 
bacteria-repelling materials deals mainly with changes in surface wettability, roughness 
and charge. Hydrophilic polymers such as PEG, poly(L-glutamic acid) (PGA) and 
poly(acrylic acid) grafted PEG, heparin and hyaluronic acid, are frequently used to 
increase the surface wettability [138, 143, 144]. The polymers might be introduced into 
the multilayers or on the top of the coating forming a highly hydrated layer that serves 
as a physical and energy barrier for bacterial adherence [143, 145, 146]. In particular, 
the anti-adhesive materials and surfaces possess potential to prevent the first step in 
biofilm growth, i.e., initial bacterial attachment, but they do not affect the pathogenic 
bacterial growth in solution, the cells stay alive and may colonise other surfaces. 
Hence, this antibacterial strategy might be feasible for temporary materials such as 
sutures, meshes, and drainage tubes, but probably not very practical to control the 
occurrence of implant associated infections. In addition, the anti-adhesive coatings 
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indiscriminately may not only suppress the surface bacterial adherence, but also the 
tissue-cells interaction with the functionalised implants, which would affect the healing 
process. Approaches attempting to kill bacteria upon surface attachment and/or in the 
device surrounding have been gaining ground (Figure 2.5).  
Up to now a powerful portfolio of functional multilayer assemblies has been created 
to inhibit the growth of both adhered and adjacent cells. Materials killing the pathogens 
upon their attachment often explore cationic compounds that interact with the 
intrinsically anionic bacterial cell wall leading to irreparable membrane damage and 
bacterial death [147]. Because the bactericidal effect depends on the availability and 
positive charge densities on the surface most of the assemblies terminate with the 
active polymer. However, the strong electrostatic interactions with the anionic 
compound as well as the layers rigidity often result in insufficient charge density and 
reduced chain mobility to alter bacterial cell membrane. Variation in the pH during 
and/or after the LbL construction has been proven as very effective to modulate not 
only the surface roughness, porosity and wettability, but also to fabricate materials and 
surfaces with high surface charge and mobility. Lichter et al. created SPS/PAH 
multilayers with reversible swelling transition and pH - tuneable antibacterial 
functionalities. The coating was assembled at high pH, incorporating mainly pockets of 
hydrophobically associated amine groups, and upon exposure to low pH the amines 
become protonated turning the adherent, nontoxic surface to highly resistant towards 
Gram-positive S. epidermidis and Gram-negative E coli [148].  
Chitosan and its derivatives have been widely used in the development of 
antibacterial and antibiofilm active materials. Chitosan coatings applied on silicon wafer 
as chitosan/κ-carrageenan multilayers, for examples, counteracted the adhesion and 
biofilm establishment of clinically relevant E. faecalis strains. Moreover, chitosan-
terminated multilayers imparted higher antibacterial activity than the layers terminating 
with anionic carrageenan [149]. Assemblies of chitosan and anionic lentinan sulphate 
onto polyurethane surface also were able to decrease the pathogenic P. aeruginosa 
growth upon contact, without affecting human cells viability [150]. The versatility of LbL 
technique was further explored for fabricating bacteria resistant multilayer coatings 
onto natural textiles, e.g. cotton and silk [151, 152]. Functional finishing of cotton fabric 
via the deposition of the oppositely charged chitosan and sodium tripolyphosphate 
resulted in the successful elimination of both Gram-positive and Gram-negative species 
[153]. Nevertheless the innate cationic charge of chitosan the differences in assembly 
conditions frequently define the amount of the active agent deposited on the surface, 
the coating thickness and rigidity, and therefore would affect the final antibacterial 
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performance of the material. To overcome these drawbacks quaternary ammonium 
salts bearing positive charge independent of the pH have been introduced to design 
surfaces with better bactericidal properties [138, 154, 155]. Quaternary ammonium salt 
of chitosan was successfully assembled with poly(acrylic acid) (PAA) on a plasma-
treated poly(ethylene terephthalate) to impart high antibacterial activity towards E. coli 
and S. aureus [156]. Quaternary ammonium and/or phosphonium salts of pyridoxine, 
alanine-derived gemini and fatty acids have also been introduced as potent broad 
spectrum antibiotic alternatives against Gram-positive and Gram-negative bacteria and 
viruses [157-161].  
Apart from the aforementioned compounds, cationic proteins and antimicrobial 
peptides have also been reported as common building blocks. LbL constructs 
comprising the lysozyme protein and negatively charged gold NPs, deoxyribonucleic 
acid (DNA) or pectin demonstrated a promising inhibitory effect towards both Gram-
negative and Gram-positive bacteria [162-164]. Positively charged antimicrobial 
peptide, defensin, was embedded within PLL and PGA multilayers to avoid the 
peptide’s chemical modification grafting and reach effective antibacterial concentrations 
on the surface. Improved antibacterial activity against Micrococcus luteus and E coli 
was achieved only for the PLL-terminated specimens, indicating that a positive surface 
charge was necessary for negatively charged bacteria to adhere and then interact with 
the incorporated antimicrobial peptide within the coating [165]. In another study, the 
authors designed homopolymer of methacrylamide bearing (oxidized) 3,4-
dihydroxyphenylalanine to insure faster layers assembly by covalent coupling with 
poly(allylamine) (PAH) and subsequent grafting of the peptide. The resulting layers 
showed durable functionality elimination B. subtilis upon the surface [166, 167]. Despite 
the advantageous of using contact-killing multilayers instead of a simple cationic layer, 
their action is restricted only to the surface. Moreover, the coatings will inevitably 
become contaminated by various types of proteins or will be buried under a layer of 
dead cells, leading to their deactivation [142, 168]. The remaining dead bacteria on the 
implants surface would trigger inflammation and immune responses. Antimicrobial 
leaching surfaces appeared the most promising alternative for controlling device 
related infections acting simultaneously on both sessile and planktonic bacteria [142]. 
Even so, the continuous release of biocides (e.g. silver ions and antibiotics), whether 
needed or not, may originate the emergence of resistant bacterial strains and 
undesirable side effect [169-171]. Various strategies for sustained and controlled-
release of the therapeutic agents have recently been developed to address this 
challenge (Figure 2.5).  
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Polyelectrolyte multilayer coatings have been widely explored as a platform for 
delivery of antibacterials on demand upon external stimuli such as pH, electric field and 
temperature [172-174]. Recently, bacteria and their metabolites have been proposed 
as polymer hydrolysing organisms, which can be turned into a robust trigger for 
antibacterial drug release in a self-defence principle [175]. Bacterial species produce 
acidic substances such as lactic and acetic acid that lead to a pH lowering in 
surroundings. Taking advantage of this phenomenon Zhuk et al. combined positively 
charged antibiotics gentamicin, tobramycin, and polymyxin B, with an oppositely 
charged tannic acid, into responsive coating that have a potential to mitigate bacterial 
infection occurrence. The main driving force for triggering the antibiotics elution from 
the material, when challenged with bacteria, is the protonation of tannic acid followed 
by charge imbalance and layers disassembly. Importantly, these self-defence LbL 
specimens were very stable and did not release the therapeutic cargos under 
physiological, infection-free conditions for more than one month [175]. In similar 
manner, gentamicin was assembled with poly(methacrylic acid) (PMMA) and PAA into 
stable coatings (up to several months) with potential to counteract S. aureus, S. 
epidermidis and E. coli surface colonisation only when needed [172, 176]. The changes 
in pH as a result of bacterial growth might also cleave the imine bonds or induce 
swelling of the coatings that will trigger the release of the incorporated active agents 
[172, 177].  
Bacteria as well produce enzymes hydrolysing the polyelectrolytes within the layers 
and therefore releasing the incorporated active agents. In contrast to the pH-triggered 
strategy, which is not species specific, the enzymatic degradation of assemblies would 
allow the targeting of specific bacteria. To date, only few enzyme triggered release 
coatings have been reported [142]. Multilayers of hyaluronic acid and chitosan have 
been shown to release the antimicrobial peptide cateslytin in presence of 
hyaluronidase, an enzyme secreted by variety of pathogens such as S. aureus and C. 
albicans [178]. In contrast to the other bactericide leaching surfaces, stimuli responsive 
micro and nanocoatings have the advantage to exhibit “on demand” their antibacterial 
activity and thus extend the useful life time of coatings decreasing the premature 
depletion of the drug reservoir [142, 179]. However, the elution of bactericides within 
the therapeutic window and the limitation of the non-triggered background release from 
the materials are the main issues to be addressed when engineering stimuli-triggered 
assemblies. Future research efforts should be also dedicated to test the effectiveness 
against repeated bacterial challenges as well as to generate more triggering pathways. 
It is worth mentioning that the drug release kinetics and the time scale over which the 
coating or material should be active are highly application-dependent. A short term, 
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high dosage release of antibacterial agents is generally preferred to control infection 
occurrence in early post-operation periods. In contrast, long lasting bacterial resistant 
properties are required for the implants that have to integrate successfully with the 
surrounding tissues.  
One of the most appealing characteristics of LbL deposition technique is the 
possibility to combine multiple therapeutic agents, e.g. classical antibiotics and/or novel 
antimicrobials, into hybrid multilayer coatings with complimentary modes of action. The 
combination of innovative and conventional antimicrobials, acting as a multiple lines of 
defences, is being put into practice to improve both the prophylactic and therapeutic 
efficacy and lower drug dosage, thus reducing toxic side effects [180]. The 
simultaneous or sequential delivery of each active principle can be achieved at the right 
time or specific stage of bacterial lifecycle by adjusting the chemistry of building blocks 
or embedding the active compounds within different levels in the coating [181, 182]. 
However, the synergism of several compounds is a relatively unexplored field for 
development of novel release-killing materials and surfaces that are highly effective in 
controlling both planktonic and sessile bacteria.   
Most of the reported multifunctional LbL constructs integrate simultaneously anti-
adhesive and bactericidal agents acting as multiple lines of defence against 
opportunistic pathogens. Sophisticated surface coating comprised of bacteria-repelling 
PEG as a top layer and releasable silver NPs (AgNPs) beneath has been engineered 
to simultaneously repulse and kill bacteria at the vicinity [183]. In a similar way, Li et al. 
generated dual-level bactericidal coating which consists of Ag+ ions reservoir made of 
20 bilayers of PAH and PAA and cationic top region of 10 bilayers of PAH and silica 
NPs (SiO2 NPs), previously modified with quaternary ammonium silane. These dual-
functional antibacterial coatings bearing both contact-killing and release-killing 
capacities significantly mitigated E. coli and S. epidermidis growth. The silver released 
from the coating reservoir provides a strong initial killing effect during the first few days 
of bacterial challenge, while the quaternary ammonium cations retained significant 
contact-killing activity after the depletion of Ag reservoir [184]. However, the release of 
biocides at high amounts frequently induces selection for resistant bacteria. Current 
researcher efforts are focused toward the generation of novel bacteria and biofilm 
resistant coatings using strategies that do not exert selective pressure on bacteria 
population and minimize the risk of resistance occurrence. Recently, the development 
of antibiofilm coatings based on molecules interfering with bacterial cell-to-cell 
communication and biofilm integrity, have been considered a valuable alternatives to 
prevent infections and tackle bacteria resistance threat.   
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2.7 Quorum Sensing Inhibitors in Next Generation Antibiofilm Coatings  
The development of novel anti-QS drugs that affect bacterial pathogenesis or biofilms, 
without killing or inhibiting their planktonic growth, has been gaining ground. Inhibition 
of bacterial cell-to-cell communication process is thought to allow the host defence 
system to eliminate non-cooperating (and hence less virulent) bacteria or substantially 
increase the effect of co-administered antibiotics at lower dosage [185]. Various anti-
QS strategies towards both Gram-negative and Gram-positive bacteria have been 
described. These approaches include compounds that may inhibit the signal 
production, inactivate the AIs in the extracellular environment or block the specific QS 
receptors. Despite the large number of synthetic compounds reported to act as anti-QS 
substances, only few of them have been used to design new generation biofilm 
resistant coatings on medical devices. Since the mechanism of action of these anti-QS 
based materials is not to kill bacteria, but to influence their ability to induce virulence 
and form sessile communities, they represent an exciting area of fundamental research 
that would provide new opportunities to control bacterial infections while minimising the 
selection for resistance. 
Macrocyclic peptides that block the agr system in S. aureus have been immobilised 
on glass slides, nonwoven meshes, or within absorbent tampons using the rapidly 
dissolving polymer carboxymethylcellulose. The peptide-loaded carboxymethylcellulose 
films released the active agent and inhibited by 95 % the agr QS system in reporter S. 
aureus suggesting their application as anti-infective agents able to block the agr 
controlled secretion of virulence factors and toxins, including the toxic shock syndrome 
toxin-1 (TSST-1) [186]. These coatings might be used further to treat the outer covers 
of tampons, wound dressings, or other objects to suppress toxin production and 
mitigate the severity of staphylococcal infections in clinical and personal care contexts. 
Although anti-QS strategies provide new routes for treating bacterial infections, 
including those caused by resistant strains, many challenges remain in terms of 
encapsulating, conferring appropriate chemical protection, and controlling the release 
of the quorum sensing inhibitors (QSIs) in their practical utilisation [187]. Kratochvil et 
al. has reported the generation of superhydrophobic coatings loaded with water-soluble 
and water-sensitive QSIs interfering with S. aureus virulence. The authors used 
nanoporous, polymer superhydrophobic coatings to host the peptide-based QSIs 
providing sustained release of the anti-infective agent into the surrounding media for 
long time periods. The released QSIs efficiently inhibited agr-based QS in pathogenic 
S. aureus for more than one month. Moreover, these non-wetting coatings can protect 
water-labile QSIs from rapid hydrolysis, thereby extending their useful lifetimes. 
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Importantly, the so formed anti-QS coatings were able to modulate the QS-controlled 
biofilm formation of S. aureus in vitro for prolonged periods without affecting the normal 
bacterial growth. This approach could prove suitable for the encapsulation, protection, 
and release of other classes of water-sensitive agents [187]. 
In addition to the synthetic AI analogues, natural compounds such as furanones are 
also interesting alternatives to overcome device associated infections of both Gram-
negative and Gram-positive bacteria. A few natural products have been shown to 
inhibit bacterial QS process and biofilm growth. For instance, halogenated furanones 
(fimbrolides) produced by red macroalga Delisea pulchra are among the most 
intensively studied natural QSIs able to inhibit the swarming motility of Serratia 
liquefaciens and bioluminescence production of V. fischeri and V. harveyi [188]. The 
furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H) produced by D. pulchra can 
also attenuate the swarming motility and biofilm formation of E. coli. Although natural 
furanones were shown to affect many QS regulated behaviours, they did not have high 
activity on pathogenic P. aeruginosa. Synthetic derivatives of furanones, however, 
showed improved survival time of mice infected with a lethal P. aeruginosa strain and 
ability to act on the QS process in other Gram-negative bacteria [65]. Based on these 
anti-virulence characteristics, the researchers focused their attention on the potential 
application of furanones as coatings that resist bacterial colonisation and biofilm 
formation on medical devices. For example, two different methods for covalent 
immobilisation of the 3-(10-bromohexyl)-5-dibromomethylene-2(5H)-furanone on 
biomaterials have been reported. Regardless the mode of surface functionalisation 
used in the study, co-polymerisation with a styrene polymer or grafting on catheter 
surface previously modified with PAA derivative bearing reactive azide groups, the 
furanone coatings significantly counteracted the establishment of drug resistant 
Staphylocccus epidermidis biofilm. In vivo results suggested that these furanone-
coated catheters might control bacterial infections up to 65 days, as demonstrated by 
the reduced number of living bacteria on the catheters [66]. In another work, furanones 
have been attached onto silicone oxide surfaces using N-(3-trimethoxysilylpropyl)-4-
azido-2,3,5,6-tetrafluorobenzamide (PFPA-silane) as a photoactive cross-linker. This 
immobilisation approach is considered as very useful, in particular for substrates and 
molecules that lack reactive functional groups [67]. However, the antibacterial and 
antibiofilm activities of these materials were not investigated.  
Dihydropyrrolones (DHPs) are synthetic analogues of halogenated furanones that 
interfere with bacterial communication without altering human cells viability. When 
these QSIs were immobilised on glass surfaces they efficiently inhibited the biofilm 
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formation of P. aeruginosa and S. aureus without affecting viability of free floating cells. 
The authors also demonstrated the potential of DPHs coated surfaces to repress by 72 
% the expression of green fluorescent protein, suggesting the existence of a 
membrane-based pathway for inhibition of the QS phenomenon in P. aeruginosa [189]. 
Furthermore, series of DHPs analogues were covalently attached to various surfaces 
via a Michael-type addition reaction. The DHPs-treated surfaces significantly 
decreased the biofilm occurrence by P. aeruginosa and S. aureus. Among all synthetic 
analogues - 5-methylene-1-(prop-2-enoyl)-4-phenyl-dihydropyrrol-2-one was identified 
as the one having broad spectrum activity and consequently was considered as an 
excellent candidate for the development of anti-infective materials and surfaces. 
Another group of natural compounds such as bromoageliferin, 3-indolylacetonitrile, 
and resveratrol with significant anti-QS activity have been also reported [185, 190-192]. 
For example, bromoageliferin, a marine natural product, possess antibiofilm activity 
against Gram-negative bacterium Rhodospirillum salexigens. Moreover, its simplified 
analogues 2-aminoimidazole (2-AI) derivative and 5-amido or 5-imido 2-
aminobenzimidazole (2-ABI) may affect the biofilm maturation in both Gram-negative 
and Gram-positive bacteria [185]. The plant auxin 3-indolylacetonitrile, phytoalexin 
resveratrol and related stilbene derivatives have been shown to disrupt bacterial QS 
process and consequently inhibit the biofilm growth of P. aeruginosa [191-193]. Frei 
and co-workers further investigated whether combining structural attributes of the 
above mentioned compounds into a simple molecular scaffold could result in molecules 
with improved antibiofilm and/or anti-QS properties. To explore their hypothesis, the 
authors synthesised a small set of stilbenes containing 2-AI or indole moieties and then 
assessed their efficiency in inhibiting P. aeruginosa biofilms. The results established 
the 2-ABI containing stilbenes as potent antibiofilm agents for the development of 
coatings to clear microbial infections and control other important aspects of bacterial 
behaviour, such as the ability to induce virulence and form drug resistant biofilms [185]. 
The most promising of all compounds, 5,6-dimethyl-2-aminobenzimidazole, was then 
encapsulated in thin films of biocompatible poly(lactide-co-glycolide) polymer on glass 
chips. The released QSI from the films was in sufficient amount to inhibit up to 75–90 
% the pathogenic biofilm formation of P. aeruginosa on the glass surface [194].  
Despite that the synthetic or natural QSIs based coatings were shown to have great 
potential to act as anti-infective agents and reduce the biofilms of various medically 
relevant bacterial species, the slow release of the inhibitor, in particular furanones, may 
limit their further biomedical application. Some furanones have the disadvantage of 
being extremely reactive and thus may be toxic and mutagenic to human cells. Thus, 
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the QSI dose and release kinetics should be carefully considered when designing 
materials for biomedical applications. Furthermore, several clinical strains may resist 
the action of these inhibitors, and the question arises as to whether the QSIs will meet 
the same fate as the antibiotics.  
 
2.8 Enzymes in Biofilms Prevention 
Enzymes – the ultimate green catalysis have been used to replace harsh chemicals, 
and improve efficiency of a wide variety of industrial processes, including food 
processing, textile finishing, biofuel manufacturing and etc. They also have been 
considered very effective in medical practice for aiding digestion, diagnosis purposes 
and disinfection in healthcare settings. Antimicrobial enzymes that: i) directly attack 
microorganisms, ii) interfere with signals and prevent biofilm formation, iii) disperse 
already mature biofilm structure, and/or iv) eliminate microorganisms through the 
production of biocides, emerged as promising alternative to create bacteria resistant 
materials and coatings.  
2.8.1  Quorum Quenching Enzymes 
Several enzymes have been reported to inactivate the AIs in Gram-negative bacteria 
and consequently inhibit the QS controlled target genes expression, a phenomenon 
known as quorum quenching (QQ) [195, 196]. Paraoxonases are enzymes originally 
found in mammalian cells, which enhance the ability of high-density lipoproteins to 
oxidize low-density lipoproteins and reduce the risk of atherosclerosis and other heart 
diseases. However, recent evidences infer their role as QQ agents able to hydrolyse 
the lactones derivatives of the AHL signals in pathogenic P. aeruginosa [197-199]. 
Acylase and lactonase are other known anti-QS active agents produced by various 
bacterial species that degrade respectively the amide bond and lactone ring of the 
AHLs QS signals and consequently act as anti-infective agents able to attenuate the 
pathogenicity of Gram-negative bacteria (Figure 2.6) [196, 200-202]. Human acylase 
has been also shown to degrade in vitro C4-HSL and C8-HSL AHLs signals and inhibit 
P. aeruginosa surface attachment through the QS interruption [203]. Besides, bacterial 
species as R. erythropolis, Burkholderia sp. GG4 are able to produce another group of 
QQ enzymes called oxidoreductases [196, 204]. These enzymes modify the AHLs by 
oxidising the 3C keto group of the acyl side chain into hydroxyl group [204] (Figure 
2.6). Upon this modification, AHL fails to bind with the cognate transcription regulator 
and then “confuse” bacterial pathogens in their talk for establishing strong sessile 
community [196].   
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Figure 2.6 Enzymatic degradation of AHL signals by lactonase, acylase and oxidoreductase. 
 
Although their great potential in inhibiting bacterial QS regulated virulence and biofilm 
growth, the surface functionalisation with QQ enzymes is still at its preliminary stage, 
mainly because of the loss of activity as a result of enzyme inactivation during the 
immobilisation process. For example, QQ acylase has been immobilised into 
magnetically separable mesoporous silica via a two-step process of enzyme adsorption 
and cross-linking. The activity of the cross-linked acylase in the silica was stabilized by 
the combination of two different mechanisms that involve the prevention of enzyme 
denaturation due to multipoint covalent linkages formed upon enzyme cross-linking and 
“ship-in-a-bottle” approach, which inhibits the leaching of cross-linked enzymes through 
the bottleneck mesoporous structure of magnetically separable mesoporous silica. 
Moreover, the coatings efficiently alleviated the maturation of P. aeruginosa PAO1 
biofilm on silica surface over several weeks [205]. Such enzyme-based approach, 
disrupting bacterial QS through the degradation of the signals in the extracellular 
environment, is believed to provide less selective pressure on the population to 
become resistant, therefore appears as a valuable alternative to the conventional 
antibiotic treatment for prevention of biofilm-related infections. However, in vivo the QQ 
activity might be significantly affected decreasing the total efficiency of the developed 
anti-infective coatings.  
2.8.2 Matrix-degrading Enzymes  
Bacteria naturally produce bioﬁlm dispersal agents that assist them to detach and 
colonize new sites. Several agents important for biofilm dispersal have been identiﬁed 
including D-amino acids, cis-2-decenoic acid, nitric oxide, some naturally occurring 
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peptides and enzymes [206]. The enzymatic degradation of the biofilm matrix affects its 
physical integrity and increases the susceptibility of the encased bacteria to 
antimicrobials. Hence, polysaccharides, eDNA and proteins, the most important 
adhesive components of the matrix, appear as attractive targets for controlling bacterial 
biofilms in clinical settings. Several enzymes including glycosidases, proteases, and 
deoxyribonucleases are considered as matrix-degrading enzymes capable to inhibit 
biofilm maturation, detach pre-formed biofilms, and most importantly, increase the 
susceptibility of pre-formed biofilms to antibiotics and biocides in vitro [206].  
One of the most studied matrix-degrading enzymes is dispersin B, which is a 
glycoside hydrolase produced by the periodontal pathogen Aggregatibacter 
actinomycetemcomitans. Dispersin B degrades the matrix poly-N-acetylglucosamine 
polysaccharide that mediates the attachment to abiotic surfaces and the intercellular 
adhesion of A. actinomycetemcomitans, as well as, plays a key role in bacterial 
resistance to detergents and human phagocytic cells [207]. This matrix-degrading 
enzyme has been loaded in surface-attached polymer matrices built in a LbL fashion. 
The LbL matrices were assembled through electrostatic interactions of PAH and PMMA 
followed by chemical cross-linking with glutaraldehyde and pH-triggered removal of 
PMMA producing a stable PAH hydrogel matrix used for loading of dispersin B. These 
enzyme loaded coatings inhibited by 98 % the biofilm development of two clinically 
relevant S. epidermidis strains, without affecting the attachment and growth of cultured 
human osteoblast cells [208]. Catheters coated simultaneously with dispersin B and 
triclosan showed synergistic antibiofilm activity inhibiting in vitro the surface 
colonisation by S. aureus, S. epidermidis, E. coli and C. albicans. Moreover, these 
materials demonstrated high in vivo efficacy against biofilms of S. aureus [209].  
Enzymes degrading the biofilm eDNA, such as deoxyribonuclease I, have been also 
used to develop antibiofilm surfaces. Coatings comprised of deoxyribonuclease I have 
been formed on polymethylmethacrylate using dopamine as an intermediate. The 
resulting materials significantly decreased the adhesion of Gram-positive S. aureus and 
Gram-negative P. aeruginosa and inhibited the biofilm formation, without affecting 
mammalian cells adhesion and proliferation. Despite the high effectiveness of the 
coatings, the enzymes lost significant part of their catalytic activity after 24 h, being 
applicable only for short-term biomaterial implants and devices [210].  
Alginate lyase is another example of antibiofilm enzyme that cleaves β-glycosidic 
bonds of matrix alginate and possess capacity to control P. aeruginosa colonisation on 
the respiratory tracts in patients with cystic fibrosis [211]. Combination of this enzyme 
with antibiotic demonstrated higher efficacy in treating P. aeruginosa infections, 
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particularly in the cystic fibrosis airway [212]. Genetically engineered alginate lyase- 
PEG conjugates removed more than 90 % of the mucoid P. aeruginosa biofilm from 
abiotic surfaces following one hour treatment, whereas the wild type enzyme neutralize 
only 75 % of the biofilm. While biofilms in the human airway have properties distinct 
from those grown on abiotic surfaces, the fact that lyase-PEG conjugates eradicated 
the mucoid biofilms, suggested that the matrix-degrading enzymes could yield 
therapeutic benefits in the treatment of cystic fibrosis [213].  
Furthermore, combinations of several matrix degrading enzymes have been shown 
to achieve better results, compromising the ability of various bacteria to establish 
antibiotic resistant biofilms. Co-administration of deoxyribonuclease I and alginate 
lyase, for instance, enhanced the activity of aminoglycoside antibiotics, gentamicin and 
tobramycin, against P. aeruginosa. In addition, during the treatment of biofilms and 
cystic fibrosis sputum containing P. aeruginosa, the conventional and liposomal 
aminoglycosides were strongly inhibited and their activity was restored when 
deoxyribonuclease I and alginate lyase were introduced [214]. Mixtures of protein (e.g. 
serine proteases) and polysaccharide degrading enzymes (e.g. alpha-amylase, β-
glucuronidase and dextranase) have also been reported to remove biofilms from 
numerous surfaces, thus being a valuable alternative to conventional antibiotic therapy 
[215, 216]. However, their simultaneous incorporation in materials or immobilisation on 
the surface of medical devices is not much investigated.  
2.8.3 Enzymes Targeting Bacterial Cells  
Lysostaphin is an example for an antibacterial enzyme capable of cleaving the cross-
linking pentaglycine bridges in the cell walls of Staphylococci. This antimicrobial 
enzyme has been covalently attached via polydopamine onto a variety of surfaces and 
even after immobilisation preserved its endopeptidase activity on the staphylococcal 
cell wall. Lysostaphin-coated surfaces were found to kill hospital strains of S. aureus in 
less than 15 min and prevent biofilm formation [217]. Lysostaphin has been also 
immobilised on carbon nanotubes. The enzyme–carbon nanotube conjugates have 
been successfully incorporated in polymer matrices producing composite materials 
capable to reduce protein adsorption and bacterial adhesion [130, 218]. This 
antibacterial and antibiofilm active enzyme was also used in formulations for direct 
intraperitoneal or subcutaneous administrations. Lysostaphin administration cured S. 
aureus infected mice whereas S. epidermidis isolates resistant to methicillin were 
effectively controlled by combination of nafcillin and lysostaphin [215, 219, 220]. 
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Coatings comprised of another well-known antimicrobial enzyme, lysozyme, have 
been lately investigated. Lysozyme coupled to PEG layer was reported to act against 
both Gram-negative and Gram-positive bacterial species [221]. Conjugates composed 
of this enzyme and synthetic triblock copolymer with a central polypropylene oxide 
block and two terminal polyethylene oxide segments, noted as pluronic F-127, also 
showed high antibacterial activity towards Gram-positive Bacillus subtilis. Further, 
deposition of the pluronic-lysozyme conjugates on a hydrophobic surface resulted in 
formation of layers adopting bifunctional brushes with both anti-adhesive and 
antibacterial properties. The number of colony-forming units present on surfaces was 
reduced to 30% for the coatings based on pluronic–lysozyme conjugates as compared 
with coatings of unmodified pluronic, i.e. without lysozyme [222]. Lysozyme was also 
successfully grafted onto stainless steel surfaces pre-functionalised with an amino-
(propyl)-triethoxysilane through a glutaraldehyde cross-linker. However, the enzyme in 
these coatings showed 20 times lower anti-adhesive activity towards Micrococcus 
lysodeikticus than the one observed in solution, due to the mode of surface grafting 
impairing the accessibility of the enzymatic active site to bacteria [223]. In the same 
study, lysozyme was further immobilised on an amino-enriched poly(ethylene imine) 
pre-activated stainless steel surface through a bifunctional PEG spacer with terminal 
aldehyde groups. The so-modified surfaces prevented bovine serum albumin (BSA) 
adsorption and the adhesion of Listeria ivanovii and M. luteus.  
Through these examples, we have highlighted that most enzymes immobilised onto 
surfaces maintain their antibacterial and antibiofilm activities. Nevertheless, this activity 
may vary considerably (being generally lower) compared to the one observed for the 
enzyme in solution. It is possible, however, to increase significantly the activity of a 
given enzyme towards bacteria by varying the immobilisation conditions, e.g. the 
nature and the conformation of the spacer between the surface and the enzyme. 
Although these enzyme-based approaches showed promising results, there are still 
several limitations. The enzymatic inhibition and eradication of biofilms usually depend 
on the nature of the matrix constituents, being different among the clinical isolates. In 
vitro and in vivo evidences showed that some Staphylococcus species may form 
biofilms without the poly-N-acetylglucosamine while in presence of urea P. aeruginosa, 
for example, does not produce alginate containing matrices [109, 224]. In these cases, 
other matrix components, e.g. proteins or eDNA, substitute the exopolysaccharide in 
the biofilm matrix. Moreover, the in vivo efficacy of such approaches is not well 
established and treating host with proteins could cause inflammatory and allergic 
reactions, further affecting their therapeutic potential. The immobilisation methods may 
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also affect protein conformation resulting in loss of the enzymatic activities [225]. 
Finally, the still elevated cost of industrial enzymes reduces the feasibility of their large-
scale application as antibiofilm agents.  
2.8.4 Enzymes Producing Biocides 
Besides of targeting the degradation or inactivation of essential biofilm components, 
enzymes may elicit antimicrobial reactions through the production of hydrogen 
peroxide, which destroys the invading pathogens. In general, hydrogen peroxide kills 
bacterial cells through peroxidation and disruption of cell membranes, oxidation of 
oxygen scavengers and thiol groups, and disruption of protein synthesis [226]. 
Hydrogen peroxide-producing enzymes such as glucose oxidase and cellobiose 
dehydrogenase (CDH) can reduce the growth of both Gram-negative and Gram-
positive bacteria, therefore they are widely exploited in the food industry, for the 
development of biosensors, bleaching systems, and continuous antioxidant 
regenerating systems [227-229]. Despite the extensive use of glucose oxidase as 
antimicrobial agent, the requirement for glucose as a substrate is an important 
drawback, because glucose is also a growth substrate for most microorganisms. In 
contrast, CDH can oxidize cello-oligosaccharides (including cellobiose) that are not 
considered essential compounds for the pathogenic bacterial growth. A novel in situ 
antimicrobial and antibiofilm approach based on CDH was able to generate H2O2 in the 
presence of cellobiose or other biofilm exopolysaccharides, thereby preventing the 
microbial colonisation on silicone urinary catheters. Recombinant CDH produced by 
Myriococcum thermophilum was shown to inhibit the growth of many common 
microorganisms colonizing the urinary catheter surfaces such as multidrug-resistant E. 
coli, S. aureus, S. epidermidis, P. mirabilis, Stenotrophomonas maltophilia, 
Acinetobacter baumannii and P. aeruginosa in presence of cellobiose as a substrate. 
Interestingly, CDH was also able to produce H2O2 during the oxidation of extracellular 
polysaccharides formed by bacteria in absence of cellobiose. Further combination with 
glycoside hydrolases enhanced CDH antimicrobial and antibiofilm activity by the larger 
amount of H2O2 produced. Moreover, CDH incorporated in catheter lubricants killed 
bacteria in biofilms already established on silicone catheters [230]. In another study, 
CDH was grafted onto plasma-activated silicone catheters reducing the amount of 
viable S. aureus cells and bioﬁlm formation under both static and dynamic conditions 
by 60 and 70 %, respectively. The CDH coated surfaces did not affect the growth and 
physiology of mammalian cell lines (HEK-293 and RAW 261.7) suggesting their 
application to control the CAUTIs [231]. The enzyme was also embedded into 
multilayer assemblies comprised of PSS and synthetic antifouling copolymer bearing 
 34 
 
zwitterionic and quaternised groups. The production of antibacterial and antibiofilm 
effective H2O2 by the CDH coated catheters depended on the enzyme location within 
the structure and the percentage of the zwitteionic fraction [232]. CDH-NPs of varying 
sizes (from 50 to 100 nm) have been generated in situ and subsequently deposited 
onto the silicone surface using ultrasonic waves. The immobilised CDH-NPs effectively 
produced in situ H2O2 able to reduce the amount of viable S. aureus cells as well as the 
total amount of biomass deposited on the urinary catheter [233]. 
Haloperoxidases (e.g. myeloperoxidase, lactoperoxidase and haloperoxidase) are 
another type of antibacterial enzymes, found in many plants, animals and humans. 
They use H2O2 as a substrate to oxidize halide/pseudohalide to more potent 
antimicrobials towards many bacterial species in both planktonic and sessile forms 
[234]. Horseradish peroxidase and glucose oxidase were incorporated in polyurethane 
electrospun fibers and significantly affected the growth of both E. coli and S. aureus 
[235].  
An important feature that should be mentioned is the fact that enzymes generating 
biocides must be submitted to the appropriate legislation before being implemented. 
Moreover, the enzymes may also contribute to the unwanted degradation of biological 
compounds present in the surrounding of the material. 
 
2.9  Nanomaterials for Controlling Bacterial Biofilms 
Nanomaterials have emerged as a potential platform that may solve limitations of 
traditional therapies such as low specificity and therapeutic efficacy. They exhibit 
unique physical and chemical properties at nanometre scale which frequently differ 
from their bulk counterparts [236]. The utility of nanotechnology as a tool to enhance 
clinical effectiveness of drugs and fight antibiotic resistance mostly rely on liposomes, 
nano/microcapsules and nano/microparticles as drug carriers for delivering the 
antibacterial agents at the site of infection [237]. The transformation of the active 
agents themselves into nanosize therapeutic entities with improved antibacterial and 
antibiofilm features has been only sparsely reported [238]. We have reported that 
antibacterial NPs of cationic biopolymer derivatives such as thiolated chitosan or 
aminocellulose were more effective than the biopolymer itself killing planktonic bacteria 
via the disturbance of the cell membrane [147]. However, preventing biofilm infections 
or treating the pre-existing biofilm is much more challenging. Numerous metals, metal 
oxides, hybrid polymer-metal and biopolymer nanomaterials have been suggested as 
next generation materials with high capacity against biofilm resistant bacterial 
 35 
 
phenotypes. Their high effectiveness is mainly because of the NPs ability to penetrate 
into the EPM and act on bacterial cells within the biofilm depths [239]. 
Besides acting as therapeutics able to eradicate already developed biofilms, NPs 
may be also used for prevention of bacterial infections. Their deposition onto surfaces 
prone to bacterial colonisation and biofilm formation is thought to significantly reduce 
the growth rate or inhibit the formation of drug resistant cells communities. Methods as 
ultrasound sonochemistry, ultraviolet (UV) irradiation and LbL assembly have been 
used to generate NPs and/or incorporate them into functional materials or coatings 
[240, 241].  
2.9.1 Sonochemistry for Synthesis of Nanoparticles  
Varieties of methods have been described for the preparation of nanostructures with 
desired size, size distribution and morphology/shape. Some of the most common 
techniques used to prepare stable colloidal NSs and nanocapsules (NCs) include 
coacervation and phase separation, emulsification diffusion, solvent displacement and 
solvent evaporation, sol-gel encapsulation, supercritical fluid technology, spray drying 
and spray congealing [242]. Synthesis of polymeric nanoscale materials by ultrasound 
emulsification is an area of considerable interest to obtain biopolymer and protein 
based nano/microcapsules with altered physical properties and novel biological modes 
of action [243-245].  
The use of sonochemical technology for generation of nanostructures is justified by 
its simplicity (one-step process), fastness and absence of aggressive organic solvents 
[246]. The ultrasound emulsification involves high intensity mixing of aqueous and 
organic solutions comprising either hydrophilic compounds for accumulation in the shell 
or hydrophobic actives for encapsulation in the NCs core. Indeed, the ultrasound 
assisted NPs generation is a combination of two acoustic phenomena, emulsification (a 
physical effect) and cavitation (the subsequent chemical effects). Sonication creates an 
emulsion with polymers in the oil/water interface [245]. However, emulsification alone is 
not sufficient to prepare stable colloidal particles. The ultrasonic irradiation of liquids 
produces acoustic cavitation comprised of formation, growth, and implosive collapse of 
bubbles. The collapse of these bubbles forms hot spots with very high temperature and 
induces water sonolysis that leads to free radicals production (e.g. HO.2). In protein 
NPs synthesis these radicals provoke disulphide bonds formation between cysteine 
thiol groups and stabilise the resulting core/shell system [245, 246]. Besides hydrogen 
bonding, van der Waals, hydrophobic, and electrostatic interactions have been also 
involved in the successful synthesis of polysaccharides, antibiotic and protein-based 
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NPs, without cysteine amino acids in their structure. Ultrasonic irradiation is very 
attractive technique for generation of variety of materials including NP coatings on 
medical devices and textiles for infection prophylaxis and formulations for complete 
bacterial/biofilm elimination.  
2.9.2  Nanoparticles Interaction with Bacteria and Biofilms 
Entire biofilm elimination requires efficient penetration and accumulation of the particles 
into the biofilm structure [236]. The NP-biofilm interactions are complex and can vary 
during the time of the treatment. Upon attachment NPs, smaller than 10 nm, easily 
diffuse through pores sizes in the biofilm structure and access the cells. Then the 
particles may affect the membrane integrity, inactivate the surface proteins or develop 
spatiotemporal aggregation patterns on Gram-positive and Gram-negative bacteria 
causing cells lysis and death (Figure 2.7) [247]. NPs deposition within the biofilms and 
consequently the interaction with the building blocks depends on the electrostatic 
interactions and heterogeneity of the charges across the entire biofilm structure [236, 
248]. For instance, cationic quantum dots functionalized with hydrophilic moieties were 
able to pass the matrix barrier and accumulate inside bacteria, whereas hydrophilic 
groups leaded mainly to their distribution in the EPM surrounding the cells [249]. The 
electrostatic interactions are more relevant for metal NPs, whereas surface properties 
such as steric effect manifests in the interplay between the matrix components and 
polymeric or lipid NPs [250-252].  
The diffusion of NPs into the biofilms matrix could be significantly hindered by the: i) 
size of the EPM pores, ii) presence of high repulsive forces between oppositely 
charged NPs and biofilm matrix components, iii) different hydrophobicity of the 
surrounding environment, and iv) existence of chemical gradients within the EPM [239, 
253, 254]. Capping the NPs surface with small ligands or polymers such as 
polysaccharides, PEG and glycolipids except to increase the suspensions stability, 
might also tune NPs surface functionality and alleviate their cellular/biofilm 
internalisation and biocompatibility. Amino-decorated SiO2 NPs were engineered to 
penetrate and eradicate pathogenic P. aeruginosa and E. coli biofilms through the rapid 
release of the bactericidal payload [255]. In another study, biodegradable lignin NPs 
infused with silver ions were coated with a cationic poly(diallyldimethylammonium) 
chloride to develop green alternative to AgNPs that killed a broad spectrum of bacteria, 
including quaternary amine-resistant strains [256]. Triblock copolymer structure 
consisting of poly(D,L-lactic-co-glycolic acid)-b-poly(L-histidine)-b-poly(ethylene glycol) 
was transformed into pH-responsive NPs that released antibiotic vancomycin only in 
presence of S. aureus at antibacterial effective concentrations [257]. Similarly, pH-
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responsive polymer-based NPs have been reported as novel carriers of hydrophobic 
drugs for treatment of antibiotic resistant bacterial communities. These NPs have a 
cationic outer shell to stick with the biofilm polysaccharides and a pH-responsive 
hydrophobic inner shell to release encapsulated antibacterial farnesol on demand 
[258]. The simultaneous application of matrix degrading enzymes and NPs could have 
been also proposed as an alternative method facilitating the NPs diffusion and the cells 
removal from tissues or materials [259].  
The biocompatibility of nanomaterials, however, is an essential characteristic for their 
therapeutic application. In principle, cationic particles or particles with a high surface 
reactivity and smaller size are toxic, while large and hydrophobic NPs are less harmful 
to the human cells [253]. The undesirable absorption of organic molecules (e.g. 
proteins form the matrix or host) and the possible reduction of the antibacterial and 
antibiofilm properties of the NPs should be taken into consideration [260].  
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Figure 2.7 Schematic representation of the mechanisms involved in the NPs (red circles) 
interaction with free floating and sessile bacterial cells. In mature biofilms the NPs efficiency is 
altered by the exchange with matrix compounds resulting in NPs aggregation or interfacial 
interaction with biofilm cells (adapted from [247]). 
 
2.9.3 Metal and Metal Oxide Nanoparticles  
Metal and metal oxide NPs are widely used for controlling bacterial biofilms. The 
underlying mechanism of killing, when bacteria exist in the form of biofilm, differs from 
the antibacterial action of metallic NPs on the free floating cells. The unique surface 
moieties, shape, size, and aggregation propensity of the particles together with the 
biofilm tolerance to most antibacterials add significant complication in understanding 
NP-biofilm interactions. For example, while AgNPs and starch-stabilised AgNPs could 
eradicate individual E. coli cells, their effect on the sessile bacterial communities was 
significantly reduced. The authors suggested that the biofilm resistance is a result of 
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lower stability and particles aggregation within biofilms, which is attributed to the 
differences in ionic strength [247, 261, 262]. In another study, however, colloidal 
suspension of AgNPs prevented bacterial attachment and biofilm growth on model 
surface and even after incorporation into plasma-deposited layers of allylamine or 
hydrocarbon matrices the effect was not decrease [263, 264]. Implants coated with 
AgNPs also resisted the biofilm growth without silver accumulation in host tissues of 
rabbits, suggesting the great potential of the particles in preventing bacterial infections. 
[265].  
Once inside the cells, metallic NPs, either by themselves or by the released ions, 
may interact with proteins, DNA or RNA molecules, inhibiting essential cellular 
functions [266]. The NPs have preferential binding sites in sulfur and phosphorous-
containing proteins and enzymes, modifying their activity and leading to cell death 
[267]. They may generate reactive oxygen species (ROS) and induce cell damage and 
death. Some nanostructured materials possess multiple antimicrobial mechanism of 
action which significantly reduce the risk of drug resistance development [268]. Despite 
the promising results metal and metal oxide NPs can be toxic for human cells [269].  
The formation of hybrid polymer-metal NPs was shown to increase significantly the 
NPs stability, biocompatibility and antibacterial activity [270]. Polymer-Ag bromide NPs 
and hydrogels containing AgNPs have been prepared showing strong inhibitory activity 
on both planktonic and biofilm forms [271, 272]. Permanent immobilisation of these 
hybrid polymer-metal NPs onto different surfaces is of great interest for durable 
antibiofilm effect [273]. In our group, hybrid Ag/chitosan system has been generated 
and then enzymatically grafted on the surface of cork. These particles synergistically 
inhibited of S. aureus and E. coli bacterial growth [273]. On the other hand, Li et al. 
constructed Ag containing polymer coatings with dual-function: chemical-releasing 
bacteria-killing capacity and contact bacteria-killing [184]. 
Copper oxide and zinc oxide (ZnO) NPs with excellent bactericidal effect against the 
common pathogens E. coli and S. aureus have been also reported. They were able to 
inhibit the biofilm growth most probably due to the generation of ROS or damage of the 
proteins involved in biofilms adhesion and formation [240]. The antimicrobial properties 
of copper have been observed also in other studies.  
The antimicrobial activity and cytotoxicity of ZnO NPs have been also widely 
investigated in the last years. Nair et al. prepared polyethylene glycol-capped ZnO NPs 
that showed even higher antimicrobial efficacy when the particle size was reduced 
[274]. In other in vitro studies on the antibacterial action of ZnO NPs alone and in 
combination with a biopolymer, the great potential of these materials to prevent drug 
resistant biofilm occurrence was also demonstrated [275]. ZnO NPs-coated fabrics, for 
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instance, showed a differential antimicrobial activity against medically relevant S. 
aureus and E. coli inhibiting their growth by 67 % and 100 %, respectively [276]. 
Furthermore, the functionalisation of textiles with hybrid ZnO-chitosan NPs resulted in 
enhanced antibacterial efficiency against S. aureus and E. coli even at low ZnO 
concentration, compared to the individual ZnO and chitosan coatings. The presence of 
biocompatible polymer in the hybrid chitosan-ZnO NP reduced the cytotoxic effect of 
Zn, avoiding the risk of adverse effects on human health [277]. Recently, combinations 
of antibacterial metal NPs - ZnO and MgF2 NPs, were used to synergistically inhibit the 
S. pneumoniae and S. aureus biofilms on cochlear implants [278]. Biocompatibility 
studies demonstrate that the antibiofilm active metal NPs coating do not exert toxicity 
toward primary human ﬁbroblasts from the auditory canal. These ﬁndings underscore 
the potential of using NP combinations to efﬁciently inhibit bacterial colonisation and 
growth on medical devices. 
2.9.4 Nanoantibiotics  
Despite some promising results, most of the above discussed antibacterial agents may 
induce cytotoxicity and inflammatory responses limiting their clinical applications. 
Nanoantibiotics (NPs of antibiotics) are new antibacterial agents able to solve these 
drawbacks and improved the efficiency of antibiotics against drug resistant bacteria 
[279]. For example, penicillin, discovered in 1928, is still in use despite of its limited 
bactericidal effect towards antibiotic resistant bacterial strains. In order to renew the 
interest in this antibiotic, Yariv et al. synthetised penicillin NPs that showed higher 
bactericidal effect on S. aureus compared to the bulk form [280]. Nystatin is an 
example of nanoencapsulated antibiotic showing superior in vitro growth inhibition 
toward C. albicans compared with conventional nystatin in solution [281]. Tetracycline 
(TET) is a broad-spectrum antibiotic that increased its bactericidal effect against both 
TET sensitive and TET resistant bacterial strains after sonochemically induced 
transformation into NPs (TETNPs) [238]. TETNPs have been also deposited on 
graphene oxide sheets by a facile one-step sonochemical technique. Sonochemically 
synthesised graphene oxide/TET composite showed an enhanced activity against both 
sensitive and resistant S. aureus compared to the same concentration of non-
transformed TET [279]. Sonochemistry was also used to simultaneously generate and 
deposit TETNPs onto parylene-C coated glass slides with potential to counteract 
pathogenic bacterial growth. In another study, TET has been loaded in microspheres of 
BSA [282]. TETNPs and TET-BSA microspheres showed high bactericidal effect 
against E. coli and S. aureus. Liposomes have also been used as carriers with 
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elevated effectiveness and safety of several antibiotics, such as amikacin [283], 
ciprofloxacin, meropenem, and gentamicin [284].  
Nano-size transformation of clinically relevant antibiotics can be a facile method to 
improve the infection treatment, as an alternative to the rather time- and resource-
consuming screening for new drugs. Moreover, the most common strategies rely on 
chemical modification of the obsolete antibiotics that does not change their interaction 
with the bacterial targets. Therefore, the underlying resistance mechanisms are still 
present. The produced nanoantibiotics are meant as novel antimicrobial agents with a 
broad-spectrum of activity, relying on a mechanism of action that comprises bacterial 
membrane disturbance and easy penetration into the biofilm structure. Further 
combination with other antibiofilm agents including QSI, enzymes, and AMPs might 
allow the development of hybrid antimicrobials able to address both the ‘’evolutionary’’ 
and “cooperatively” acquired antimicrobial resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
3 Objectives of the Thesis 
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The overall objective of this thesis is to develop materials and coatings for 
prevention or eradication of biofilm-related bacterial infections. Novel strategies 
for counteracting bacterial growth and biofilm establishment will be adopted based on 
the mode of their action either on the biofilm matrix and signalling molecules or 
bacterial cells membrane. These approaches have advantages over the known 
methods because effectively reduce bacterial spread on the surface of interest without 
the use of antibiotics, thereby having a great potential to minimise the selection for 
resistant emergence.  
 
To achieve the main goal of the thesis, the following specific objectives have been 
set up:  
i) To develop stable at use multilayer coatings comprising the QS disrupting 
enzyme acylase on silicone urinary catheters using LbL technique. The 
main advantage of this approach is that it might attenuate bacterial 
virulence exerting less selective pressure on bacteria and reducing the 
risk of resistance development. The pathogen may fail to establish 
infection and could be eliminated by the host immune system without the 
need of harsh antibiotic treatment.  
ii) To design novel integrated strategies to coat indwelling medical devices in 
order to impart specific surface activity toward bacterial biofilms. The 
approach relies on multilayer assembling of QQ enzyme, able to interrupt 
the communication among bacteria and matrix-degrading enzyme targeting 
the extracellular matrix polysaccharide. Considering the key stages of the 
biofilm formation, the combination of both enzymes into hybrid 
nanocoatings is expected to enhance their antibiofilm activity  against 
medically relevant bacteria in vitro and in vivo. 
iii) To engineer self-defensive surface coatings that release on demand 
bactericidal biopolymer NSs. Polycationic AC will be sonochemically 
processed into polymer NSs with improved antibacterial and antibiofilm 
potential against common Gram-negative pathogens found in catheter 
related infections. The processed NS will be then assembled into multilayer 
coatings on silicone catheters and their ability to eradicate bacteria and 
prevent the biofilm formation in an in vitro model of catheterised human 
bladder will be assessed. 
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iv) To permanently embed antimicrobial polycationic NSs on silicone 
through epoxy/amine grafting. The NSs decorated materials will 
counteract bacterial attachment and biofilm growth and therefore might have 
potential as a platform for prevention of biofilm infections on silicone based 
materials and implants. 
v) To transform sonochemically into nano-form a clinically relevant 
antibiotic as a facile method to create broad-spectrum bactericidal 
drugs. The nano-size antibiotic is expected to physically interact with the 
bacterial cell wall and demonstrate higher antibacterial and antibiofilm 
activities against Gram-negative bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 Materials and Methods 
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4.1 Materials and Reagents  
Acylase from Aspergillus melleus (4.5 % (w/w) protein content and 0.05 U/mg specific 
activity) and α-amylase from Bacillus amyloliquefaciens (32 mg/mL protein content and 
20 U/mg specific activity), both purchased from Sigma-Aldrich (Spain), were used as 
QQ and matrix degrading enzymes, respectively. QS signalling compounds of Gram-
negative bacteria including N-Butyryl-DL-homoserine lactone (C4-DL-HL), N-Hexanoyl-
DL-homoserine lactone (C6-DL-HL), N-(3-Oxodecanoyl)-L-homoserine lactone (3-oxo-
C10-L-HL) and N-(3-Oxododecanoyl)-L-homoserine (3-oxo-C12-L-HL) were also 
obtained from Sigma-Aldrich (Spain). AlamarBlue® Cell Viability Reagent and 
Live/Dead® BacLight™ kit (L7012) were purchased from Invitrogen, Life Technologies 
Corporation (Spain).  
Medical grade chitosan (15 kDa) was obtained from Kytozyme (Belgium). Cationic 
derivative of cellulose, 6-deoxy-6-(ω-aminoethyl) aminocellulose (AC, ~15 kDa), was 
synthesised from microcrystalline cellulose (Fluka, Avicel PH-101) via a tosyl cellulose 
intermediate, using a previously described procedure [273, 285]. Negatively charged 
hyaluronic acid (HA) with average Mw~750 kDa was obtained from Lifecore Biomedical 
(USA) in the form of its sodium salt, whereas a 25 kDa linear polyethyleneimine (PEI) 
bearing a positive charge was purchased from Polysciences, Inc., (Spain). 
Polydimethyl/vinylmethyl siloxane (PDMS) urinary (Foley) catheters and strips from 
the same material, defined by the ASTMD 1418 standard, were provided by Degania 
Silcone Ltd. (Israel). All other chemical and microbiological reagents were purchased 
from Sigma–Aldrich unless otherwise specified. 
 
4.2 Bacterial and Human cells  
Proficient in biofilm formation bacteria P. aeruginosa (ATCC® 10145™), E. coli (ATCC® 
25922™), and S. aureus (ATCC® 25923™), and human foreskin fibroblast cells (ATCC® 
CRL-4001™, BJ-5ta) were obtained from American Type Culture Collection (ATCC, 
LGC Standards S.L.U, Spain). C. violaceum (CECT 5999), a mini-Tn5 mutant of C. 
violaceum (ATCC® 31532™) which cannot produce violacein without exogenous 
addition of AHLs, was purchased from Spanish Type Culture Collection (CECT, Spain).  
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4.3 Experimental Methods 
4.3.1 Enzymatic Degradation of Biofilm Components 
4.3.1.1 Acylase Assisted Degradation of Bacterial Quorum Sensing 
Signals  
The degradation of several QS signals of Gram-negative bacteria as C4-DL-HL, N- C6-
DL-HL, 3-oxo-C10-L-HL and 3-oxo-C12-L-HL by acylase was carried out as follows: 30 
µg/mL of each AHL compound and 2.16 U/mL of the enzyme were incubated in 100 
mM tricine buffer pH 8 for 15 min at 37 ºC in a thermo-shaker bath. The resulting 
degradation products were analysed by a fluorescamine fluorimetric assay and C. 
violaceum CECT 5999 bioassay. In the fluorimetric quantification assay, 150 µL of the 
reaction mixture containing HL was added to 50 µL of fluorescamine reagent (3 mg/mL 
in dimethyl sulfoxide, DMSO) and after incubation at room temperature (RT) for 3 min 
the fluorescence at 390/470 nm was measured. The amount of HL released in the 
enzymatic reaction was calculated from the calibration curve built with α-amino-γ-
butyrolactone hydrobromide as a standard.  
In the C. violaceum bioassay only the degradation of C6-DL-HL by acylase was 
tested. C. violaceum is a mutant that produces a purple pigment, called violacein, only 
in the presence of AHLs. The most easily detectable AHL is C6-DL-HL, whereas the 
sensitivity to the other model compounds is different depending on their structure [286]. 
Before performing the bioassay, the products from the reaction mixture were extracted 
three times with ethyl acetate as previously described [287]. The organic phase was 
then evaporated to dryness and the sample reconstituted in 300 µL methanol. 
Thereafter, 60 µL of the reconstructed sample were tested for the presence of AHLs by 
C. violaceum bioassay. The sample solutions were pipetted into wells (Ø = 7 mm) 
punched in the LB agar (supplemented with 25 µg/mL kanamycin) and the plates were 
incubated at 26 °C for 48 h. Then, the degradation of C6-DL-HL signal by acylase was 
confirmed by the decrease of the purple zones surrounding the wells. C6-DL-HL 
extracts without acylase served as a control. 
4.3.1.2 Amylase-Induced Degradation of Model Biofilm 
Exopolysaccharides 
Chitosan, hyaluronic acid from Streptococcus equi, polygalacturonic acid and sodium 
alginate were used as model exopolysaccharide (EPS) components to evaluate the 
biofilm matrix degrading activity of α-amylase. The reaction between 700 µL of 5 
mg/mL polysaccharide solutions in 20 mM sodium phosphate buffer pH 6.9 (NaPB) 
with 6.7 mM sodium chloride (NaCl) and 300 µL α-amylase (100 U/mL) was carried out 
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for 15 min at 37 °C in a thermo-shaker bath. The same solution without the 
polysaccharides served as a control. After the incubation period, the samples were 
subjected to 3,5-dinitrosalicylic acid (DNSA) assay for determination of the reducing 
sugars released upon polysaccharides degradation [288]. Briefly, 100 µL of tested 
samples were mixed with 100 µL DNSA solution and the samples incubated at 100 °C 
for 15 min. Then, the samples were cooled down on ice and diluted (ratio 1:3) with 
distilled H2O. The absorbance was measured at 540 nm using TECAN Infinite M200 
(Austria). All experiments were performed in triplicate. The amount of the glucose-
equivalent reducing sugars in the reaction mixture was determined from the standard 
curve prepared by plotting absorbance versus glucose concentration. 
4.3.2 Enzyme Multilayer Coatings for Prevention of Bacterial Biofilm Formation 
on Silicone Foley Catheters 
4.3.2.1 Silicone Surface Pre-treatment  
Prior to coating, silicone catheter samples (3.5 × 9 cm2) were washed for 30 min with 
0.5% (w/v) sodium dodecyl sulfate (SDS), distilled H2O and 96% ethanol (EtOH, 
Scharlau, Spain). The silicone stripes and catheters were pretreated using 5% (v/v) (3-
aminopropyl)triethoxysilane (APTES) in 96 % EtOH for 24 h at RT. After the incubation, 
the samples were washed with EtOH to remove the unbound APTES molecules and 
dried under nitrogen. The amination of the silicone was confirmed by attenuated total 
reflection-Fourier transform infrared (ATR-FTIR) analysis and ninhydrin test [289].  
4.3.2.2 Assembling of Acylase Multilayer Coatings 
The APTES treated silicone stripes were coated in a layer-by-layer (LbL) fashion 
(Scheme 4.1). Acylase, having isoelectric point between pH 5 and 6 (negatively 
charged at a pH higher than 6) was used as polyanion, whereas linear PEI (Mw = 25 
kDa) was used as a polycation. A bilayer of oppositely charge polymers was 
constructed by dipping the silicone stripes for 10 min in 1 mg/mL acylase solution in 
100 mM tricine buffer pH 8, followed by dipping in 1 mg/mL PEI solution, pH 8. After 
each polyelectrolyte deposition, a 10 min rinsing step in 0.15 M NaCl, pH 8 was 
performed. This procedure was repeated for ten times, and the coated silicone samples 
were finally dried with a continuous flow of nitrogen. LbL coating with a bilayer 
architecture of (Acy/PEI)10/Acy was built, with the outermost layer being acylase (LbL 
Acylase) (Scheme 4.1). The same procedure was performed to coat silicone Foley 
urinary catheters. 
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Scheme 4.1 LbL assembly of acylase on the silicone catheters. 
 
4.3.2.3 Assembling of Hybrid Multilayer Coatings Comprising Quorum 
Quenching Acylase and Matrix-Degrading Amylase 
Amino-preactivated silicone stripes were coated with the QQ and/or matrix-degrading 
enzymes by LbL deposition technique as described above with some modifications. For 
each polyelectrolyte deposition step, silicone pieces were first immersed for 10 min into 
anionic enzyme solution (1.5 mg/mL of acylase in 100 mM tricine buffer, pH 8, or 1.5 
mg/mL of α-amylase in 20 mM NaPB buffer with 6.7 mM NaCl, pH 6.9) and then in 1.5 
mg/mL solution of positively charged branched PEI (Mw = 75 kDa) in tricine buffer for 
acylase or NaPB for α-amylase. Each deposition step was followed by 10 min of 
washing in 0.15 M NaCl solution, pH 8. LbL coatings with the following architectures 
((Acy/PEI)10/Acy, (Amy/PEI)10/Amy, (Acy/PEI/Amy/PEI)5/Amy, and 
(Acy/PEI/Amy/PEI)5/Acy (hybrid coatings)) were formed, with the uppermost layer 
being acylase for the LbL Acy and the LbL Hyb-Acy and α-amylase for the LbL Amy 
and LbL Hyb-Amy coatings.  
4.3.2.4 Coatings Formation with Non-Antibiofilm Active Protein  
Considering the antibacterial properties of PEI its role in inhibiting bacterial biofilms on 
catheter surface after the LbL assembling was further investigated. Cationic PEI 
(Mw=75 kDa) and a nonactive protein (e.g., bovine serum albumin (BSA)) bearing 
negative charge were sequentially deposited in a LbL fashion on silicone material as 
already described. The resulting PEI/BSA coatings always had the non antibiofilm 
active protein as an outermost layer. 
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4.3.2.5 Characterisation of Enzyme Multilayers 
Attenuated Total Reflection Fourier Transform Infrared Spectroscopy Analysis. The 
deposition of enzyme proteins on the silicone surface was analysed by FTIR-ATR 
using a Spectrum 100 FT-IR spectrometer (Perkin Elmer, USA). The FTIR-ATR spectra 
of non-treated silicone and LbL samples were collected in the range over 4000 to 625 
cm-1. All the spectra were obtained after 64 scans at 4 cm-1 resolution and the data 
were analysed using essential eFTIR - 3.00.019 software.  
Atomic Force Microscopy. The morphology of the different surfaces was studied by 
atomic force microscopy (AFM) using a Dimension 3100 AFM from Veeco. The AFM 
images where analysed and post-processed using the Nanotec WSxM software [290].  
Water Contact Angle Measurements. The hydrophilicity of the coatings comprised only 
of QQ acylase was assessed measuring the static contact angle (sessile drop method) 
of 5 µL ultra-pure water droplet on the material, using drop shape analysis system DSA 
100 (Krüss, Hamburg, Germany), equipped with ½ CCD camera. Three independent 
measurements were performed and analysed using Krüss DSA3 v1.0.1.3-02 software 
for each sample. 
Stability of Enzyme Multilayers. The stability of enzyme-based multilayers was 
assessed by monitoring the fluorescein isothiocyanate (FITC)-labelled amylase or 
acylase released from the silicone surface in artificial urine. For enzyme labelling, 
acylase and amylase (2 mg/mL) were dissolved in 0.1 M sodium carbonate buffer, pH 
9. Then, 1 mg/mL FITC solution was prepared in anhydrous DMSO and mixed with 
protein solutions (for each 1 mL of protein solution 50 μL of FITC solution were added). 
The reaction mixture was incubated in the dark for 12 h at 4 °C. Thereafter, the 
unreacted FITC was separated from the FITC-enzyme conjugates using PD-10 
desalting columns (GE healthcare), and the LbL assembly with the labelled proteins 
was performed as already described. 
The treated silicone strips were cut into small pieces (1 × 1 cm2) and incubated in 5 
mL of artificial urine at 37 °C under slow shaking (20 rpm) for 7 days. At desired time 
intervals, 0.2 mL of urine sample was collected and replaced with 0.2 mL of pre-
warmed urine (37 °C). The fluorescence intensity of the urine samples was measured 
at Ex/Em (490/525) using TECAN Infinite M 200. Then, the cumulative fluorescence 
intensity divided by the total fluorescence intensity of FITC-labelled enzymes in the 
multilayers, I/Itotal, was used to determine the amount of labelled enzyme released from 
the coatings as a function of the incubation time. 
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The stability of the FITC-labeled coatings was further studied through the changes of 
coatings intensity before and after incubation in artificial urine by fluorescence 
microscopy. The same gain and offset settings were used to acquire all images. 
Total Amylase and Acylase Fluorescence Intensity in the Multilayer Coatings. The total 
fluorescence intensity of the proteins, amylase or acylase, in the multilayer coatings 
was determined after the detachment of the fluorescently labelled coatings from the 
surface using a surgical blade. The pieces (1 × 1 cm2) and the corresponding blades 
were placed in 2 mL 5% (w/v) SDS solution and vortexed for 1 min. Afterward, 200 μL 
of the FITC-labelled protein solutions were transferred in 96−black well plates and the 
fluorescence intensity of each test sample was measured at Ex/Em (490/525). The 
relative amount of protein immobilised per square centimetre of silicone was calculated 
using calibration curves plotted between fluorescence intensity of the FITC-labelled 
acylase or amylase and their protein content. 
4.3.2.6 Enzymatic Activities in Multilayer Coatings 
Acylase Activity in the Assemblies. The activity of acylase, in both free and immobilised 
forms, was initially evaluated by a colorimetric assay using N-acetyl-L-methionine 
(NAMET) as a substrate. Briefly, 2 mL of 100 mM tricine buffer, pH 8.0 and 1 mL of 0.5 
mM cobalt chloride solution were added to the samples and equilibrated at 37 °C. 
Then, 1 mL of 100 mM NAMET in tricine buffer was added and the test tubes were 
incubated for 30 min. The reaction was stopped by rising the temperature to 100 °C for 
4 min. The product of the enzymatic reaction was determined using the colorimetric 
ninhydrin assay as follows: 1 mL of the sample was mixed with 2 mL of 2% (w/v) 
ninhydrin solution (prepared in 200 mM citrate buffer pH 5 and ethylene glycol 
monomethyl ether (1:1)) and 0.1 mL 1.6% (w/v) stannous chloride solution. The 
samples were incubated for 20 min at 100 °C and cooled down before measuring their 
absorbance at 570 nm. Non-treated silicone material was used as a control in all 
experiments. The immobilisation efficiency of acylase on silicone material was 
evaluated as a percentage of the enzyme specific activity retained after immobilisation 
on the surface. 
In addition, the potential of the acylase coatings to degrade the AHLs molecules in 
bacterial surroundings and consequently quench the QS process was assessed in a 
reporter bacterial strain C. violaceum. Untreated silicone sample (negative control) and 
acylase-coated silicone stripes were cut into 2 x 2 cm2 pieces and placed in sterile test 
tubes. The silicone pieces were inoculated with 5 mL overnight bacterial culture of C. 
violaceum (grown at 26 ºC) diluted to OD660 = 0.002 in Luria−Bertani Broth (LB), 
supplemented with 25 µg/mL kanamycin and 5 µM C6-HSL. Thereafter, the tubes were 
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incubated at 26 ºC with shaking (230 rpm) for 18 h. After the incubation period 200 µL 
of the cell suspension were transferred into Eppendorf tubes and mixed with 200 µL 
10% SDS (w/v) [291]. The samples were mixed, vortexed for 5 s and the violacein 
extraction was performed by addition of 500 µL 1-butanol followed by centrifugation for 
5 min at 13 000 rpm. After phase separation, the butanol (upper phase) was collected 
and the absorbance measured at 584 nm. Non-immobilised acylase was used to 
compare the QQ efficiency of the enzyme in the coatings. 
Amylase Activity Using Bacterial Extracellular Polymeric Matrix as Substrate. The EPS-
degrading activity of amylase in the hybrid multilayers was evaluated using P. 
aeruginosa biofilm matrix as a substrate. A culture of P. aeruginosa grown overnight in 
tryptic soy broth (TSB) was poured on tryptic soy agar plates. Afterward, the plates 
were incubated at 37 °C for 24 h to allow biofilm development. The biofilms were 
harvested using a sterile spatula and washed with sterile distilled H2O. The cell 
suspension was then immediately subjected to EPM extraction with high-speed 
centrifugation at 20 000 rpm and 4 °C for 20 min. The supernatants were filtered 
through a 0.22 μm membrane, and the filtrates were used as the EPM sample 
containing EPS constituents [292]. Afterward, 7 mL of P. aeruginosa EPM extracts 
were incubated with silicone samples (2 × 2 cm2) at 37 °C with shaking for 24 h. After 
the incubation period, samples were analysed for reducing sugar content using DNSA 
assay as described. Pristine silicone and EPS-containing extracts served as controls. 
The amount of reducing sugars present in the extracts was subtracted from the values 
obtained for all amylase-containing samples. Free amylase was used to compare the 
activity of the enzyme multilayer coatings toward the biofilm EPS. 
4.3.2.7 Functional Characterisation of Catheters Coated With Antibiofilm 
Enzymes 
Initial Bacterial Adhesion. Initial bacterial adhesion was studied on acylase-coated and 
non-treated silicone sheets. The samples were cut into 1 x 1 cm2 pieces and placed in 
a cell-culture 24-well plate. Then, the samples were inoculated with 1 mL of bacterial 
culture of P. aeruginosa in TSB in which the concentration of glucose was 0.25% (w/v). 
The bacterial inoculum was prepared from overnight culture grown in TSB and diluted 
to OD600 = 0.01. The culture plate was incubated for 3 h at 37 °C to allow bacterial 
adhesion. Thereafter, the samples were washed three times with sterile phosphate 
buffered saline (PBS) and left in 4% (v/v) formaldehyde at 4 °C overnight to allow 
fixation of the bacteria. Then, the samples were washed with sterile PBS and 25, 50, 
75 and 96 % ethanol for 10 min. The initial bacterial attachment was studied in a bright 
field mode using Eclipse Ti-S microscope (Nikon Instruments Inc., The Netherlands). 
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Single Species Biofilm Inhibition. Crystal violet (CV) assay was used to quantify the 
biofilm inhibition activity (i.e. total biomass reduction) of enzyme-coated catheter 
materials in both static and dynamic conditions, against Gram-positive P. aeruginosa or 
Gram-positive S. aureus. Briefly, inoculum of each bacterium was prepared form 
overnight grown culture in TSB diluted to OD600 = 0.01. The enzyme-coated samples 
were cut into 1 x 1 cm2 pieces and placed in a cell-culture 24-well plate. Thereafter, 1 
mL of bacteria was inoculated in each well and the plate was incubated for 24 h at 37 
ºC. The liquid media was removed and the biofilm washed with distilled H2O three 
times to eliminate non-adhered bacteria. The biofilms were further fixed by heat (60 °C 
for 60 min) and the biofilm mass quantified using CV. Briefly, 700 µL of 0.1% (w/v) 
crystal violet were added to each well and incubated for 10 min at RT. Then, CV was 
discarded and samples washed with sterile distilled H2O three times. The remaining 
stain was eluted with 1 mL 30% (v/v) acetic acid and the total biomass was determined 
as the amount of CV bound to each sample by measuring the absorbance at 595 nm. 
Untreated silicone samples served as negative control (no biofilm inhibition) in all 
experiments. 
Mixed Species Biofilm Inhibition. Following the combination of the two enzymes, 
acylase and amylase, into a hybrid multifunctional coating, the biofilm inhibition 
potential was evaluated against mixed-species biofilms of Gram-negative bacteria. The 
silicone samples were incubated with 1 mL of bacterial suspension containing mixture 
of P. aeruginosa and E. coli (OD600 = 0.01, final concentration of each bacterium) 
pathogens frequently found in urinary catheter biofilms. Then, the biofilms were allowed 
to grow statically and the total biofilm mass was measured with the CV assay as 
described.  
Bacterial Viability in the Biofilms. Single- and dual-species biofilms were grown on 
acylase on hybrid silicone samples and then subjected to analysis with Live/Dead® 
BacLight™ kit. Following 24 h of incubation, the non-adherent bacteria were rinsed with 
1 mL of sterile 0.9% NaCl, pH 6.5, and the biofilms were stained using a mixture of two 
dyes: green fluorescent Syto 9 and red fluorescent propidium iodide (1:1). Then, the 
biofilms were analysed by fluorescence microscopy at Ex/Em (480/500) for Syto® 9 
labelling the nucleic acid of all bacteria, with intact and damaged membranes in green 
and at Ex/Em (490/635) for propidium iodide quenching the green fluorescence of 
Syto® 9 dye after penetration into the damaged cells, consequently staining dead 
bacteria in red. 
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Effect of Enzyme Multilayer Coatings on Bacterial Growth. The effect of enzyme coated 
silicone materials on planktonic bacterial growth was also evaluated. Overnight culture 
of bacteria in TSB was diluted to OD600 = 0.01 (final concentration) and then 1 mL of 
freshly prepared single or mixed bacterial inocula was cultured with treated and non-
treated silicone for 24 h at 37 °C. After incubation, single- or dual-species bacterial 
growth was determined spectrophotometrically by measuring the OD at 600 nm. 
Functional Stability of the Coatings. The stability of acylase-comprising coatings was 
studied after incubation in artificial urine containing 25 g/L urea, 9 g/L sodium chloride, 
2.5 g/L disodium hydrogen orthophosphate, 3 g/L ammonium chloride, 2.5 g/L 
potassium dihydrogen orthophosphate, 2 g/L creatinine, and 3 g/L sodium sulfite, pH 
6.8. The samples were cut, placed in a test tube containing 2 mL artificial urine and 
incubated for 1 and 7 days at 37 ºC with 20 rpm shaking. Afterwards, the silicone 
pieces were washed with distilled H2O and the antibiofilm activity was determined in 
static conditions against P. aeruginosa, as already described. 
Dynamic Biofilm Inhibition Tests. LbL assemblies on Foley urinary catheter were 
analysed for their stability under dynamic conditions using a previously described 
physical model of catheterized human bladder [293]. This model consists of a glass 
bladder model maintained at 37 °C by a water jacket (Scheme 4.2 ). After the insertion 
of non-treated and treated Foley catheters, the model was filled up to the catheter’s 
eye with sterile artificial urine, pH 6.8 (supplemented with 1 mg/mL TSB), containing 
only Gram-negative P. aeruginosa, Gram-positive S. aureus or both P. aeruginosa and 
E. coli bacterial species (final OD600 = 0.01 for each bacterium). During the 7 days of 
catheterisation, the model was maintained at 37 °C and supplied with sterile artificial 
urine at a flow rate of 1 mL/min. Then, the catheter was removed, and the biofilm 
formation on the catheter-balloon (1×1 cm) and catheter shaft (also referred to as 
urethra) surface were subjected to analysis for biofilm formation using CV and 
Live/Dead kit as described. The same parts of pristine silicone Foley catheter were 
used as controls for biofilm formation (no antibiofilm effect). 
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Scheme 4.2 Physical glass model of catheterised bladder used in dynamic biofilm inhibition 
tests. 
 
Biocompatibility Tests. The biocompatibility of the silicone samples (1 × 1 cm2) coated 
with acylase, amylase, and both enzymes (hybrid coatings) was studied using human 
foreskin fibroblasts. The cells were maintained in 4 parts Dulbecco’s Modified Eagle’s 
Medium (DMEM) containing 4 mM L-glutamine, 4500 mg/L glucose, 1500 mg/L sodium 
bicarbonate, 1 mM sodium pyruvate and 1 part of Medium 199, supplemented with 
10% (v/v) of foetal bovine serum, and 10 g/L hygromycin B at 37 ºC, in a humidified 
atmosphere with 5 % CO2. At pre-confluence, the cells were harvested using trypsin-
EDTA (0.25 % (w/v) trypsin/0.53 mM EDTA solution in Hank’s BSS without calcium or 
magnesium) and seeded on 24-well tissue culture-treated polystyrene plate (Nunc) at a 
density of 4.5 x 104 cells/well. After 24 h of culturing, silicone samples were placed in a 
contact with the cells for 1 and/or 7 days. Thereafter, the cell viability was determined 
using alamarBlue® assay.  
Resazurin, the active blue ingredient of the alamarBlue®, is a nontoxic, cell-
permeable compound that, once in a viable cell, is reduced to red-coloured resorufin. 
AlamarBlue® reagent was diluted in culture medium (1:10) and added to each well after 
aspirating the culture medium containing the samples in contact with cells. After 4 h of 
incubation at 37 °C, the absorbance at 570 nm was measured in a microplate reader, 
using 600 nm as a reference wavelength. The quantity of resorufin formed is directly 
proportional to the number of viable cells. The cell viability (%) was assessed for each 
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silicone sample (treated and non-treated) and compared to that of a control sample of 
culture medium, corresponding to 100 % cell viability. The error bars represent the 
standard deviation of three independent measurements. 
In Vivo Biofilm Tests. The antibiofilm potential of hybrid coatings containing acylase as 
outermost layer was also assessed using an in vivo rabbit model. All the experiments 
with rabbits were performed after the acceptance by the appropriate ethical approval 
committee. New Zealand white male rabbits (3−4 kg body weight) were catheterized 
with treated (n = 3) and non-treated (n = 3) silicone Foley catheters for 7 days. During 
the catheterisation, the weight and temperature of the animals were recorded. To 
minimise pain and distress, the rabbits were treated with buprenorphine according to 
the requirements of the ethical committee. The rabbits received physical examinations, 
and only these that met the health and weight criteria were used in the study. Prior to 
catheterisation, the animals were anaesthetised, and the penis was cleaned and 
swabbed. Throughout the experiment, anaesthesia was maintained with 
isoflurane/oxygen, and the body temperature and vital signs were monitored. The 
urethra was filled with lubricant, and the catheter was then threaded into the penis 
meatus. After insertion into the bladder, the catheter balloon was inflated with 4 mL of 
sterile 0.9 % NaCl, pH 6.5. The ports that connect the catheters with the drainage bag 
were removed, so that the animal did not need to be restrained. To maintain the 
catheter into the animal’s body, the entrance was blocked and held by suture. Although 
the catheter’s opening could distress the animals, the trauma would be less than that of 
movement restriction and attachment to a drainage bag. 
The procedure for rabbit catheterisation allowed spontaneous bacterial 
contamination, mimicking the occurrence of catheter-associated infections. The 
continuous urine flow through the catheter shaft and the wet zone exposed to 
nonsterile conditions in the housing cage contribute to the catheter’s contamination 
after insertion. 
Bacterial growth in the urine collected from the rabbits was monitored every day 
during the catheterisation. Briefly, the urine was serially diluted in sterile 0.9% NaCl, pH 
6.5, and then plated on LB agar. The plates were incubated at 37 °C for 24 h, and the 
number of live bacteria was determined. After 7 days of incubation, the control and 
enzyme-coated catheters were removed and examined for the presence of biofilm. 
4.3.2.8 Statistical Analysis 
All data are presented as mean ± standard deviation. For multiple comparisons, 
statistical analysis by a one-way analysis of variance (ANOVA) followed by posthoc 
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Tukey test was carried out using Graph Pad Prism Software 5.04 for windows (USA). P 
values less than 0.05 were considered statistically significant. 
 
4.3.3 Nanomaterials for Controlling Planktonic Bacterial Growth and Biofilm 
Occurrence: Polycationic Aminocellulose Nanospheres  
4.3.3.1 Preparation of Polycationic Aminocellulose Nanospheres 
Highly cationic ACNSs with sunflower oil as a lipid core were prepared by an adapted 
sonochemical method of Suslick, reported elsewhere for different kinds of biopolymers 
and their derivatives (Scheme 4.3) [294, 295]. Briefly, the pH of the AC aqueous 
solution (1 mg/mL) was adjusted to 5.5 using 0.1 M hydrochloric acid (HCl). Then, a 
mixture of 70 % AC and 30 % commercial sunflower oil was prepared in a 
thermostated (4 ± 0.5 °C) sonochemical cell. The NSs were generated using a Ti horn 
of a high-intensity Vibra-Cell VCX 750 ultrasonic processor (Sonics and Materials, Inc., 
USA), employing 20 kHz at 35 % amplitude. The Ti horn was positioned at the 
aqueous-organic interface. An acoustic power of  ̴0.5 W/cm3 was applied for 3 min and 
the resulted suspension was cleaned from non-encapsulated oil by three consecutive 
centrifugations at 1500 rpm for 15 min. 
 
 
Scheme 4.3 Nanospheres formation via one-step sonochemical process. 
 
4.3.3.2 Nanospheres Deposition onto Silicone Material  
Multilayer coatings of ACNSs were assembled on APTES functionalised silicone 
supports (Section 4.3.2.1 Silicone surface pre-treatment) to facilitate the deposition of 
the first negatively charged HA layer. A solution of HA polyanion and a dispersion of 
ACNSs polycation were prepared with 0.15 M NaCl to reach final concentrations of 0.5 
mg/mL. The pH was adjusted to 5.5 with 1 M HCl or 1 M sodium hydroxide aqueous 
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solutions. The polyelectrolytes were alternately deposited using a multi-vessel 
automated dip coater system (KSV NIMA, Finland) on silicone starting with HA and 
finishing with ACNSs to form 5, 10 and 100 bilayers. Each deposition lasted for 10 min 
and was followed by a 10 min rinsing step with 0.15 M NaCl, pH 5.5 (Scheme 4.4). The 
obtained multilayer coatings were named after the number of bilayers employed for 
their assembling: (HA/ACNSs)5, (HA/ACNSs)10 and (HA/ACNSs)100. Non-processed AC 
in solution and the same procedure for 5 and 10 bilayers were used to prepare the 
corresponding controls designated as (HA/ACsol)5 and (HA/ACsol)10.  
 
 
 
Scheme 4.4 LbL assembly of aminocellulose nanospheres (ACNSs) on the catheters surface. 
 
The LbL build up was followed by a quartz crystal microbalance with dissipation (QCM-
D, E4 system from Q-Sense, Sweden). The deposition was carried out on gold-coated 
AT-cut quartz crystals (QSX301, Q-Sense, Sweden) previously cleaned with 5:1:1 
solution of H2O:NH3:H2O2 at 80 °C for 10 min, and amino functionalised with 11-amino-
1-undecanethiol hydrochloride (HS(CH2)11NH2) as described elsewhere [296]. Briefly, 
the crystals were immersed into 20 µM ethanol solution of HS(CH2)11NH2 for 48 h to 
ensure well-ordered amino ended self-assembled monolayers. After this treatment, the 
sensors were washed several times with ethanol, dried under N2 and placed in the 
QCM-D flow chambers. A stable baseline was acquired in 0.15 M NaCl solution at 25 
°C. The polyelectrolytes (0.5 mg/mL) deposition was carried out at a constant flow rate 
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(50 µL/min). Each polyelectrolyte solution was injected into the measurement chamber 
for 10 min followed by a rinsing step with 0.15 M NaCl pH 5.5 to remove loosely bound 
material. The measurements (changes in the frequency ΔF and dissipation ΔD) were 
performed at several harmonics (n = 3, 5, 7, 9, 11 and 13). ΔF/n and ΔD were fitted for 
the seventh and ninth overtone using the Q-Tools software (v 3.0.6.213). Voigt 
element-based model was used to obtain the thickness of the produced multilayers. 
4.3.3.3 Characterisation of Aminocellulose-based Coatings 
The multilayer coatings with 5 and 10 bilayers of HA/ACsol and HA/ACNSs were 
characterised by ATR-FTIR (Section 4.3.2.5-Characterisation of enzyme multilayers). 
Prior to analysis, the coated silicone stripes were thoroughly washed in distilled water 
at 100 rpm for 24 h and then dried under N2. The morphology of the LbL coatings was 
investigated by SEM (JSM 5610, JEOL Ltd, Japan) and AFM. Changes in the surface 
hydrophilicity of the material as a result of the polyelectrolytes deposition were followed 
by static water contact angle measurements (OCA 15+, DataPhysics Instruments, 
Germany) using the sessile drop method (drop of 1 L in high-performance liquid 
chromatography (HPLC) grade water). At least six measurements per sample were 
performed and averaged. 
4.3.3.4  Antimicrobial activity 
The antibacterial activity of the coated silicone towards the P. aeruginosa planktonic 
growth was evaluated using shake flask method. Briefly, a single colony from the P. 
aeruginosa stock bacterial culture was grown overnight in nutrient broth (NB, Sharlab, 
Spain). Then, the bacterial cells were harvested by centrifugation and diluted in sterile 
0.9% NaCl solution, pH 6.5, until reaching solution absorbance of 0.28 ± 0.1 at 600 nm, 
which corresponds to 1.5 − 3.0 × 108 colony-forming unit (CFU)/mL. The silicone 
samples (1 x 1 cm2) were incubated with 2 mL cells suspension at 100 rpm and 37 °C 
for 2 h. These suspensions were serially diluted in the same NaCl solution, then plated 
on a cetrimide agar and incubated at 37 °C for 24 h to determine the number of viable 
bacteria. Three independent measurements were performed per sample and the 
results are expressed as a reduction percentage of the survived bacterial colonies 
(CFU) after incubation with the specimens (B) compared to the CFU survived from the 
suspension in contact with pristine silicone (A), calculated as follows: 
Reduction (%) = (A-B)/A×100.  
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4.3.3.5 Degradation of the Coatings in Presence of Bacteria 
The degradation of the multilayer coatings in the presence of P. aeruginosa was 
assessed using FITC-labelled AC component (Section 4.3.2.5 Characterisation of 
enzyme multilayers, Stability of enzyme multilayers. Prior to immobilisation, AC (6 
mg/mL) was dissolved in 0.1 M sodium carbonate buffer, pH 9. Then, 1 mg/mL FITC 
solution was prepared in anhydrous DMSO and mixed with AC in buffer (for each 1 mL 
of AC 50 µL of FITC were added). The reaction mixture was incubated in the dark at 4 
°C for 12 h. The unreacted FITC was separated from the AC-FITC conjugate and the 
LbL assembly between HA and AC-FITC was performed on silicone stripes as 
described. The coated silicone samples were further cut in equal pieces and incubated 
in distilled H2O and TSB (both as control samples) and TSB containing P. aeruginosa 
(OD600 = 0.01) at 37 °C for 6 and 24 h. At the end of these time intervals, the samples 
were withdrawn and washed with distilled H2O prior to analysis by fluorescence 
microscopy. The same microscope gain and offset settings were used to acquire all 
images. The stability of the coatings was further assessed by their fluorescence 
intensity in absence and presence of P. aeruginosa. 
4.3.3.6 Biofilm Inhibition Tests  
The ability of the ACNSs coated silicone materials to control P. aeruginosa biofilms in 
both static and dynamic conditions was studied using Live/Dead® BacLight™ bacterial 
viability kit as described in the section 4.3.2.7 Functional characterisation of catheters 
coated with antibiofilm enzymes, Bacterial Viability in the Biofilms. 
4.3.3.7 Statistical Analysis 
The results for the samples hydrophilicity and antibacterial activity are presented as 
mean values ± standard deviation (SD). Statistical analysis was carried out by Graph 
Pad Prism 6 Software (USA) by performing ANOVA followed by post-hoc Tukey test to 
determine the statistical significance of the observed differences among the samples. 
The differences were considered significant only if p<0.01. 
4.3.4 Covalent Grafting Of Aminocellulose Nanospheres onto Silicone Material 
for Escherichia Coli Biofilm Prevention  
4.3.4.1 Silicone Material Functionalisation with Aminocellulose 
Nanoshperes  
PDMS stripes (9 x 3.2 cm2) were washed and then functionalised with 5 % (v/v) 3-
(glycidoxypropyl) trimethoxysilane (GOPTS) solution in 96 % EtOH for 12 h at room 
temperature. The samples were washed with EtOH, dried at 85 °C for 2 h and stored in 
the dark for at least 2 days prior to functionalisation with ACNSs. The presence of 
 61 
 
epoxy groups on the surface was confirmed by development of characteristic pink 
colour in a 4-(para-nitrobenzyl) pyridine (p-NBP) test. Briefly, treated and non-treated 
silicone samples were incubated in 5 mL of 200 mM p-NBP solution in methoxyethanol 
for 30 min at 80 ºC.  
 ACNSs were prepared as previously described ACNSs (Section 4.3.3.1 Preparation 
of Polycationic Aminocellulose Nanospheres). For epoxy/amine curing reaction, the 
pre-activated silicone strips were cut and placed in 15 mL test tubes containing 5 mL of 
0.1 mg/mL and conditioned at pH 3 and 6. Then, the tubes were transferred in a water 
bath at 60 ºC and kept overnight with shaking. Afterwards the silicone stripes were 
washed three times with distilled H2O, until no spheres were released into the washing 
solution, verified by optical microscopy and dynamic light scattering (DLS) and stored 
at 4 °C for further analysis.  
 The deposition of ACNSs on the silicone material was assessed by ATR-FTIR using 
a Spectrum 100 FT-IR spectrometer (Perkin Elmer, USA) as describes. The shape and 
morphology of immobilised NSs onto silicone was assessed with SEM using a cross-
beam workstation (Zeiss Neon 40) with Focused Ion Beam FIB/SEM beams for 
observation. Prior to imaging the silicone samples (1x1 cm2) were coated with carbon 
under vacuum. 
4.3.4.2 Inhibition of E. coli Biofilms 
Prior to immobilisation of the spheres on silicone samples, the biofilm inhibition activity 
of the ACNSs was evaluated and compared to non-processed AC in solution. For 
optimal biofilm growth, fresh single E. coli colony was inoculated in 5 mL TSB and 
cultured overnight at 37 °C with shaking (230 rpm). 100 µL of E. coli cells were mixed 
with 100 µL ACNSs or ACsol at 0.5 mg/mL in a 96-well plate (polystyrene, surface-
treated) and then cultured for 24 h at 37 °C. After incubation, the mixtures were 
withdrawn from the wells and the surfaces further washed with sterile distilled H2O, 
fixed by heat (60 °C for 60 min) and the total biofilm mass was measured with 0.01 % 
(w/v) crystal violet solution. Total biomass assessment and cells viability was also 
performed for the ACNSs decorated silicones as described.  
4.3.5 Nano-sized Penicillin G for Overcoming Gram-Negative Bacterial 
Resistance  
4.3.5.1 Sonochemical Preparation of Penicillin G Nanospheres 
Penicillin and control nanospheres (NSs) were prepared using ultrasound. Two-phase 
solution containing 70 % of 0.250 g/L antibiotic aqueous solution containing 0.1 % (w/v) 
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of Poloxamer 407 surfactant (the antibiotic is omitted in the control NSs) and 30 % 
commercial sun-flower oil (organic phase) was prepared and placed into a 
thermostated sonicator cell (Section 4.3.3.1 Preparation of Aminocellulose 
Nanospheres). The resulted NSs dispersion was purified by three consecutive 
centrifugations at 1500 rpm for 15 min to remove the organic phase.  
4.3.5.2 Nanospheres Characterisation 
Dynamic light scattering (DLS) was used to measure the size of NSs (DL135 Particle 
Size Analyzer, Cordouan Technologies, France). The data were analysed using NanoQ 
1.2.1.1 software to calculate the mean particle diameter. The determination of zeta 
potential was carried out using a Zetasizer Nano Series (Malvern Instruments Inc., 
Worcester, UK) after appropriate dilution of NSs using ultrapure-grade water at pH 6. 
The shape and morphology of NSs was visualised with SEM using a cross-beam 
workstation (Zeiss Neon 40) with Focused Ion Beam FIB/SEM beams for sample 
observation. SEM samples were prepared by applying a small drop of NSs suspension 
on a glass slide and dried at RT before gold-palladium sputtering. 
4.3.5.3 Interaction with Cell Membrane Models  
The interaction of penicillin and nanopenicillin with cell membrane models was 
assessed using a Langmuir monolayer technique by measuring the effect of the 
antimicrobial agents in contact with L-α-Phosphatidylethanolamine (PE) phospholipid 
extracted from E. coli [297, 298]. 
The interaction was evaluated by the Langmuir monolayer compression technique 
and by measuring the kinetics of insertion of the both agents into the monolayer 
performed in a Langmuir trough (KSV NIMA model KN2002, Finland) with a total area 
of 273 cm2 mounted on an antivibration table and housed in an insulation box at a 
temperature of 22 ± 2 ºC.  
Langmuir Monolayer Compression Measurements. Penicillin solutions, nanopenicillin 
and control NSs suspensions at 0.250 mg/mL were used. The samples were then 
diluted 500 times with MilliQ water (18 MΩ cm) to a concentration of 0.5 µg/mL and 
studied in the subphase for their interaction with an E. coli PE monolayer. The 
Langmuir trough was filled with a subphase solution that was either MilliQ water 
(control) or the nanopenicillin, penicillin diluted solutions or control NSs suspension, 
and 10 µL of 0.5 mg/mL PE solution in chloroform was carefully spread onto the 
subphase with a gas-tight syringe. After chloroform evaporation (10 min), the floating 
film was continuously compressed at the air-water interface at a linear speed of 25 
mm/min. The surface pressure (π) was recorded against the area (A), measured with a 
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Wilhelmy balance plate (Pt) connected to an electrobalance. The isotherms provide 
information about the film states, phases and phase transitions, where π is the 
difference between the surface tension of pure water (γ0) and that of the film (γ), i.e. π 
= γ0 – γ. The compression modulus (in-plane elasticity) Cs
-1 was calculated from the 
slope of the π vs A isotherm in order to elucidate the phase transitions that occur in the 
monolayer [299]: 
𝐶𝑠
−1 =  −𝐴 (
𝑑𝜋
𝑑𝐴
)
𝑇
       (1) 
Whereas the minimum value in the plot of Cs
-1 vs π indicates a phase transition, the 
maximum allows the classification of these transitions as liquid-expanded (12.5 < Cs
-1 < 
100 mN/m), liquid-condensed (100 < Cs
-1 < 250 mN/m) and condensed (Cs
-1 > 250 
mN/m). 
Insertion into Phospholipid Monolayer. The kinetics of insertion of penicillin, 
nanopenicillin and control NSs into monolayers was measured using the phospholipid 
monolayer built at surface pressure of 30 mN/m that corresponds to the lateral 
pressure of bacterial cell membrane [300]. 40 µL of 0.5 mg/mL PE phospholipid 
solution in chloroform was carefully spread onto the subphase with a gas-tight syringe. 
The monolayer was then compressed until a surface pressure of 30 mN/m was 
obtained at a velocity of 5 mm/min. The monolayer was allowed to reach equilibrium 
(20 - 30 min) and once stabilised 10 mL of 25 µg/mL penicillin and nanopenicillin were 
injected in the subphase. The surface pressure was monitored over time until it 
reached a constant value.  
4.3.5.4 Antibacterial and Antibiofilm Activities 
Bacterial Susceptibility to Penicillin G. Serial twofold dilutions of Pencillin G was 
prepared in test tubes containing 1 mL of NB medium. The inoculum density of P. 
aeruginosa, E. coli and S. aureus had a final concentration of ≈ 5 × 105 CFU/mL. 10 μL 
of bacterial suspension was added to the 96-well plate previously filled with 190 μL of 
different concentrations of penicillin G and incubated at 37 °C overnight. The OD=600 
nm was recorded and the susceptibility of the bacterial strains evaluated. 
Antibacterial Activity of Nano-sized Penicillin. P. aeruginosa and E. coli growth 
inhibition assay was performed in presence of the nanopenicillin and penicillin (as a 
control). The absorbance of the inoculated bacterial culture was adjusted to 0.01 at 600 
nm in NB medium. Thereafter, 200 µL of antimicrobial agent at 250 µg/mL was 
incubated with 200 µL of diluted bacterial suspension. This was further incubated at 37 
ºC and 230 rpm for 24 h. After 24 h the suspensions were serially diluted in sterile 
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buffer solution, plated on appropriate plate count agar and further incubated at 37 ºC 
for 24 h to determine the number of surviving bacteria colonies. The bacterial reduction 
(Log10 reduction) was calculated using the following formula: 
Bacterial log10 reduction = log10 (CFU/ml control sample) – log10 (remaining 
CFU/ml after exposure with antimicrobial agent) 
All antibacterial data represent mean values ± SD (n=3). 
Bacterial Viability in Biofilm. The viability of P. aeruginosa and E. coli bacteria within 
biofilms after treatment with penicillin, nanopenicillin and control NSs was assessed by 
fluorescence microscopy using Live/Dead® BacLight™ cell viability kit and by Calgary 
Biofilm Device using a Minimum Biofilm Eradication Concentration (MBEC™) High-
throughput (HTP) assay (Biofilm Technologies, Calgary, Alberta).  
Live/dead cells viability assay: P. aeruginosa and E. coli biofilm was grown 
on tissue culture-treated polystyrene 24-well plates for 24 h at 37 °C as previously 
described (Section 4.3.2.7 Functional Characterisation of Catheters Coated with 
Antibiofilm Enzymes, Biofilm Inhibition Tests). Then, the biofilm was washed with TSB 
under aseptic conditions to eliminate non-adhered bacteria and 1 mL of the samples 
diluted in TSB at a concentration of 125 µg/mL was added to each well. After exposure 
to penicillin, nanopenicillin and control NSs for 24 h at 37 °C the solutions were 
discarded and biofilm washed with 0.9 % NaCl, pH 6.5. The biofilm eradication was 
analysed using Live/Dead BacLight kit (Section 4.3.2.7 Functional Characterisation of 
Catheters Coated with Antibiofilm Enzymes, Bacterial Viability in the Biofilms). Non-
treated with antibiotic biofilm was used as a negative control (lack of biofilm 
eradication).  
MBEC™ HTP Assay on Calgary Biofilm Device: Biofilms of P. aeruginosa and 
E. coli were grown on a device comprised of a microtiter plate lid with 96 pegs, which 
provide the surface for cells to adhere, colonize and form a uniform biofilm (Error! 
Reference source not found.). The pegs fit precisely into the wells of a standard 96-
well microtiter plate. The lid was used in conjunction with special troughs for growing of 
bacteria, washing, and incubating. The trough was inoculated with bacteria and placed 
in contact with the pegged lid and further incubated in a Plate Shaker-Thermostat for 
24 h at 37 ºC, 100 rpm. Afterwards, the pegs with the developed biofilm were washed 
twice with 0.9 % NaCl with pH 6.5 and then placed in contact with the 96-well plate 
containing different concentrations of the test compounds including penicillin solution, 
and penicillin and control NSs at 37 °C for 24 h. The pegged lids were then transferred 
in 96-well plate containing 200 µl recovery medium (Mueller Hinton Broth, 
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supplemented with 20 g/L saponin, 10 g/L Tween-80 and 2.5 % (v/v) neutralizing agent 
containing L-histidine (50 g/L), L-cysteine (50 g/L) and reduced glutathione (100 g/L) 
and placed in a ultrasonic bath for 10 min. The viable bacterial cells after treatment with 
antibacterial agents were count after appropriated dilution in sterile buffer and plating 
on specific agar (Scheme 4.5). 
 
 
 
Scheme 4.5 Inoculation of Minimum Biofilm Eradication Concentration (MBEC
™
) High-
throughput (HTP) assay assay kit. A fresh sub-culture of P. aeruginosa or E. coli was used to 
create an inoculum with OD600 = 0.28. The bacterial suspension was diluted with TSB (1:30) and 
22 ml of dilution were added to the trough of the MBEC™-HTP device. The device was placed 
at 37 °C with shaking to assist the formation of biofilms on the polystyrene pegs. After washing 
with 0.9 % NaCl, pH 6.5, the lid with the developed biofilm was transferred to another plate 
containing different concentrations of penicillin G solution and nanospheres.  
 
4.3.5.5 Cytotoxicity Evaluation 
The potential toxicity of the NSs towards human foreskin fibroblast was also evaluated. 
Different concentrations of NSs were placed in contact with previously seeded cells 
and after 24 h the number of viable cells was quantified using alamarBlue® (section 
4.3.2.7 Functional Characterisation of Catheters Coated With Antibiofilm Enzymes, 
Biocompatibility Tests). Cells were seeded at a density of 4.5 x 104 cells/well on a 96-
well tissue culture-treated polystyrene plate (Nunc) the day before experiments and 
then exposed to different concentrations of NSs (1000, 100 and 1 µg/mL diluted in 
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DMEM) at final volume of 150 µL and incubated at 37 ºC in a humidified atmosphere 
with 5 % CO2. After 24 h contact with cells, the NSs were removed, the cells washed 
twice with PBS and stained with 100 µL of 10 % (v/v) AlamarBlue® Cell Viability reagent 
in DMEM. BJ5ta cells relative viability (%) was determined for each concentration of 
NSs and compared with that of cells incubated only with cell culture medium. H2O2 500 
µM was used as a positive control of cell death. Data are expressed as the mean of 
three measurements with a standard deviation as a source of error. 
4.3.5.6 Data analysis 
Results were analysed using Graph Pad Prism 5.04 (Graph Pad Software, San Diego, 
CA). Statistical significances were determined using ANOVA, followed by the Dunnett 
post-hoc test or, alternatively, by the unpaired two-tailed Student’s t-test. P values < 
0.05 were considered to be statistically significant (expressed in the figures with 
asterisks [*]: *p < 0.05, significant; **p < 0.01, very significant; ***p < 0.001, extremely 
significant). 
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Enzyme Multilayer Coatings for Inhibition of 
Bacterial Biofilm Formation on Silicone Foley 
Catheters 
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5.1 Quorum Quenching Acylase in Multilayer Coatings 
 
 
Despite the advances in 
QQ enzymes for anti-
virulence purposes, 
these have never been 
applied to prevent the 
QS regulated biofilm 
formation on indwelling 
medical devices. The 
goal of the present 
study is to develop 
multilayer acylase 
coatings on silicone 
urinary catheters able to 
interfere with bacterial 
QS phenomenon in the 
extracellular space and thereby inhibit the growth of drug resistant biofilms. Taking into 
account the advantages of the nanostructured polymeric systems to preserve proteins 
folding and bioactivity, the LbL deposition technique is used to incorporate the enzyme 
acylase into biologically stable multilayer coating on the silicone material. The 
disruption of QS process in Gram-negative bacteria, through the enzymatic 
degradation of the signals by the LbL construct is studied with reporter strain C. 
violaceum. Then, the ability of the resulting coating to prevent P. aeruginosa biofilm 
formation on urinary catheters is assessed in both static and dynamic conditions using 
an in vitro model of a catheterised human bladder. 
 
 
 
 
 
 
This section is based on the following publication: 
Ivanova K, Fernandes MM, Mendoza E, Tzanov T, “Enzyme multilayer coatings inhibit Pseudomonas 
aeruginosa biofilm formation on urinary catheters”, Applied Microbiology and Biotechnology, 2015, 
99(10):4373-85. doi: 10.1007/s00253-015-6378-7.  
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5.1.1  Acylase Induced Degradation of QS Signals 
The increased antibiotic resistance of bacteria within biofilms is a common reason for 
difficult-to-treat infections caused by foreign bodies. This is a medical and public health 
issue that requires the application of novel approaches to counteract the biofilm growth 
on indwelling catheters. Strategies that target the bacterial molecular mechanisms 
involved in biofilm occurrence such as QS are reported to exert less evolutionary 
pressure on the bacterial population and thus could decrease the possibility of 
resistance development. Previous studies have demonstrated the key role of QS in 
biofilm differentiation of pathogenic P. aeruginosa into complex multicellular structures. 
P. aeruginosa uses las, rhl and pqs QS systems to regulate a number of factors 
important for biofilm development on various surfaces [301]. Therefore if any of these 
QS systems is blocked by mutation or by QSIs, the individual bacterial cells could lose 
ability to communicate with the others and form well defined surface-attached biofilms 
structures [302]. Davies et al., for example, showed that mutants lacking the las QS 
system are incapable of producing the 3-oxo-C12-HSL signal molecules and form frail 
and unstructured biofilms which are sensitive to detergents [303]. The las QS system is 
involved in the expression of numerous genes; hence it is believed that the biofilm-
defective phenotype is multifactorial including defects in swarming, DNA release, and 
defects in the production of other structural components of the biofilm matrix [304].  
The ability of acylase to act upon different model AHLs was first evaluated in order to 
confirm the QS inhibiting concept of this study. Acylase was able to degrade several 
AHL model compounds, including C4-DL-HL, C6-DL-HL, 3-oxo-C10-L-HL, and 3-oxo-
C12-L-HL (Figure 5.1A), through amide bond cleavage, producing HL and the 
corresponding fatty acid. Among them, the acylase-induced degradation of 3-oxo-C12-
L-HL was of main importance as this signal was found to play a key role in P. 
aeruginosa biofilm formation [109, 303]. The enzyme showed higher activity on 3-oxo-
C10-L-HL and 3-oxo-C12-L-HL (more than 50 and 40 % conversion, respectively) 
when compared to C4-DL-HL and C6-DL-HL (up to 10 and 15 % conversion, 
respectively) (Figure 5.1A). Acylase I from A. melleus is highly enantioselective in its 
interaction with the substrate mainly promoting the degradation of the L-configuration of 
amide bond, which suggests that the lower conversion of C4-DL-HL and C6-DL-HL 
was due to the presence of both D- and L-configurations in the substrates [305]. This 
factor may play a significant role in quenching the QS, as bacteria recognize and 
respond to these configurations [306]. 
The bioassay using C. violaceum also revealed the decreasing concentration of the 
QS molecule C6-DL-HL upon contact with acylase (smaller purple area in presence of 
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acylase) accounting for the QQ activity of this enzyme (Figure 5.1B) [287]. Based on 
the observed in vitro enzymatic inactivation of the QS molecules, we assumed that 
acylase from A. melleus could inactivate the AHLs of Gram-negative bacteria such as 
P. aeruginosa and thereby inhibit the signal accumulation in the extracellular 
environment and subsequent biofilm formation. Xu et al. reported similar findings about 
acylase isolated from kidney, which efficiently degraded in vitro several model QS 
signals, C4-HSL and C8-HSL, and inhibited P. aeruginosa biofilm formation on 
polystyrene surface [203]. Therefore, the ability of acylase to interrupt the cell-to-cell 
communication process that the Gram-negative P. aeruginosa uses to coordinate and 
establish resistant biofilm lifestyle, suggested the enzyme application as antibiofilm 
coating on indwelling medical devices. 
 
 
 
 
Figure 5.1 A) AHL degradation by acylase assessed with fluorescamine method and B) C6-DL-
HL degradation study using the C. violaceum CECT 5999 
 
5.1.2 Acylase Multilayer Coatings Build-Up onto Silicone and its 
Characterisation 
In order to obtain a coating with QQ activity, acylase was immobilised in an LbL fashion 
onto silicone sheets and urinary catheters. A pre-amination of the silicone surface with 
APTES was performed in order to provide amine groups for better deposition of the first 
enzyme layer. This chemisorption procedure has been described by some authors as 
likely to take place with a thin water layer on the substrate and not only with hydroxyl 
groups scarcely present on the surface of the material [307]. The successful amination 
of silicone with APTES was confirmed by the formation of Ruhemann’s purple in 2 % 
ninhydrin solution (Figure 5.2A). This was further supported by the presence of two 
dominating vibrational modes found around 1575 and 1485 cm−1 and the shoulder at 
A B 
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1330 cm−1 in the FTIR spectra of the APTES treated silicone. The oxidation upon air 
exposure of such salts gives rise to the formation of imine groups responsible for the 
absorption peak at around 1650 cm−1 (Figure 5.2B) [289, 308].  
 
 
 
 
Figure 5.2 A) Non-treated and APTES-treated silicone sheets after incubation in 1mL of 2 % 
ninhydrin solution. The formation of characteristic Ruhemann’s purple demonstrated the 
presence of amino groups on the surface. B) ATR−FTIR spectra of non-treated and APTES-
treated silicone. Two dominating vibrational modes around 1575 and 1485 cm
−1
 appeared in the 
FTIR spectra of the APTES-treated samples. 
 
After ten consecutive immersions of the silicone material into anionic enzyme 
solution and oppositely charged linear PEI (Mw=25 kDa) typical protein bands, that 
were not observed on the untreated silicone control, appeared in the FTIR spectra of 
the acylase coated samples (Figure 5.3). The band with a maximum around 3300 cm−1 
was assigned to N–H stretching vibrations, whereas the band at 1650 cm−1 and the 
broad region between 1490 and 1590 cm−1 were ascribed to amide I (C=O stretching) 
and amide II (mainly N–H bending) vibrations. The FTIR analysis demonstrated the 
development of the enzyme multilayer assemblies onto the catheter surface [309]. 
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Figure 5.3 Representative FTIR-ATR spectra of (a) untreated silicone and (b) acylase multilayer 
coatings. 
 
The surface morphology and roughness of the acylase/PEI multilayer coatings were 
also studied by AFM. AFM two-dimensional and three-dimensional analysis 
demonstrated nanostructural changes in the silicone surface topography after the 
multilayer coating assembly (Figure 5.4). After deposition of ten bilayers, the silicone 
surface was coated with relatively large clusters (Figure 5.4, right image). The 2D AFM 
topographic profiles, analysed using Nanotec WSxM software, showed that the surface 
roughness of acylase-coated silicone increased when compared to non-treated 
silicone, with a peak height maximum about 35 nm (Figure 5.4). According to the 
generally accepted polyelectrolyte multilayer build-up mechanism, the oppositely 
charged polyelectrolytes form small islets on hydrophobic surfaces, such as those of 
PDMS, at early deposition stages [310]. As the number of deposited layers increases, 
the islets coalesce and become larger until a continuous coating is formed. However, in 
this study, the deposition of ten enzyme-PEI bilayers was not sufficient for a continuous 
and homogeneous coating formation. The number of bilayers required to completely 
cover a substrate surface would be lower when (i) the electrostatic interactions 
between the components of the coating are stronger and (ii) the conformations of the 
adsorbed components are adequate to favour the deposition [311].  
The differences in the surface coverage of the catheter material could be also 
observed in terms of wettability (Figure 5.4). From AFM and water contact angle 
images, it is apparent that the wettability is directly proportional to the extent of silicone 
surface coverage with enzyme protein. The water contact angle of the untreated 
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silicone specimen (136°±10°) decreased significantly after depositing the acylase 
multilayer coating (94°±9°) due to its hydrophilic character (Figure 5.4). 
 
 
 
Figure 5.4 AFM (2D and 3D topographic) and water contact angle images of untreated 
silicone before APTES functionalisation and acylase multilayer coatings. 
 
5.1.3 Acylase Activity in The Multilayers  
The activity of the enzyme in the multilayer coating was evaluated through the 
degradation of N-acetyl-methionine using a standard colorimetric method. Despite 
acylase in the free form efficiently degraded the QS signals and inhibited the P. 
aeruginosa biofilm formation, after immobilisation this efficacy could be impaired due to 
the lower amounts of active protein attached onto silicone surface and loss of 
enzymatic activity [203]. Acylase retained 80 % of its specific activity, when compared 
to the relative amount of protein immobilised on the silicone surface determined by 
measuring the fluorescence of FITC-labelled acylase multilayer coatings. In fact, the 
LbL technique used to construct these enzyme multilayer coatings is considered as a 
method that uses mild conditions (e.g., aqueous solutions) and could preserve the 
protein folding and activity. Most probably, the entrained water presented in between 
the polyelectrolyte layers is the reason why the proteins remained active on the surface 
[141]. Previous studies have shown that enzymes immobilised on different surface 
using LbL approach retained high percentage of their catalytic activity and also were 
more stable than their free counterparts [312-314].  
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The activity of acylase in the multilayered coatings and in solution was further 
determined at physiological conditions by measuring the QS-regulated violacein 
production in reporter bacterial strain C. violaceum [315]. The degradation of C6-DL-
HSL QS molecule by acylase was indicated by the decrease of violacein pigment 
production in the AHL containing liquid broth. Clear difference was observed between 
the positive control (non-treated silicone in the presence of QS molecules) and the 
samples containing immobilised/non-immobilised acylase together with the same 
concentration of QS molecule, where less violacein was synthesized (Figure 5.5A). 
Therefore, acylase multilayer coatings show the ability to act upon the QS signals 
produced by Gram-negative bacteria involved in UTIs, e.g. P. aeruginosa.  
The degradation of C6-DL-HSL in the liquid broth was also quantified 
spectrophotometrically after the extraction of violacein from the C. violaceum cultures 
with butanol [291]. The C6-DL-HSL-inducible violacein production was inhibited by 
acylase up to 40 % in both free and immobilised forms of the enzyme (Figure 5.5B). 
The reduced QS-regulated response of C. violaceum by acylase-coated silicone 
catheters showed their potential for inhibition of QS-controlled biofilm formation. 
 
 
 
Figure 5.5 Violacein production by C. violaceum CECT 5999 in presence of free acylase 
solution and acylase multilayer coatings on silicone. The control - untreated silicone was set as 
100% violacein production.  
B 
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5.1.4 Functional Properties of the Acylase Multilayer Coatings  
After proving the functionalisation of silicone catheters with acylase using LbL 
technique as well as the activity of these multilayered coatings toward the P. 
aeruginosa QS signals, their functionality in terms of antibiofilm activity was also 
assessed. Since the initial bacterial adhesion is thought as a part of the biofilm 
development process on the surface, we studied whether the cell adherence would be 
delayed by the protein multilayer coatings. The initial attachment of P. aeruginosa (after 
3 h of contact) was reduced by the acylase multilayer coating when compared to the 
untreated silicone material (Figure 5.6A). Microscope images showed that P. 
aeruginosa formed bacterial clusters on untreated silicone as a first indicator for the 
initiation of biofilm growth, while the cells present on the acylase coatings were spread, 
and the clusters formed on the surface were considerably smaller (Figure 5.6A). 
Hydrophobic interactions have been suggested as one of the important factors 
promoting bacterial cell adherence on surfaces [316]. The hydrophobic character of the 
silicone surface is believed to govern the primary adhesion of P. aeruginosa, which 
possesses a thin layer of glycoprotein covered by a thick layer of lipoproteins and lipids 
facilitating the interaction of bacterial cells with various hydrophobic surfaces [145]. The 
decrease of P. aeruginosa initial adhesion on the acylase-coated silicone surface could 
have been favoured by the increased hydrophilicity of the enzyme-modified surface. 
These qualitative observations suggested that the process of mature biofilm formation 
could be delayed when silicone is coated with QQ enzyme, e.g. acylase, corroborating 
the results obtained on the ability of acylase coatings to affect the QS process in the 
reporter strain C. violaceum (Figure 5.5). 
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Figure 5.6 A) Initial adhesion of P. aeruginosa on untreated silicone and acylase multilayer 
coatings after 3-h contact (×40 magnification). B) Fluorescence microscopy images of 24 h-old 
P. aeruginosa biofilms (formed in static conditions) on untreated silicone and acylase multilayer 
coatings analyzed after Live/Dead staining (×20 magnification). 
 
Besides increasing the wettability of silicone surface, the specific enzyme function in 
the coating is believed to have a major contribution to the inhibition of biofilm 
maturation on the catheter material. To prove this assumption, the formation of P. 
aeruginosa biofilms after 24 h contact with pristine and coated silicone samples was 
studied in static conditions using CV for total biomass assessment and Live/Dead® cell 
viability kit for structural characterisation of the developed biofilm. Fluorescence 
microscopy images after Live/Dead staining showed that the biofilm is well established 
on the untreated silicone material, with characteristic microcolonies of bacterial cells, 
while on the acylase coated silicone, the biofilm was significantly reduced (Figure 
5.6B). A characteristic 3D structure was observed on the control with both viable 
(stained in green) and non-viable (stained in red) cells due to the repeatable pattern of 
death and lysis in biofilms, which corresponds to the normal course of biofilm 
development of P. aeruginosa [317]. In contrast, only few bacteria spread individually 
on the silicone surface without the presence of typical bacterial clusters were observed 
for the acylase multilayer coatings (Figure 5.6B). The total biomass assessment of the 
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biofilms supported these results showing about 50 ± 0.2 % inhibition of biofilm 
formation on silicone coated with QQ enzyme, when compared to the untreated sample 
(Figure 5.9). 
With the emergence of antibiotic-resistant bacteria, alternative approaches targeting 
different processes than bacteria killing mechanisms to control pathogenic biofilm 
formation on medical devices have been sought. While conventional antibiotics kill or 
inhibit bacteria by targeting their survival processes, interrupting the QS pathways 
through signal degradation efficiently quenched the QS process and inhibited P. 
aeruginosa biofilm formation in static conditions without affecting planktonic bacterial 
growth after 24 h contact (Figure 5.7). Consequently, these multilayer coatings might 
prevent biofilm-associated urinary tract infections exerting less selective pressure on 
the target bacteria and reducing the risk of resistance development. 
 
 
 
Figure 5.7 Inhibition of P. aeruginosa planktonic growth in the presence of untreated silicone 
and acylase multilayer coatings. 
 
Aiming at developing enzymatic coatings for urinary catheters, the stability of the 
developed materials in artificial urine is a prerequisite due to the possible influence of 
the various compounds present in the human fluids on the enzyme activity. Hence, we 
evaluated the biofilm inhibiting activity of acylase coated silicone samples (1 × 1 cm2) 
after 1 and 7 days incubation in artificial urine. No significant difference in the biofilm 
inhibiting capacity of acylase based coatings and the freshly prepared ones was 
observed (Figure 5.9). 
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Figure 5.8 Crystal violet assessment of biofilm formation of P. aeruginosa on untreated silicone 
and acylase multilayer coatings after incubation in artificial urine for 1 and 7 days. 
 
5.1.5 Antibiofilm Efficacy of Acylase Multilayer Coatings in an In Vitro Model of 
Catheterised Human Bladder  
Biofilm formation on pristine and acylase-coated urinary catheters was also evaluated 
in dynamic conditions using a catheterised bladder model, where the shear stress and 
flow rate vary similarly to the situation in the human bladder during catheterisation. 
Biofilms were allowed to grow on the catheters for 7 days, and the biofilm inhibition by 
the acylase-based coating was analysed (Figure 5.9). The fluorescence images after 
staining of live and dead bacteria attached to the balloon and urethra demonstrated 
decreased biofilm formation, when compared to pristine Foley catheters after 7-day of 
catheterisation (Figure 5.9A). The bacterial biofilm formation was inhibited by 80 % in 
the balloon part, which was immersed over 7 days in the bladder model infected with P. 
aeruginosa. The acylase-coated urethra part inserted into the model bladder was also 
able to inhibit the biofilm formation by 45 % compared to the untreated silicone Foley 
catheter (Figure 5.9B). The results obtained with the dynamic system showed the same 
tendency in inhibiting biofilm formation as in static conditions. Therefore, the acylase-
coated Foley catheters would have potential in preventing biofilm-associated UTIs. 
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Figure 5.9 A) Microscopic images of untreated and acylase coated Foley catheters after 7 days 
incubation in dynamic bladder model system (40x magnification); B) Crystal violet assessment 
of total biomass formed on urinary catheters: untreated and acylase multilayer coatings on 
silicone Foley catheter.    
 
5.1.6 Biocompatibility Evaluation 
Prior to the utilisation of these enzyme multilayer coatings on urinary catheters in vivo 
their potential cytotoxicity to human cells is an essential parameter that should be taken 
into account. Despite the presence of PEI, regarded as toxic, the acylase coated 
B 
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silicone material did not cause any adverse effect upon interaction with human cells 
compared to the pristine silicone (Figure 5.10) [318]. Neither 24 h nor 7 days of contact 
affected cells viability, suggesting that the PEI in the coatings is in a rather low 
concentration to affect the human cells viability [318]. Moreover, the combination with 
negatively charged enzymes during the LbL assembly may reduce the availability of 
positively charged PEI amino groups thought to induce human cells cytotoxicity [319]. 
Previous studies have shown that the toxicity of amine-terminated polymers is solely 
related to their positive charges. In particular, the acylation of the amine groups of PEI 
to form neutralized and negatively charged materials has been shown to provide 
biocompatibility with mammalian cells [320]. Based on the results about the cytotoxicity 
and antibiofilm activity (Figure 5.10 and Figure 5.9, respectively), we assumed that the 
prolonged usage (over 7 days) of enzyme-modified catheters in vivo would not imply 
any concern for consumer’s safety. Thus, the QQ active coatings could be a promising 
alternative to control biofilm-associated urinary tract infections. 
 
 
Figure 5.10 Viability of fibroblasts (BJ5ta) after being in contact with untreated silicone and 
acylase multilayer coatings: 1 day and 7 days. 
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5.1.7 Conclusions  
The strategy used in this work to induce antibiofilm activity on indwelling medical 
devices is considered beyond the state of the art because it targets the inactivation of 
bacterial QS process, instead of simple killing of bacteria and related antibiotic 
resistance issue. While conventional antibiotics kill or inhibit bacteria by targeting their 
structure or survival processes, interfering with QS pathways is thought to exert less 
selective pressure on bacterial population and could reduce the threat of resistance 
emergence. In fact, inactivation of AHL signals in the extracellular environment is a way 
of breaking down the bacterial communication before it starts. As a consequence, 
bacteria will not realise that the threshold population density was achieved necessary 
to establish mature biofilm on silicone material.  
In summary, we have developed coating on silicone catheter surface that significantly 
reduced the formation of P. aeruginosa biofilm due to the acylase-induced degradation 
of QS signals involved in bacterial cell-to-cell communication process. These findings 
suggested that the acylase coated catheters could be a viable alternative to prevent 
QS-regulated biofilm occurrence on urinary catheters.  
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5.2 Quorum Quenching and Matrix Degrading Enzymes in Hybrid Multilayer 
Coatings  
 
Herein we attempt 
to integrate for the 
first time two 
enzymatic inhibition 
approaches into a 
unique and efficient 
antibiofilm strategy. 
The enzymes 
acylase and α-
amylase were used 
to interfere 
simultaneously with 
bacterial QS 
phenomenon and biofilm stability of Gram-negative species, respectively. To achieve 
this, we deposit acylase and/or α-amylase in a LbL fashion to build multilayer coatings 
on silicone catheters able to prevent drug-resistant biofilm formation. The ability of 
these enzymes to interfere with the bacterial QS process and to degrade the 
polysaccharides of P. aeruginosa biofilm matrix is assessed. The activity of the 
coatings comprising both enzymes against Gram-negative P. aeruginosa, Gram-
positive S. aureus, and dual-species (P. aeruginosa and E. coli) biofilms is further 
investigated under static and dynamic conditions using a physical model of 
catheterised bladder. Finally, the in vivo rabbit model is used to assess the potential of 
the developed materials to control bacterial biofilm formation on indwelling medical 
devices in a clinical setting. 
 
 
 
 
 
This section is based on the following publication: 
Ivanova K, Fernandes MM, Francesko A, Mendoza E, Guezguez J, Burnet M, Tzanov T “Quorum-
quenching and matrix-degrading enzymes in multilayer coatings synergistically prevent bacterial biofilm 
formation on urinary catheters”, ACS Applied Materials & Interfaces, 2015, 7(49):27066-77. doi: 
10.1021/acsami.5b09489.   
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5.2.1 Enzymatic Degradation of Biofilm Matrix Components 
The efficacy of acylase in inhibiting QS-regulated biofilm formation through the in vitro 
degradation of several model AHL signals was already demonstrated in the previous 
section (Figure 5.1). Therefore, prior to catheter coating, only the ability of α-amylase to 
degrade the EPS biofilm components in vitro was assayed in order to evaluate the 
potential of the entire concept. 
Exopolysaccharides are one of the major fractions of EPM that play an important 
adhesive and structural role in biofilms. Depolymerisation of EPS is expected to 
prevent irreversible bacterial adhesion and further biofilm formation [25]. Taking into 
account the wide heterogeneity of EPS between bacterial species, we investigated in 
vitro the ability of α-amylase to degrade several model EPS including alginate, 
hyaluronic acid, polygalacturonic acid, and chitosan (Figure 5.11). Alginate is the main 
capsular EPS produced by mucoid bacterial strains such as pathogenic P. aeruginosa, 
and it aids surface colonisation and biofilm persistence [321]. Hyaluronic acid was 
shown to support Streptococcus pneumonia growth within biofilms in vitro [322]. The 
other exopolysaccharides herein examined (polygalacturonic acid and chitosan) are 
model EPS components and potential α-amylase substrates. The enzyme efficiently 
hydrolysed chitosan and hyaluronic acid glycosidic bonds, yielding 10 and 4 μg/U 
reducing sugars (in glucose equivalents), respectively, in good agreement with 
literature (Figure 2.1) [323]. In contrast, polygalacturonic acid and alginate were 
degraded to a lower extent, releasing 2.6 and 2.5 μg/U reducing sugars, respectively. 
α-Amylase normally catalyses the endohydrolysis of 1,4-α-glycosidic bonds in 
polysaccharides, but other factors such as the specific tertiary and quaternary 
structural domains, i.e., crystalline and amorphous regions, can also affect the 
breakdown process [324]. Relying on the successful in vitro degradation of the model 
EPSs, α-amylase was further evaluated in the form of multilayer coatings for preventing 
biofilm formation. 
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Figure 5.11 In vitro degradation of model exopolysaccharide components of bacterial biofilm 
matrix by α-amylase. 
 
5.2.2 Characterisation of the Multilayer Enzyme Coatings 
To obtain active antibiofilm coatings, amylase and/or acylase were further deposited in 
a LbL manner on APTES pre-treated silicone stripes and Foley catheters (Figure 5.2). 
The aminated silicone/catheter was subjected to 10 sequential immersions into 
negatively charged acylase or amylase solution and cationic PEI. Three typical protein 
bands were observed in the FTIR spectra of all enzyme-coated surfaces (Figure 5.12A: 
b−e). The absorption band around 3300 cm−1 was assigned to the N−H stretching 
vibrations, whereas the vibration modes found at 1650 cm−1 and the region between 
1490 and 1590 cm−1 correspond to amides I and II. These signals did not decrease 
even after 7 days of incubation in artificial urine, pH 6.8, at 37 °C with shaking (20 rpm), 
demonstrating the formation of stable enzyme-based multilayer assemblies. For 
simplicity, only the LbL Amy spectra are shown here (Figure 5.12B). 
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Figure 5.12 A) ATR-FTIR spectra of a) pristine silicone, and multilayer assemblies: b) LbL Acy, 
c) LbL Amy, d) LbL Hyb-Acy and e) LbL Hyb-Amy; and B) normalised LbL Amy spectra: non-
washed (dot line), washed (solid line). 
 
The morphology of the obtained coatings was further studied using AFM. The 2D and 
3D AFM images clearly demonstrated the changes in the surface topography after the 
enzymes deposition onto silicone (Figure 5.13). The 2D topographic profiles were 
further analysed along the drawn lines to determine the surface roughness (Figure 
5.13, inset images). For comparison, the unmodified silicone surface was also 
examined and was found to display a roughness with a 60 nm peak height maximum 
(Figure 5.13A). The AFM images show uneven build-up of protein multilayer coatings 
after 10 sequential depositions of enzyme and PEI (Figure 5.13 B−E). Nevertheless, 
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considering that the coatings are made of enzymes the observed nonhomogeneous 
surface could even be an advantage. Deposition of enzymes in continuous coatings 
may hinder the substrates’ diffusion and consequently decrease the specific activity of 
the amylase and acylase per layer [318, 325]. 
 
 
 
Figure 5.13 AFM images of A) pristine silicone surface and enzyme-coated silicone: B) LbL 
Amy, C) LbL Acy, D) LbL Hyb-Acy and E) LbL Hyb-Amy 
 
The interactions between polyelectrolytes govern the build-up process of the 
polyelectrolyte multilayer coatings, distinguishing between linear and exponential mode 
of growth [326]. The exponential mode, a faster mode of growth, implies an effective 
diffusion of the polyelectrolytes “in and out” of the coating during the build-up process 
[326]. On these particular AFM images, acylase-containing coatings (LbL Acy and LbL 
Hybrid with either acylase or amylase as outermost layer) displayed larger islets 
compared to the amylase-based multilayers (LbL Amy) and, consequently, greater 
silicone surface coverage (Figure 5.13). In fact, more enzyme protein was deposited on 
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the silicone material when both enzymes (amylase and acylase) were used for the LbL 
build-up process (Table 5.1).  
Table 5.1 Protein content on silicone surface. 
Sample 
Protein content 
(ng/cm2) 
LbL Amy 77,72 ± 3,65 
LbL Acy 81,33 ± 1,32 
LbL Hyb-Acy 301,65 ± 9,24 
LbL Hyb-Amy 322,15 ± 2,53 
 
This probably means that the mode of growth is different when acylase versus α-
amylase is used as a polyanion (exponential vs linear, respectively). The former 
hypothesis is corroborated by the surface morphology of the obtained multilayers. The 
uneven surfaces of the acylase-containing assemblies indicate heterogeneity in their 
outermost layers in agreement with the polyelectrolyte diffusion in and out of the 
coating during the exponential growth. In contrast, the smoothness of the amylase 
assembly indicates homogeneity of the outermost surface with no diffusion of the 
polyelectrolytes, corresponding to a linear coating growth. 
The non-continuous nature of the enzymatic assemblies further allowed for a direct 
measurement of their thicknesses (without scratching the coating with the tip of the 
cantilever; Figure 5.13, graph insets). It is worth mentioning that the size of the islets 
was not related to the coating thickness, with the LbL Amy multilayer being the thickest 
among all experimental groups. 
The protein release from the surface as a function of incubation time was further 
analysed using fluorescence spectroscopy to assess the physical stability of the 
coatings in urine. The relative cumulative release of FITC-labelled enzymes, amylase 
or acylase, in artificial urine, pH 6.8, was monitored over 7 days, corresponding to the 
extended useful life of the enzyme-treated urinary catheters in this study (Figure 5.14). 
The increase in the fluorescence intensity with time was sharp during the whole 7 day 
period for the LbL Amy assembly. In contrast, when acylase was used individually or in 
a combination with amylase, a different release pattern was observed (Figure 5.14A). 
The cumulative release of LbL Acy, LbL Hyb-Acy, and LbL Hyb-Amy assemblies within 
the time of incubation demonstrate an exponential tendency with negligible burst 
release at the beginning (after 1 day of incubation; Figure 5.14A). Such outcome might 
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be related to the presence of branched PEI in the multilayer coatings that increases 
their stability similar to previous works demonstrating prolonged stability of PAA/DNA 
multilayers due to PEI insertion [314]. 
Additionally, fluorescence microscopy was used to qualitatively assess the stability of 
the coatings in the presence of artificial urine after 7 days of incubation. The 
fluorescence intensity images of silicone surface did not show detectable differences in 
the intensity and surface homogeneity before (0 days) and after (7 days) incubation, 
which indicated the formation of stable enzyme coatings. For simplicity, only the LbL 
Hyb-Amy images are shown here (Figure 5.14B). 
 
 
Figure 5.14 A) Cumulative fluorescence intensity vs. time of incubation for: LbL Amy (▪), LbL 
Acy (●), LbL Hyb-Acy and (∆)LbL Hyb-Amy (○). B) Microscopic images of FITC labelled LbL 
Hyb-Amy coatings before (0 days) and after (7 days) incubation in artificial urine. 
  
 90 
 
5.2.3 Enzymes Activities in the Multilayers 
The activity of the enzymes, in both immobilised and free forms, on biofilm components 
was further evaluated. The ability of acylase to interfere with bacterial QS process 
through AHL inactivation in bacterial surroundings (i.e., acylase QQ activity) was 
assessed at physiological conditions by C. violaceum. The antibiofilm potential of 
amylase was determined by the amount of the released reducing sugars upon the 
degradation of EPS-based biofilm matrix extracted from P. aeruginosa. 
All acylase-containing coatings (LbL Acy, LbL Hyb-Amy, and LbL Hyb-Acy) 
inactivated the C6-HSL signal in the extracellular environment of C. violaceum and 
inhibited QS-regulated violacein production up to 40 % compared to 100 % violacein 
production in the control (untreated silicone, Figure 5.15A). In addition, no significant 
difference in QQ activity was observed between acylase in free and immobilised forms. 
Therefore, the LbL approach used to deposit acylase on silicone material favours the 
preservation of the enzyme QQ activity. The enzyme treated surfaces did not affect C. 
violaceum growth after 24 h (turbidity was observed with naked eye), suggesting their 
potential to inhibit bacterial biofilm formation by interfering only with the QS process. 
Therefore, the enzyme based approach used in this study would not induce selective 
pressure on bacteria to become resistant [302]. 
After 10 sequential deposition steps on the silicone surface, individually or together 
with the QQ acylase, α-amylase was still able to degrade P. aeruginosa biofilm EPS, 
confirmed by the amount of released reducing sugars (Figure 5.15B). Lower values of 
reducing sugars were obtained for the LbL Amy assembly when compared to those 
obtained with the hybrid coatings that demonstrated higher EPS-degrading activity, 
especially when amylase was the outermost layer (Figure 5.15B). In fact, the EPS 
components of P. aeruginosa EPM are high-molecular-weight biomolecules that diffuse 
slowly in the multilayers; consequently, the contact with the enzymes could be limited 
and the specific activity decreased [321]. In contrast, less enzyme protein was 
deposited in the LbL Amy assemblies, suggesting that these amounts do not possess 
sufficient activity to act on the EPS of P. aeruginosa biofilm matrix (Table 5.1). Despite 
the lower α-amylase activity on EPM extracted from previously formed P. aeruginosa 
biofilms, we believe that at physiological conditions, i.e. during the biofilm formation, α-
amylase would affect the EPS once bacteria are attached and biofilm matrix is 
produced. Therefore, the potential of the hybrid coatings to inhibit P. aeruginosa biofilm 
formation was further investigated and compared to that of the coatings of amylase and 
acylase applied individually on the silicone material.  
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Figure 5.15 A) Quantification of violacein production in presence of acylase and 
acylase/amylase comprising coatings. B) EPS-induced degradation by α-amylase comprising 
silicone samples.  
 
5.2.4 Antibiofilm Activity of Enzyme Multilayers in Static Conditions 
The biofilm occurrence by P. aeruginosa was assessed on treated and untreated 
silicone catheters under static conditions using CV assay. After 24 h of incubation with 
P. aeruginosa, the total biofilm mass formed on enzyme multilayers was reduced when 
compared to that on pristine silicone (100 % biofilm formation, Figure 5.16). Individually 
immobilised acylase or amylase inhibited the biofilm growth by 30 %, whereas the 
hybrid coatings demonstrated an enhanced antibiofilm efficiency, decreasing the total 
biomass by 38 and 60 % for LbL Hyb-Amy and LbL Hyb-Acy, respectively (Figure 
5.16A). The QQ enzyme of the hybrid’s outermost layer played a key role in the biofilm 
inhibition, increasing significantly its antibiofilm activity by more than 20 % of that of the 
other LbL Amy, LbL Acy, and LbL Hyb-Amy assemblies (Figure 5.16A). Such outcomes 
could be related with the natural sequence of P. aeruginosa biofilm development−from 
bacterial communication to surface attachment and EPS based matrix production. The 
deposition of acylase as the top layer (closest to the solution) reduces the diffusion 
time and path for the QS signals increasing the overall biofilm inhibiting effect of the 
hybrid coatings [327]. 
Amylase in the multilayer coatings may insert its activity upon the biofilm matrix of 
both Gram-negative and -positive bacterial species; thus, the potential of these 
assemblies to counteract biofilm formation of S. aureus was also evaluated [328, 329]. 
As expected, acylase-coated silicone samples were able to quench only the AHL-
based QS of Gram-negative bacteria and did not affect the biofilm occurrence of Gram-
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positive S. aureus, a bacterium that uses other QS signals to induce virulence and form 
biofilms [38]. In contrast, all amylase coatings demonstrated different tendencies in 
inhibiting S. aureus biofilms (Figure 5.16A), with LbL Amy being the most efficient. 
Following the combination of both enzymes in the hybrid assemblies, the antibiofilm 
activity decreased. Although both enzymes acylase and amylase in these coatings act 
sequentially on two key components (QS and EPS) of P. aeruginosa biofilm growth, in 
the case of S. aureus, amylase may exert its activity only on the biofilm matrix. 
Therefore, the overall synergistic efficiency of the hybrids toward this Gram-positive 
bacterium will be reduced. On the basis of these observations, we assume that the 
developed materials possess greater potential against Gram-negative bacteria (Figure 
5.16A). Fluorescence microscopy images of live (green) and dead (red) bacteria in the 
biofilm corroborated these results: A well-established S. aureus biofilm was observed 
on pristine silicone and acylase multilayers, whereas fewer bacterial clusters were 
attached on LbL Amy, LbL Hyb-Amy, and LbL Hyb-Acy (Figure 5.16C). Moreover, the 
bacterial clusters depicted in the images were smaller on LbL Hyb-Amy than on LbL 
Hyb-Acy, suggesting that the antibiofilm activity of these coatings is a function of the 
QQ or EPS-degrading enzymes position in the layers. 
 
 
  
 
 
 
 
  
 
 
 
 
 
 Figure 5.16 (A) Inhibition (%) of single-species (P. aeruginosa and S. aureus) and dual-species 
(P. aeruginosa and E. coli) biofilm formation on enzyme coated silicone catheters. Stars 
represent the statistical differences between the different groups of samples; p < 0.05. (B) 
Fluorescence microscopy images of P. aeruginosa biofilms grown for 24 h on pristine and 
enzyme-coated silicone materials analysed after Live/Dead staining. (C) Fluorescence 
microscopy images of S. aureus biofilms grown for 24 h. (D) Fluorescence microscopy images 
of mixed P. aeruginosa and E. coli biofilms. The green and red fluorescence images are 
overlaid in one picture for better comparison of live and dead cells, respectively. 
 
Most biofilms that colonise catheter surfaces are mixed bacterial communities with 
enhanced resistance and virulence. Therefore, the occurrence of dual-species biofilm 
with two Gram-negative bacterial species, P. aeruginosa and E. coli, was also studied. 
CV assessments of total biomass grown on treated and untreated silicone material 
revealed the same tendency as single P. aeruginosa biofilms (Figure 5.16A). 
Significant biofilm reduction was observed for LbL Hyb-Acy assemblies with acylase 
initially acting on the AHLs produced by P. aeruginosa and α-amylase exerting its 
activity on the EPS produced by both P. aeruginosa and E. coli (Figure 5.16A). The 
single- and dual-species biofilms were well-established on pristine silicone material, 
fully covering its surface, whereas on the enzyme based multilayer coatings, the 
biomass was decreased (Figure 5.16B and D). Although no significant difference was 
observed for the coatings individually comprising amylase or acylase, less viable 
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bacteria (stained in green) were visualized on the LbL Hyb-Acy assemblies on silicone 
(Figure 5.16B and D). The overlapped images of green and red fluorescence showed 
the presence of live bacteria on the enzyme-coated catheters, which suggested that 
these active agents do not possess antibacterial activity, i.e., do not kill bacteria. The 
lower quantity of biomass observed on these images indicated the prevention capacity 
of the multilayered coatings on the silicone surface, due to the ability of the enzymes to 
exert QQ and/or EPS-degradation activities against biofilm-forming Gram-negative 
bacteria. 
Further studies have shown that the hybrid coatings could control the single- and 
dual-species biofilm formation without affecting planktonic bacterial growth (Figure 
5.17), an important outcome that is believed to decrease the risk of emergence of 
multidrug resistance. Consequently, interfering simultaneously with the QS process 
and EPM constituents that are essential for pathogenic biofilm growth could be a viable 
alternative for controlling biofilm establishment on urinary catheters. 
 
 
 
Figure 5.17 Planktonic growth of Gram-negative P. aeruginosa, Gram-positive S. aureus, and 
mixed inoculum of P. aeruginosa and E. coli in the presence of pristine silicone and multilayer 
enzyme coatings. 
 
Considering the previously reported antibiofilm activity of PEI, it was also reasonable 
to assess its biofilm inhibition potential in the multilayers [330]. Thereby, PEI and an 
inactive protein (e.g. BSA) were sequentially deposited in a LbL fashion on silicone 
material. The developed coatings did not reduce the total P. aeruginosa biomass, 
confirming that the above demonstrated antibiofilm activity towards Gram-negative 
bacteria is a result of acylase and amylase activity upon the target biofilm components 
(Figure 5.18). Likewise, the electrostatic interactions with the enzymes in the 
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multilayers might decrease the amount of PEI amino groups required to interact with 
negatively charged membrane and disrupt bacterial cells [331]. 
 
 
 
Figure 5.18 P. aeruginosa biofilm growth on pristine silicone and polyethyleneimine/bovine 
serum albumin (PEI/BSA) multilayer coatings 
 
5.2.5 Dynamic Biofilm Inhibition Tests 
The hybrid coatings, which demonstrated high efficiency in controlling single- and dual-
species biofilm formation of Gram-negative bacteria, were further subjected to dynamic 
biofilm inhibition tests in a physical model of the human bladder. After 7 days of 
catheter incubation in the bladder model, the biofilms formed on urinary catheters 
surface were studied using CV and live/dead cell viability assays. Although different 
growth conditions are present in the dynamic system, the observed biofilm inhibition by 
the enzyme-treated silicone catheters was comparable to that obtained under static 
conditions. The total biofilm mass of Gram-negative bacteria on the catheter shaft was 
significantly reduced for the LbL Hyb-Acy catheters (Figure 5.19). However, when the 
bladder was infected with Gram-positive bacteria, the hybrid assemblies with amylase 
as outermost layer were more active, similar to what was observed in the static 
environment. Single-species P. aeruginosa biofilm formation was inhibited up to 70 % 
by the acylase-terminated hybrid LbL coatings, whereas only 10 % of biofilm was 
reduced for the hybrid assemblies with EPS-degrading amylase as the outermost layer 
(Figure 5.19A). Recently, Cole et al. demonstrated that urea might induce the 
production of an EPS-independent biofilm matrix in some P. aeruginosa strains [109]. 
Under dynamic conditions, simulated urine may affect the EPS production by this 
bacterium, hindering the matrix-degrading potential of amylase in the coatings. Hence, 
to establish biofilm on the catheter surface, P. aeruginosa switches its genetic program 
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and produces extracellular DNA-based matrix, under the control of the QS process 
[332]. Under these conditions, QQ acylase on the top of the layers play a key role in 
inhibiting the QS-regulated P. aeruginosa, as confirmed by fluorescence microscopy. 
Thinner biofilms lacking the characteristic mushroom formations on the urethra surface 
were observed after microscopic visualization of live and dead bacteria on the LbL 
Hyb-Acy surface (Figure 5.19B). We hypothesise that the efficiency of the hybrid 
coatings is a function of the position of the active agent in the layers, which was further 
confirmed through the biofilm inhibition tests toward S. aureus. Although no significant 
difference was obtained in between the hybrids in static conditions, dynamic 
experiments in vitro revealed improved functional characteristics when amylase was 
assembled as a top layer (Figure 5.19). 
Under dynamic conditions, S. aureus showed a lower degree of biofilm formation on 
pristine silicone catheter shaft (Figure 5.19B) than when grow in static conditions 
(Figure 5.16C). Because of the low urine flow, the catheter shaft presents a liquid−air 
interface, and in contrast to P. aeruginosa and E. coli, under these conditions the 
facultative anaerobic S. aureus hardly builds biofilms [289, 333]. Because most of the 
biofilms colonising catheter surfaces contain more than one species, we assumed that 
the presence of α-amylase in the multilayers could interfere with EPS dependent 
biofilms of other Gram-negative species that do not rely only on the AHLs based 
signalling to establish biofilms. Herein, we demonstrated that the biomass formed 
simultaneously by P. aeruginosa and E. coli was decreased when the silicone surface 
was functionalized with both acylase and amylase. Despite the fact that LbL Hyb-Amy 
catheters did not exert significant antibiofilm activity toward single P. aeruginosa 
species, the dual species biofilm occurrence was inhibited by more than 20 % (Figure 
5.19A). Considering the previously described mode of growth in artificial urine of mixed 
P. aeruginosa and E. coli biofilms, we suggested that the EPS-degrading enzyme in 
the hybrid coatings could affect the initial E. coli colonisation on the catheters and 
prevent the total dual-species biofilm growth [334]. Previous studies demonstrated the 
importance of EPS such as cellulose, colanic acid, and poly-L-1,6-N-acetyl-D-
glucosamine for E. coli biofilm occurrence; therefore, their degradation by amylase 
might reduce the total biomass attached to the silicone materials [334]. LbL Hyb-Acy 
samples however showed enhanced antibiofilm activity by up to 15 % when compared 
to that of LbL Hyb-Amy (Figure 5.19A), which could be associated with the acylase QQ 
activity against P. aeruginosa because E. coli cannot produce AHLs. The inhibition of 
single- and dual-species biofilm formation up to 50 % demonstrated the potential of 
these enzyme-decorated silicone surfaces to control bacterial biofilms of one or more 
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species targeting simultaneously AHL based QS systems and EPS adhesives of the 
most frequently found Gram-negative pathogens in CAUTIs [95]. 
The fluorescence images of LbL Hyb-Acy catheters also confirmed their capacity to 
delay the single- and dual-species mature biofilm formation over 7 days in the in vitro 
catheterized human bladder (Figure 5.19B). Although characteristic bacterial clusters 
were visualized on pristine silicone surface, fewer live P. aeruginosa bacterial cells 
(stained only in green) were observed on LbL Hyb-Acy catheter shaft in the single-
species experiments (Figure 5.19B), whereas the presence of small cells clusters in the 
mixed biofilm tests on the treated coatings in the CV quantification assay showed 
reduction of the biofilm growth by 50 % (Figure 5.19A), suggesting their potential to 
control dual-species biofilm development on medical devices. 
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Figure 5.19 Biofilm inhibition tests of in vitro catheterized bladder model system. (A) Inhibition 
of P. aeruginosa, S. aureus, and mixed species (P. aeruginosa and E. coli) biofilm formation on 
enzyme-coated silicone urinary catheters assessed with CV. Stars represent the statistical 
differences between the different groups of samples; p < 0.05. (B) Fluorescence microscopy 
images of live (green) and dead (red) bacteria in biofilms grown for 7 days on pristine and 
enzyme-coated silicone Foley catheter shaft. The green and red fluorescence images are 
overlaid in one picture for better comparison. 
 
5.2.6 Biocompatibility Tests 
Because the PEI used in the assembly of the hybrid multilayers is regarded as a toxic 
compound, it was important to evaluate the effect of the developed materials on human 
cells for further biomedical application [335]. To assess the cytotoxicity of the materials 
independent from the influence of their mechanical properties, the coated silicone 
samples were placed in contact with previously cultured cells. This method would allow 
study of the potential effect of the released PEI from the surface on the skin fibroblasts 
during the time of incubation [336]. The results obtained after 1 week of contact with 
human cells demonstrated no significant difference between enzyme-coated materials 
and control-pristine silicone (nontoxic material; Table 5.2). The human cells viability 
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was not affected, and more than 90 % of the cells were viable, suggesting that the PEI 
is in amounts insufficient to cause toxicity and/or is not released to the medium [335]. 
The interaction of positively charged PEI with negatively charged amylase or acylase 
could also lead to the neutralization of PEI amino groups and subsequent reduction of 
its cytotoxicity. In principle, polymers containing amino groups damage human cells 
because of their strong positive charges [320, 337]. Modifications of polymeric 
backbone in order to decrease the positive charge of PEI including the acylation of the 
amine groups were shown to possess very good biocompatibility with mammalian cells 
[338]. 
Table 5.2 Viable human fibroblasts (BJ5ta) after 7 days of contact with silicone samples  
Sample Silicone LbL Acy LbL Amy 
LbL Hyb-
Acy 
LbL Hyb-
Acy 
Fibroblasts 
viability 
(%) 
88.3 ± 6.7 88.9 ± 7.1 87.7 ± 3.6 91.4 ± 4.2 88.8 ± 4.6 
 
5.2.7 In Vivo Biofilm Inhibition Tests 
The antibiofilm activity of the hybrid multilayer coatings in which the outermost layer 
was the QQ enzyme acylase was further studied in vivo using a rabbit model. After 7 
days of catheterisation, the catheters were removed and analysed for biofilm formation. 
Because the enzymes used in this work do not affect planktonic bacterial growth but 
rather the mechanism of biofilm formation, only the reduction of bacterial biofilm growth 
inside and outside the catheters surface was examined. 
Photographs of the collected catheters demonstrate that LbL Hyb-Acy coatings inhibit 
to a certain extent biofilm formation on silicone catheters. Nevertheless, the antibiofilm 
activity of the enzyme based coatings varied depending on the catheter segments and 
their location, inside or outside the animal body (Figure 5.20). 
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Figure 5.20 Biofilm formation in in vivo rabbit model. A) Representative images of the control 
catheter and enzymes coated silicone urinary catheters and B) Total biomass formation after 7 
days of catheterisation.  
 
Quantification of the total biofilm growth on the catheters surface further revealed the 
potential of acylase and amylase in the multilayer coatings to synergistically reduce 
biofilm formation up to 70 % on the balloon part (Figure 5.20, right side photo). The 
biofilms on catheter balloon are frequently associated with bacterial colonisation of 
bladder epithelia; thus, the significant biofilm reduction observed in this part of the 
catheter is thought to decrease the trauma to the bladder and consequently delay UTI 
occurrence [339]. The main complication during catheterisation, however, is the 
A 
 102 
 
blockage of the urine flow through the catheter as a result of mature biofilm formation 
on the luminal surfaces/catheter shaft. A common way for bacteria to access the 
bladder and colonise the device surface is through the catheter tip during the insertion 
into the body. Once attached, bacteria move with the urine flow along the catheters 
segments and establish biofilms [339]. Despite the biofilm growth on the catheter tip, 
the enzymes delayed biofilm spread along the inner side of the catheter shaft by more 
than 30 % when compared to the spread along the control silicone catheter. 
Consequently, we believe that amylase and acylase multilayers are able to delay the 
biofilm growth of medically relevant bacterial species such as P. aeruginosa and E. coli 
that prefer to grow on the air−liquid interface constantly present on the catheter shaft, 
which is the most attractive site for bacterial growth. Similarly, enhanced antibiofilm 
activity of the balloon immersed in the urine during the time of incubation versus the 
lower effect on the tip and catheter shaft was obtained previously in the in vitro model 
of human catheterized bladder infected with Gram-negative P. aeruginosa [289]. 
Although our initial findings are in good agreement with the results obtained in vitro, the 
in vivo study has revealed several limitations. A small number of rabbits were tested in 
each group, and the enzymes in the coatings prevented biofilm occurrence on catheter 
segments depending on the location in the animals’ body. Considering the resistance 
mechanisms of bacterial biofilms, it can be hypothesized that delaying the biofilm 
growth would further increase the bacteria susceptibility to antimicrobials at 
subinhibitory concentrations. 
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5.2.8 Conclusions 
Emerging resistance of bacteria and their biofilms to conventional antibiotic treatments 
requires the development of novel approaches to counteract the biofilms and device-
associated infections in clinical settings. Targeting the extracellular components of 
biofilms is thought to decrease the possibility of resistance development because of 
reduced selective pressure on bacterial population and is emerging as a potential 
alternative for antibiofilm strategies. The ability of acylase and α-amylase to degrade 
QS signalling molecules and polysaccharide components of the biofilm matrix makes 
them potentially applicable as antibiofilm active agents. This study combined these two 
negatively charged enzymes with positively charged branched PEI in a sequential 
multilayer fashion to build stable and biocompatible multilayer coatings on silicone 
catheter material. Both individual enzyme coatings inhibited the aggregation of 
medically relevant Gram-negative P. aeruginosa and Gram-positive S. aureus on 
silicone catheter under static conditions. However, combining the two antibiofilm 
enzymes into a hybrid multifunctional surface coating resulted in enhanced antibiofilm 
activity against only P. aeruginosa and mixed-species (P. aeruginosa and E. coli) 
biofilms because of their simultaneous action on biofilm components, i.e., QS signals 
and EPS adhesives. Moreover, the obtained preliminary results in the in vivo rabbit 
model suggested the potential of this alternative enzyme-integrated strategy to delay 
pathogenic biofilm formation on urinary catheters. 
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5.3 Bacteria-Responsive Multilayer Coatings Comprising Polycationic 
Nanospheres 
 
 
In the current study, 
sonochemically-processed 
NSs from cationic AC 
conjugate are combined 
with biodegradable HA to 
engineer “smart” 
bacteria/biofilm resistant 
coating. The rationale of 
this work comes from 
previous findings in our 
group that planktonic 
bacteria are more 
susceptible to nano-sized cationic biopolymers than to their free counterparts [147]. 
The bactericidal efficacy is result of massive membrane surface defects caused by 
ACNSs and consequent disruption of bacterial cell wall. The efficiency of the developed 
multilayer coatings incorporating ACNSs to eradicate bacteria and prevent biofilm 
occurrence on demand, i.e. only in presence of pathogenic bacteria, is demonstrated in 
both static and dynamic conditions, mimicking the real situation during catheterisation.  
 
 
 
 
 
 
This section is based on the following publication:  
Francesko A, Fernandes MM, Ivanova K, Amorim S, Reis RL, Pashkuleva I, Mendoza E, Pfeifer A, Heinze 
T, Tzanov T “Bacteria-responsive multilayer coatings comprising polycationic nanospheres for bacteria 
biofilm prevention on urinary catheters”, Acta Biomaterialia, 2016, 33: 203-12. 
10.1016/j.actbio.2016.01.020.  
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5.3.1  Assembling Of the Multilayer Coatings 
The successful build-up of the LbL assemblies was confirmed by QCM-D. The obtained 
results suggested an exponential growth of the coatings with each deposition (Figure 
5.22). Typical stepwise decrease in frequency (F) was measured for both coatings, 
i.e. for (HA/ACsol)5 and (HA/ACNSs)5, showing the overall increased mass adsorption 
(F in Figure 5.21, A1 vs. B1, black lines) bigger in the case of the coating obtained 
with ACsol as polycation. Since ΔF accounts for both polyion and water deposition on 
the QCM crystal, the bigger mass adsorption obtained for ACsol specimen may 
indicate less adsorbed polycation in the case of ACNSs or more hydrated LbL 
constructs when ACsol is used. The dissipation curves supported the former statement 
as true. In contrast, more dissipative layers were measured for (HA/ACNSs)5 (Figure 
5.21, A1 vs. B1, blue lines). The formation of the first layer, HA on APTES treated 
silicone is characterized with a strongly attached (very small ΔD) ad-layer formed (the 
first green arrows on Figure 5.21, A1 and B1), followed by the attachment of a loosely 
bound polycation in both cases (Figure 5.21, A3 and B3), seen via higher dissipation 
shifts from the second layers (the first red arrows on Figure 5.21, A1 and B1). The 
formation of the first layer is the same for both constructs and it is merely 
electrostatically driven, as the negatively charged carboxyl groups from HA interact 
with the positively charged amino groups (from APTES) available on the silicone 
surface. Because of the charge compensation between the surface and the first layer, 
the second layer is not fixed by strong electrostatic interactions. Weakly bound 
polycations (from the second layer) allow for larger amount of trapped water that 
contributes to the higher dissipation shifts [340].However, the absolute values for ΔD, 
as well as the shape of the dissipation signal for the second layer are different for 
ACsol and ACNSs. Upon the injection of ACsol in the QCM chamber, a burst increase 
of ΔD is observed, followed by a common stabilization of the dissipation signal (marked 
by the first blue arrow on Figure 5.21, A1). When ACNSs is used as a polycation, a 
steady increase of ΔD is detected instead. We have also plotted ΔD vs ΔF (Figure 
5.21, A2 and B2) to relate the dissipation caused by a unit frequency (mass) change. A 
comparison between these two plots demonstrate clearly that in the case of 
(HA/ACNSs)5 there is less adsorbed material that is more dissipative in comparison 
with the (HA/ACsol)5. Finally, the thicknesses of the constructs were calculated by a 
viscoelastic model based on a Voigt element. We obtained 82.33 nm for the 
(HA/ACsol)5 and 141.5 nm for the (HA/ACNSs)5 constructs. 
The shape of the shifts for the second layer are different for ACsol and ACNSs, 
because of the different structure of the employed polycations: ACsol is a linear 
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polymer deposited in a single step, while ACNSs has a spherical shape that needs 
reorganization and hydration upon the deposition. The greater dissipation measured for 
ACNSs can be related with both the shape of the NSs and the hydration state of the 
layers. Moreover, the difference in the adsorbed material reflected in the ΔD/ΔF plot is 
expected, since ACNSs cannot be closely packed in a layer because of the repulsion 
forces between the NSs due to their high positive charge (the main reason for the 
stability of ACNSs dispersion). The free space between the spheres is hydrated and as 
a result the obtained layer is much more dissipative. The differences in the structure of 
the used polycations and the mechanism of their deposition were also reflected in the 
thickness of the final constructs. The main observation from QCM-D findings is that the 
thickness is not fully a function of the adsorbed material, but also depends on the 
structure and shape of the used polyions. 
 
Figure 5.21 Representative frequency and dissipation changes obtained for the LbL build-up 
onto amino-functionalised gold surfaces using ACsol (A1) or ACNSs (B1) as polycations and the 
respective ΔD/ΔF plots for the same experiments (A2 and B2). Schematic presentation of these 
build ups (A3 and B3) based on the obtained data – HA in green, water in red and 
ACsol/ACNSs in blue. The presented data are for the 7th overtone.  
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5.3.2 Characterisation of the Coated Silicone Materials 
FTIR spectra confirmed the presence of the multilayer assemblies on the surface of 
silicone (Figure 5.22A). Three new bands appeared in spectra of all coated stripes: the 
signal at around 3300 cm-1 was assigned to stretching vibrations of N-H and O-H in AC, 
and O-H in HA, whereas the broad band between 1500 cm-1 and 1700 cm-1 was 
associated with the amines of AC. In general, all the bands were more pronounced 
after the deposition of 10 bilayers revealing that the coating thickness is directly 
proportional to the number of the deposited layers. The typical AC and HA bands found 
in the spectra of the coatings were more intense when ACsol was used for multilayer 
build-up (dotted lines), again suggesting more deposited material when compared to 
HA/ACNSs. Moreover, several new peaks that could be associated with triglycerides 
[341] and fatty acids [342] appeared in the spectra of HA/ACNSs specimens 
(containing sunflower oil), particularly pronounced in (HA/ACNSs)10 spectra (marked 
with arrows).The peaks at around 2930 cm-1 and 2850 cm-1 could be associated to C–H 
stretching vibrations in methylene (–CH2–) and methyl groups (–CH3), respectively, 
whereas the large peak around 1740 cm-1 is due to C=O double bond stretching 
vibration.  
The coating deposition was also suggested by changes in the wettability of the 
treated silicone (Figure 5.22B). The untreated silicone is a hydrophobic surface 
(112.7±0.4º). Upon coating, the water contact angle decreased significantly (p<0.01) 
only for (HA/ACsol)10 (83.4±1.7º), whereas the values measured for the silicone 
functionalized with (HA/ACsol)5, (HA/ACNSs)5 and (HA/ACNSs)10 were 105.9±0.6º, 
111.0±0.5º and 106.4±2.6º respectively (Figure 5.22B, inset images). The contact 
angle measurements demonstrated that 5 sequential depositions are not sufficient to 
alter significantly the silicone wettability, regardless of the used AC. On the other hand, 
despite of the lower degree of polyion deposition, the higher hydrophobicity of both 
HA/ACNSs specimens is explained by the presence of oil in the NSs core which 
additionally repels water from the silicone surface. 
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 Figure 5.22 A) Representative FTIR spectra of silicone control (silicone-APTES) with dotted 
line and multilayer assemblies on silicone: HA-ACsol specimens with dashed lines and HA-
ACNSs specimens with full lines. B) Water contact angles of HA/AC coatings deposited onto 
silicone. Statistical difference in the case of (HA/ACsol)10 is related to the pristine silicone and 
represented as **p<0.01. Images of water contact angle measurements are given for each 
specimen. 
 
The surface topography and morphology of the 10-bilayered coatings were visualised 
using AFM and SEM. Both (HA/ACsol)10 and (HA/ACNSs)10 coatings exhibited rough 
and irregular surfaces typical for LbL coatings (Figure 5.23A). The mean squared 
roughness (R) values were 7.7 nm and 3.0 nm, whereas the average heights (H) were 
2.6 nm and 1 nm for ACsol and ACNSs, respectively. Unexpectedly, the profile of the 
ACNSs coating was smoother compared to the one built with ACsol [343]. Increased 
roughness of the ACsol-containing compared to relatively smooth surface of the 
structure with NSs is owed to the higher mobility of the free biopolymer, which after 
deposition takes the shape of the previous layer. Taking into account that the build-up 
of multilayers starts with the formation of isolated islets that grow and coalesce into 
continuous coatings only in the second stage of the build-up process (usually above 10 
bilayers), the obtained AFM profile for (HA/ACsol)10 is expected. In contrast, ACNSs 
solely dictates the morphology of the multilayer constructs independently of the shape 
of the below layers [310]. Due to both spherical shape and lower mobility of the NSs 
the related coating displayed a smoother surface [175].  
Important for proving the hypothesis that nanostructures are more efficient than their 
molecular counterparts even after immobilisation onto solid surfaces, the incorporation 
of the intact soft NSs in our multilayer structures (SEM images in Figure 5.23) made 
relevant the further investigation. The SEM images taken at the cross-section of the 
coatings confirmed an irregular surface structure after 10 depositions, but also revealed 
a complete surface coverage by either (HA/ACsol)10 or (HA/ACNSs)10 (Figure 5.23B). 
The dry thicknesses of ~3 µm for (HA/ACsol)10 and ~7 µm for (HA/ACNSs)10 confirmed 
A B 
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the same tendency as calculated from the QCM-D data - ACNSs coating is thicker. 
Since the outermost layer of the coatings was made from the polycations, the top view 
on the surface revealed additional details about the coating structures (Figure 5.23C). 
The key difference was the presence of spheres on top of (HA/ACNSs)10, which appear 
intact (black arrows in Figure 5.23C). Besides the NSs, some bigger than 1 µm 
formations (marked with red arrows on Figure 5.23C) also visible are oil bubbles which 
were not completely removed by the centrifugation steps. Previously we have observed 
the same artefacts in ACNSs dispersions [147]. This finding was also confirmed by the 
presence of the residual sunflower oil, identified with FTIR (Figure 5.22). Overall, the 
assembling of multilayers using intact core/shell NSs with a soft core as in our case is 
considered advantageous, since the added value of processing polymers into 
nanostructures could be transferred to the functionalised materials/surfaces. 
 
 
 
Figure 5.23 (A) AFM images (5 x 5 µm
2
) of (HA/ACsol)10 and (HA/ACNSs)10 deposited onto 
silicone strips. (B) Cross-section and (C) top view of the same samples taken with SEM. 
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The feasibility for deposition of 100 bilayers onto silicone surface was directed to 
demonstrate versatility of the LbL technique to fabricate macroscopic materials 
comprising ACNSs. Since such materials are not suitable to be employed as urinary 
catheter coatings, the deposition of 100 bilayers was performed only on silicone 
stripes. Moreover, these materials allowed to verify the presence of unbroken NSs in 
the HA/ACNSs multilayers due to the ease of sample handling, i.e. to make a suitable 
transversal cut. Figure 5.24A shows a side view SEM image of the membrane 
comprising 100 sequential HA/ACNSs depositions with an approximate thickness of 85 
µm. The image was taken after 3 weeks storage of silicone in water (at 4 ºC), revealing 
high stability of the material in aqueous solutions. The top view of the 100-bilayer 
material is similar to the 10-bilayer coating with NSs dispersed over the last layer 
(Figure 5.24B). As mentioned above, the membrane was further intentionally damaged 
with a small cut in order to investigate the state of ACNSs inside the material. Once 
again, the NSs embedded in multilayers were intact (Figure 5.24C and D), 
demonstrating the suitability of the LbL technique for such application. At the same 
time, these findings also confirm the feasibility of the technique for production of free-
standing membranes with embedded soft nanoarchitectures. 
 
 
 
Figure 5.24 SEM images of (HA/ACNSs)100 deposited onto silicone: (A) side view, (B) top 
view, (C) view at 60º with a cut, and (D) magnified zone of the cut. 
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5.3.3 Antimicrobial Action upon Bacteria-Induced Degradation of Coatings 
AC is well known antibacterial agent owing to its positive charge and related 
perturbation of the bacterial membrane [344]. AC processed into NSs displays even 
higher disturbing capacity on bacterial membrane and bactericidal effect on planktonic 
bacteria [147]. Such bactericidal mechanism induces less selective pressure on 
bacterial population and consequently reduces the risk of resistance development. 
After proving their effectiveness in solution, the next step is incorporation of these 
antibacterial NSs into biomedical devices to effectively control nosocomial infections. In 
this aspect, building the multilayer polyelectrolyte coatings are regarded as a simple, 
but efficient approach for immobilisation of bioentities with preserved bioactivity [345]. 
Antibacterial and antibiofilm activities of the developed coatings were assessed 
against P. aeruginosa. A significant improvement (p<0.001) in inhibition of the P. 
aeruginosa growth was observed already after 2 h incubation with most of the 
specimens, compared to the control (non-coated silicone). The ACNSs in the multilayer 
coatings (5 and 10 sequential depositions) reduced planktonic bacterial growth similarly 
(around 70 %), whereas the ACsol-based coatings affected up to 42 % the bacterial 
cells (Figure 5.25, Table 5.3). Interestingly, in the case of (HA/ACsol), the 5-bilayer 
coating was more efficient compared to the 10-bilayer one, which reduced the bacterial 
growth only 9 %. We relate this effect to the motility of the layers and their availability to 
interact with bacterial cells. An increased motility of the layers in thicker coatings 
usually favours bioactivity, e.g. antimicrobial effect, due to improved availability of 
polycations [295]. Nevertheless, the deposition of greater number of layers also results 
in enhanced motility of a polycation which could lower the effect. A lower hydration of 
the thinner assemblies results in compactly packed structures (reduced mobility) that 
favour the interactions between the polycation and adhered bacterial cells, which could 
result in stronger effect. In this study, the (HA/ACsol)10 coating was more hydrated with 
higher motility of the polyelectrolytes, which translates into less amino groups of AC 
available on the surface to interact with bacteria membranes, and consequently a lower 
antibacterial activity. Nevertheless, such phenomenon was not observed for the 
ACNSs coatings where the spheres preserve the polymer motility regardless of the 
number of deposited layers. In this case the effect may be also assigned to the large 
surface area and improved cationic character of ACNSs when compared to ACsol. 
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Figure 5.25 Antibacterial activity of silicone coated with HA/ACsol and HA/ACNSs against P. 
aeruginosa as compared to pristine silicone. Statistical differences are represented as ***p < 
0.001. 
 
Table 5.3 Antibacterial activity of silicone coated with HA/ACsol and HA/ACNSs against P. 
aeruginosa 
 Sample 
Number of 
colonies 
Average 
number of 
colonies 
Reduction of P. 
aeruginosa growth 
(%) 
 
Pristine 
silicone 
59, 54, 57 56.7 ± 2.5 - 
5-
bilayer 
coating 
(HA/ACsol)5 28, 39, 35 34 42.4 ± 9.4 
(HA/ACNSs)5 24, 13, 17 18 69.5 ± 9.4 
10-
bilayer 
coating 
(HA/ACsol)10 54, 52, 55 53.7 9.0 ± 2.6 
(HA/ACNSs)10 25, 20, 16 20.3 65.5 ± 7.6 
 
The integrity of the multilayer coatings after contact with P. aeruginosa was further 
evaluated in order to elucidate whether the antibacterial effect of the NSs was due to 
their release or they act from the surface. The incubation of (HA/ACNSs)10 multilayer in 
P. aeruginosa suspension resulted in a partial collapse of the coating (Figure 5.26). 
After 6 h incubation the coating was still completely covering the silicone surface, 
although lower fluorescence indicate loss of upper layers of the structure. Further 
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incubation with the bacteria resulted in merely a partial silicone coverage. But even 
after 24 h the coating was found on the surface, revealing a gradual disintegration of 
the structure with the bacteria presence. The degradation was in contrast to the coating 
stability in water and the culture broth. The coating degradation by P. aeruginosa could 
be explained by the expressed hydrolytic activity and depolymerisation of the HA 
component. In such scenario, the antibacterial effect is a consequence of the release of 
the antibacterial ACsol and ACNSs upon triggered by bacteria degradation of the 
coating. Thus, the effective bacteria killing by (HA/ACsol)10 and especially 
(HA/ACNSs)10 coatings can be attributed to the locally high concentrations of 
polycationic antibacterials released. Release from the catheter coatings into a narrow 
space is relevant for urinary tract infections, where typically a small volume of urine 
surrounds the indwelling device surface. Even more important, a gradual collapse 
detected together with only a partial loss of the coating indicated a possible achieving 
of a days-long effect. 
 
 
 
Figure 5.26 Fluorescence microscopy (20x magnification) of (HA/ACNSs)10 coating incubated 
for 6 and 24 h in the absence and presence of P. aeruginosa. Scale bars 100 µm. 
 
5.3.4 Antibiofilm Properties of the Layered Assemblies  
5.3.4.1 Under Static Conditions 
The potential of HA/ACNSs and HA/ACsol coated silicones to prevent P. aeruginosa 
biofilm formation in static conditions was investigated using fluorescence microscopy. 
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Microscopy images after staining of live (green) and dead (red) bacteria attached to the 
surface showed that the bacteria develop well-established biofilms on the control 
material (untreated silicone), with several colonies merging into a continuous biofilm 
(Figure 5.27). The surfaces with deposited 5 bilayers were still colonised with bacteria, 
although the biofilm occurrence was considerably lower and represented with a smaller 
number of bacterial clusters. Despite the decrease in total biofilm growth for both 
ACNSs- and ACsol-based coatings, better antibiofilm effect was observed for the 
ACNSs coatings due to their stronger antibacterial effect. The P. aeruginosa cells were 
individually spread on the latter assemblies with limited number of aggregates that 
consisted mainly of dead cells (stained in red). Increasing number of layers brought 
about nearly total prevention of the biofilm formation, regardless of the shape of the AC 
polycation (free polymer vs. NSs): both 10 bilayers coatings showed higher biofilm 
inhibition efficiency compared to the 5 bilayer structures. Only few live bacteria were 
detected on (HA/ACsol)10 coating, whereas the sporadic single cells on ACNSs-based 
surface were all dead. Nevertheless, it should be taken into account in this comparison 
that less material is deposited in the case of ACNSs (based on QCM-D and FTIR data), 
confirming that the embedded NSs also have stronger antibiofilm activity than the free 
AC macromolecules (deposited from solution). Interestingly, despite the negligible 
antibacterial effect observed for ACsol assemblies with 10 bilayer (less than 10 %, 
Figure 5.25), these coatings still effectively prevented the biofilm growth. Such 
observation could be explained with their relatively high hydrophilicity compared to the 
other multilayers (Figure 5.22). Hydrophobic interactions are suggested as one of the 
important factors promoting P. aeruginosa attachment and consequent biofilm 
development on silicone surfaces. This pathogen possesses a thin layer of glycoprotein 
covered by a thicker layer of lipoproteins and lipids that facilitate its interaction with 
hydrophobic surfaces such as silicone [346]. Thus, increased surface hydrophilicity is 
another way to prevent biofilm formation without affecting planktonic bacterial growth, 
as in the case of the (HA/ACsol)10 coating. 
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Figure 5.27 Fluorescence microscopy images (20x magnification) of P. aeruginosa biofilms on 
non-treated and silicone coated with HA/ACsol and HA/ACNSs, analysed after Live/Dead 
staining. Scale bars 100 µm. 
 
5.3.4.2 Under Dynamic Conditions – Catheterised Bladder Model 
The biofilm inhibition capacity of urinary catheter coated with (HA/ACNSs)10 was also 
assessed under dynamic conditions in an in vitro model of catheterized bladder 
(Section 4.3.2.7 Functional Characterisation of Catheters Coated With Antibiofilm 
Enzymes, Dynamic Biofilm Inhibition Tests). Prior to the assay, photos were taken of 
an untreated Foley catheter and the LbL-treated one. A clean surface is seen on the 
untreated catheter, whereas the immobilisation of ACNSs could be appreciated by a 
white colour on the catheter surface, typical for materials comprising this type of NSs 
(Figure 5.28, left side photo). Upon analysis, after 7 days in the catheterised bladder 
model, a bacterial biofilm is formed on the pristine catheter (especially visible on the 
catheter shaft), whereas the LbL-treated one was biofilm-free (Figure 5.28). 
Fluorescence images after staining of live and dead bacteria attached to the inner part 
of the catheter shaft confirmed the biofilm formation on the non-treated catheter and 
the absence of biofilm on the LbL-treated catheter (Figure 5.28). Unfortunately, the 
coatings were not as effective in inhibiting biofilm formation in the balloon section, 
although the effect is visible to a certain extent. Our investigation in catheterised 
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bladder model also suggested that the ACNSs-containing coating is effective in biofilm 
prevention on the commercially available Foley catheters, acting upon its degradation 
by P. aeruginosa and the consequent NSs release (the catheter displayed a clean 
surface after the incubation in the bladder model). The results obtained with the 
dynamic system showed the same tendency in inhibiting biofilm formation as in static 
conditions. These findings represent a proof-of-concept for antimicrobial effectiveness 
of the novel NSs-containing coatings evaluated during 7 days. Nevertheless, the 
stability, possible degradation and antibiofilm performance of the coatings over the time 
of use should be further considered for in vivo and evidence-based studies. 
 
 
 
Figure 5.28 Photos and fluorescence microscopy images (20x magnification) of the shaft and 
balloon sections of untreated Foley catheter (top row) and catheter coated with (HA/ACNSs)10 
(bottom row) after a 7 day incubation in a dynamic bladder model system with P. aeruginosa. 
Scale bars 100 µm. 
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5.3.5  Conclusions 
In this study, cationic nanostructures were employed as powerful bactericides with 
great potential in suppressing biofilms These were incorporated into catheter surface 
coatings in order to elicit their effect only in presence of pathogenic bacteria, e.g. upon 
release triggered by a certain stimuli, aiming to avoid unnecessary elution and 
rendering the coating inefficient. We demonstrated that the LbL deposition of HA and 
ACNSs resulted in inclusion of intact NSs within bacteria-responsive coating, as a key 
for effective prevention of bacterial biofilms. The coatings were non-eluting in 
physiological conditions, but gradually degraded in the presence of P. aeruginosa that 
causes most of the infections related to biofilm formation on urinary catheters. The 
responsiveness of the multilayers to the presence of bacteria leads to eradication of the 
biofilm upon release of the ACNSs. The antibiofilm properties were also demonstrated 
in a catheterised bladder model during seven days. 
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5.4 Covalent Grafting Of Aminocellulose Nanospheres onto Silicone Material 
 
 
In this section, we used 
another strategy to 
impart silicone material 
with antibiofilm 
functionality against E. 
coli, a common Gram-
negative pathogen 
related with UTIs. The 
approach is based on 
our previous findings 
that sonochemically 
processed ACNSs 
inhibit the growth and 
biofilm formation of P. 
aeruginosa on urinary catheters when released in response to certain stimulus. Herein, 
we decorated silicone surface with epoxy functional groups for covalent immobilisation 
of ACNSs through the well-known epoxy-amine chemistry. The curing reactions of 
epoxy resins with aliphatic amines have been widely used for the development of 
coatings because they easily react at room temperature [147, 347-349]. The main goal 
of the study is to provide the proof of concept for permanent functionalisation of 
silicone-based material as an alternative strategy to counteract the E. coli attachment 
and avoid biofilm formation. 
 
 
 
This section is based on the following publication:   
 Fernandes MM,
a
 Ivanova K,
a
 Francesko A, Mendonza E, Tzanov T.“Immobilization of antimicrobial core-
shell nanospheres onto silicone for prevention of Escherichia coli biofilm”, Process Biochemistry, 2016, 
10.1016/j.procbio.2016.09.011.   
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5.4.1 Inhibition of E. Coli Biofilms – Proof of Concept 
In order to obtain a silicone-based material with antibiofilm properties we developed a 
surface functionalised with ACNSs, previously shown to eradicate planktonic E. coli 
cells [147]. The use of ultrasound sonochemistry for the formation of ACNSs resulted in 
a stable dispersion with spheres of an average hydrodynamic diameter of 268 ± 7 nm, 
narrow size distribution and extremely high ζ-potential, +103 ± 2 mV. Besides an 
extremely high stability, such high cationic charge was also found to be the main 
reason for the interaction with the negatively charged bacterial cell membrane and 
efficient bacterial eradication. This strategy presents other advantages in terms of 
overcoming the emergence of drug resistant strains. The NSs affect the membrane of 
bacteria, which is highly evolutionarily conserved and therefore unlikely to be changed 
by a single gene mutation. In fact, different macromolecules processed in the form of 
NSs and NPs were previously suggested as superior antibacterial agents against 
bacteria in both planktonic and biofilm forms because of their small size, high charge 
density and surface reactivity [350]. For that reason we also tested the ACNSs for their 
capacity to prevent biofilm formation and compared it with AC in solution (ACsol). The 
E. coli was grown on a polystyrene surface together with ACNSs or ACsol for 24h and 
then the biofilm formation was analysed. Characteristic biofilm structure of E. coli cells 
was observed when the biofilm grew in contact with ACsol, whereas few bacterial 
clusters were formed in the presence of bactericidal spheres (Figure 5.29B). The total 
biofilm mass decreased by up to 80 % in the presence of NSs, while almost no 
significant reduction was observed in the case of 0.5 mg/mL non-processed ACsol 
(Figure 5.29A). The spherical shape and large surface area of the ACNSs is believed to 
be the main reason for the prevention of bacterial biofilms. 
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Figure 5.29 E. coli biofilm formation on polystyrene surface assessed by: A) crystal violet assay 
(the OD595 is directly proportional to the amount of total biomass formed) and B) Live/dead cells 
viability kit (ACsol left and AC NS on the right). The green and red fluorescence are overlaid in 
for better comparison of live and dead cells. Scale bar indicate 100 μm. 
 
5.4.2 Incorporation of Cationic Nanospheres onto Silicone Material 
This study further exploited the possibility for coating PDMS with the polycationic NSs 
in order to engineer novel antibiofilm surfaces. In the previous section we have proven 
the ability of these ACNSs within multilayer assemblies to impart antibiofilm and 
antibacterial functionalities onto the silicone/catheter surface. Herein, to develop biofilm 
resistant silicone material, the surface was initially functionalised with reactive epoxy 
groups that will interact with the amino bearing ACNSs.  
Despite the fact that PDMS has been reported as an inert material for 
functionalisation, possessing scarcely distributed reactive hydroxyl groups on the 
surface, some authors have described a chemisorption phenomenon that allows for the 
formation of an oligomeric siloxane layer on the silicone surface. In this process both 
PDMS and GOPTS are hydrolysed in the presence of water, resulting in the generation 
of hydroxyl groups that further may interact via hydrogen bonding, leading to the 
A 
B 
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functionalisation of the PDMS with epoxy pendant groups (Scheme 5.1). Since the 
epoxy groups could not be identified by FTIR, the success of the used functionalisation 
strategy was confirmed by the development of characteristic pink colour after the 
interaction with p-NBP, a dye commonly used to spectrophotometrically identify the 
presence of epoxy groups [351].  
 
 
 
Scheme 5.1 Strategy used to functionalise silicone material: chemisorption of GOPTS followed 
by the reaction of epoxy groups with ACNSs using the epoxy-amine curing method and 
evaluation of the colour of silicone after reaction with p-NBP to assess the efficiency of epoxy 
immobilisation. 
 
The addition of epoxy functionalities provided a reactive site for further immobilisation 
of amino-containing compounds. This reaction occurs via a nucleophilic attack of the 
amine nitrogen on the terminal carbon of the epoxy function. The mechanism is a SN
2-
type II, in which a primary amine can react twice with two epoxy group while a 
secondary amine can react only once [347, 349]. The amino groups from our AC 
biopolymer and within ACNSs are primary amines and thus able to react with the epoxy 
group on the functionalised surface through the active amine hydrogen (Scheme 5.1). 
The pre-functionalisation of silicone with epoxy groups was essential for the 
immobilisation of ACNSs. The infrared spectra of the epoxy-functionalised silicone 
treated with ACNSs, showed the characteristic for amine groups and the N-H stretching 
vibrations peaks at around 1650 cm-1 and 2900 cm-1, suggesting that ACNSs were 
indeed present at the surface of silicone (Figure 5.30). Without the epoxy pre-
treatment, the infrared spectra of the pristine and treated with ACNSs silicones are the 
same – no immobilisation of the biopolymer on the surface.  
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Figure 5.30 ATR-FTIR spectra of non-treated silicone (blue line), silicone (black line) epoxy 
silicone treated with ACNSs at pH 6 (red line). 
 
Therefore, the epoxy-treated silicone was further functionalised with antimicrobial 
ACNSs previously dispersed in a solution at pH 3 and pH 6. These variations in pH 
were used to manipulate the properties of the amino groups of the spheres, namely: at 
pH 3 the amino groups are mainly protonated (-NH3
+) and thus more reactive towards 
negatively charged surfaces, while at pH 6 the amino groups are more nucleophilic, 
which should favour the epoxy-amino curing reaction. SEM images have shown that 
the immobilisation of ACNSs was successful when both pHs were used, revealing the 
presence of intact spheres on the surface. The size of the spheres corresponds to the 
size measured in the dispersion. The bigger spheres that appear in the SEM images 
are air-filled microbubbles, shelled by oil-filled ACNSs (smaller spheres in the images). 
This pattern has been described to occur in sonochemically generated dispersions 
from polysaccharide conjugates (Figure 5.31) [352]. The immobilisation of intact 
nanostructures, e.g. core/shell NSs with a soft core, is advantageous, since the added 
value of processing polymers into nanostructures is transferred to the functional 
materials/surfaces. Important for our study observation is that considerably more NSs 
were fixed on the epoxy-treated silicone when the immobilisation reaction was 
performed at pH 6 because of the improved nucleophilicity of the amine groups at 
these conditions (Figure 5.31). For this reason, only the silicone treated with the 
spheres at pH 6 was used for further experiments.  
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Figure 5.31 SEM images of ACNSs functionalised silicone surface at pH 3 and 6. 
 
5.4.3 Functional Properties  
The functionalised silicone surface was then tested for preventing E. coli biofilm 
formation. E. coli is one of the most frequently isolated microorganisms in catheter-
associated UTIs [89]. It is a highly versatile bacterium ranging from harmless intestinal 
inhabitant to deadly pathogen, including common colonisers of medical devices, small 
intestine and the urethra [353]. On the surface of urinary catheters E. coli may establish 
biofilms and cause difficult to treat urogenital infections. 
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Figure 5.32 E. coli biofilm formation on epoxy-treated silicone decorated with ACNSs and 
unmodified silicone assessed by: A) crystal violet assay (the OD595 is directly proportional to 
the amount of total biomass formed) and B) Live/dead cells viability kit. The green and red 
fluorescence images are overlaid for better comparison of live and dead cells. Scale bar indicate 
100 μm.  
 
Since ACNSs were found to be efficient in preventing the E. coli biofilm growth on 
polystyrene surface, we assessed the ACNSs decorated silicone surface for their ability 
to prevent the biofilm growth. Similarly to the results shown above, the ACNSs on the 
surface of silicone were able to inhibit E. coli biofilm formation reducing the total mass 
of sessile bacteria up to 80 % when compared to the control epoxy treated silicone 
(Figure 5.32A). Furthermore, the fluorescence microscopy images after Live/Dead 
staining corroborated this finding and well-established biofilm of live (stained in green) 
and dead (stained in red) bacteria was visualised on the surface of the pristine silicone 
material. In contrast, the functionalisation with ACNSs resulted in significant reduction 
of drug resistant E. coli biofilm and only few cells individually spread on the surface 
were observed (Figure 5.32B). At that stage the individual cells are considered less 
virulent and even more susceptible to antibiotics at lower therapeutic dosages. Since 
the concentration of NSs used to immobilise the silicone surface was previously found 
to be innocuous towards fibroblasts cells [147], we believe the functionalisation 
A 
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described herein may constitute an efficient approach to obtain a biocompatible and 
anti-biofilm surface for the prevention of E. coli associated infections and biofilms.  
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5.4.4 Conclusions 
The inherent resistance of established biofilms to antibacterial drugs and their 
pervasive involvement in implant-related infections has prompted the search for 
surfaces/coatings that inhibit the initial stages of bacterial attachment, thus preventing 
or restricting the occurrence of biofilm formation. Herein, ACNSs were used to develop 
permanent antibiofilm coatings on silicone material. The NSs were grafted onto silicone 
surface using an epoxy/amine immobilisation reaction. The nanostructured surface was 
found to be efficient in preventing the E. coli biofilm growth. The sonochemically-
induced nanospherisation of cationic biopolymer derivatives such as aminocellulose 
appears as a novel approach for improvement not only of their bactericidal activity 
towards free E. coli cells, but also their inhibition potential against biofilms. Further 
functionalisation of catheter surfaces with intact nanospheres may decrease the 
incidence of the E. coli biofilms and significantly reduce the urinary tract infections 
occurrence, increasing the usage time of the medical devices. 
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5.5 Nano-sized Penicillin G for Overcoming Gram- Negative Bacterial 
Resistance 
 
 
 
In this section, we opted for altering the form and enhancing the interaction with the 
bacterial cell wall of an existing and already Food and Drug Administration approved 
antibiotic, e.g. penicillin G, as a facile method to create a broad-spectrum antibiotic, 
rather than undertaking a time- and resource-consuming screening for new drug 
entities. The strategy we propose would shorten the drug development process, 
because it does not alter the drug target, but simply adds a supporting mechanism to 
the main activity of penicillin G. Moreover, mostly Gram-positive spectrum agents are 
currently in clinical trials [354], while the hereby produced nano-size antibiotic will 
extend its activity also to Gram-negative species, relying on a mechanism of action that 
comprises additionally bacterial membrane disturbance and easy penetration into 
biofilms.  
 
 
 
 
This section is based on the following publication: 
Fernandes MM, Ivanova K, Francesko A, Rivera D, Torrent-Burgués J, Gedanken A, Mendonza E, 
Tzanov T. “Escherichia coli and Pseudomonas aeruginosa Eradication by Nano-Penicillin G”, 
Nanomedicine, 2016, S1549-9634(16)30065-X. doi: 10.1016/j.nano.2016.05.018  
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5.5.1 Antibacterial Activity of Penicillin G towards Gram-negative Bacteria  
Penicillin G is a beta-lactam antibiotic mainly used in the treatment of bacterial 
infections caused by Gram-positive organisms. The four-membered β-lactam ring binds 
and inhibits the transpeptidase enzymes involved in the synthesis of the peptidoglycan 
layer and hinder the synthesis of bacterial cell wall. An imbalance between cell wall 
production and degradation is thus created, leading to cell death [355]. 
Transpeptidases are located in the periplasmic space, which is easily accessible by 
antibiotics in Gram-positive bacteria [356]. In Gram-negative bacteria, β-lactams have 
to cross the outer membrane of bacteria either by passive diffusion or via porin 
channels. However, bacteria were able to create a resistance mechanism in which a 
permeability barrier to the antibiotic by porins modification, which explains the poor 
effect of penicillin against these pathogens [357, 358].  
In fact, Gram-negative bacterial strains such as E. coli and P. aeruginosa used in this 
work were not susceptible to the action of the Penicillin G while the growth of Gram-
positive S. aureus was completely inhibited at concentrations above 15 g/mL (O.D.600 
≈ 0) (Figure 5.33). In order to extend the activity spectrum of penicillin G also to Gram-
negative bacteria, a sonochemical nanospherization of the free antibiotic was carried 
out. This method has already been applied to boost the antibacterial activity of 
biopolymers such as aminocellulose and thiolated chitosan [147].  
 
 
Figure 5.33 P. aeruginosa, E. coli and S. aureus growth after 24 h incubation with Penicillin G. 
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5.5.2 Penicillin Nanospheres Preparation and Characterisation  
The use of nanotechnology to overcome bacteria resistance to β-lactams appears to 
hold significant promise as different biological modes of action towards cells are 
created. In fact, the nano-transformation has been considered as a novel tool to boost 
the antibacterial activity of materials. One common example is silver, which once 
transformed into NPs acquires a high antimicrobial activity due to the large surface 
area of the NPs and better contact with the microorganisms [359]. In this work, we 
sonochemically transformed the penicillin G into NSs as a novel tool for overcoming 
resistance in Gram-negative bacteria, aiming the improved interactions and penetration 
of the NSs with the bacterial membrane. The generation of penicillin nanoparticles 
using ultrasound has also been reported by Yariv et al. (although in absence of an 
organic phase or surfactant), as a way of enhancing the antimicrobial activity against a 
S. aureus clinical isolate [280]. However, the reported penicillin NPs did not kill Gram-
negative bacteria. Herein, we obtained nano-sized, oil-filled, surfactant-containing 
spheres able to efficiently interact with the membrane of Gram-negative bacteria. The 
generated nanomaterials were spherical in shape (Figure 5.34B) with a mean size of 
192  6 nm, a polidispersity of 0.12  0.04 (Figure 5.34FA) and a zeta potential of - 
12.8  1.2 mV. Despite the relatively low zeta-potential (< - 20mV) the NSs were stable 
in aqueous solution for more than 6 months, i.e. did not aggregate in solution, related 
to the presence of poloxamer. Poloxamer is hydrophilic surfactant, comprised of 
polyethylene oxide (PEO) and polypropylene oxide (PPO), which is able to induce 
steric stabilization of the spheres. The hydrophobic PPO chains adsorb on the particle 
surfaces as the “anchor chain”, while the hydrophilic PEO chains pull out from the 
surface to the aqueous medium, producing a stabilizer layer [360]. This effect shifts the 
plane of shear to a farer distance from the particle surface thus reducing the measured 
zeta potential [361]. Poloxamers have been frequently applied for stabilisation of NPs, 
regardless of the method used for their synthesis. Pezeshki et al. have synthesized 
nanostructured lipid carriers with similar size as the one obtained in this study using 6 
% Poloxamer while we used only 0.1 % (w/v) [360]. Vineeth et al. also suggested that 
not only the surfactant influences the size of particle, but also the choice of the organic 
solvent [362]. However, most of the organic solvents used in the cited studies are 
considered cytotoxic, while our NSs encapsulate edible sunflower oil as an organic 
phase in order to avoid harmful effects in humans. Besides poloxamers, other anionic, 
cationic and/or amphoteric surfactants have also been reported to efficiently stabilise 
nanoparticulate systems. The choice of the best surfactant for each formulation 
depends on the final application and several factors such as the type of stabilisation 
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required (electrostatic versus steric stabilisation) and the route of administration (for 
example, steric stabilisation is recommended because it is less susceptible to 
electrolytes in the gut or blood). Several studies have been carried out to determine the 
effect of different surfactants and organic solvents in nanoemulsions [363-366].  
 
A B 
 
 
Figure 5.34 A) Dynamic light scattering, and B) scanning electron microscopy images of 
nanopenicillin. 
 
The nano transformation of penicillin G induced some changes on the chemical 
structure of the antibiotic, confirmed by infrared spectroscopy. The most noticeable 
ones were the disappearance of the β-lactam carbonyl group band at 1790 cm-1 and 
the increase of the broad band at 3500 cm-1, which corresponds to the -OH group from 
the carboxylic group (-CO2H) due to the hydrogen bonding effect (Figure 5.35). The 
sonochemical-induced formation of nanopenicillin was accompanied by the creation of 
a hydrogen bond network between the hydroxyl group and the β-lactam carbonyl that 
contributed for the stabilization of the NSs. This effect has already been observed 
when tetracycline was formulated into NPs using the same sonochemical method 
[238]. Nevertheless, the peaks assigned to penicillin found at 1600 cm-1 and 
corresponding to amide I band were not significantly changed, suggesting that no 
major changes were induced in the structure of Penicillin G upon spherization. The 
remaining peaks were assigned to the surfactant and oil as could be seen in their 
spectra. On the other hand, the IR spectra of control NSs presented a combination of 
the surfactant, oil and hydrogen bonding peaks. The hydrogen bonding is present 
either in the spectra of nanopenicillin and control NSs, suggesting their important role 
in the formation of the spheres (Figure 5.35).   
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Figure 5.35 FTIR spectra of lyophilized penicillin, nanopenicillin, surfactant (poloxamer) and oil. 
 
5.5.3 Antibacterial and Antibiofilm Activities  
Penicillin and nanopenicillin were further evaluated for their antibacterial and antibiofilm 
activity against the Gram-negative P. aeruginosa and E. coli. Control NSs, i.e. spheres 
without penicillin comprised solely of surfactant and oil, were also produced in order to 
determine both the effect of the surfactant and the effect of the particle spherical shape 
on the interaction with planktonic bacteria and their biofilms. 
Penicillin in solution, tested at the same concentration and under the same assay 
conditions, was less effective in killing both Gram-negative bacteria than nanopenicillin. 
The last induced a 3 log10 reduction of P. aeruginosa and 1.2 log10 reduction of E. coli 
while the penicillin in solution induced less than 0.3 log10 reduction of both 
microorganisms (Figure 5.36). An improvement of 10- and 4-fold, respectively, in the 
inhibition of these planktonic Gram-negative bacteria was achieved.  
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Figure 5.36 Antimicrobial activity of 125 μg/mL penicillin and nanopenicillin on E. coli and P. 
aeruginosa after 24 h contact. 
 
The effect of the nanopenicillin on biofilms was also evaluated. A decrease of the 
total biomass was observed under fluorescence microscopy after Live/Dead staining 
when either penicillin or nanopenicillin was applied (concentration of 125 μg/mL) on 
previously formed and well-established biofilms (Control in Figure 5.37). Nevertheless, 
the effect was more pronounced when nanopenicillin was applied (Figure 5.37) and in 
the case of P. aeruginosa, red cells could also be observed which is indicative of a 
killing effect. The control NSs, on the other hand, did not produce a decrease on the 
biomass neither a killing effect, confirming that NSs lacking the antibiotic were not able 
to penetrate and prevent biofilm formation.  
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Figure 5.37 Fluorescence microscopy live/dead images of 24 h grown P. aeruginosa and E. coli 
biofilms incubated with 125 μg/mL penicillin, nanopenicillin and control NSs (live cells are 
represented in green and dead cells in red). Scale bars denote 100 micron. 
 
To sustain these results, the quantification of viable microorganisms within the 
biofilms after application of the antimicrobial agents was also performed using the 
MBEC™ HTP assay. This technique allows microorganisms to grow on 96 identical 
pegs protruding down from a plastic lid to form a biofilm. Treating the established 
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biofilm with the antimicrobial compounds and further quantification of the survived 
bacteria assess the therapeutic potential of the NSs. Nanopenicillin was also able to kill 
more bacteria within P. aeruginosa and E. coli biofilms than Penicillin G. P. aeruginosa 
was more susceptible to the action of nanopenicillin being reduced in 2.5 log10 while 
less effect was observed for E. coli biofilms, in which a 1.65 log10 reduction was 
detected. Penicillin in solution was not effective against P. aeruginosa but it was able to 
induce a 0.8 log10 reduction of E. coli in biofilms, corroborating the results found by 
fluorescence microscopy and antibacterial assays (Table 5.4). 
 
Table 5.4 Viable cells within P. aeruginosa and E. coli biofilms before (control) and after 
applying 125 μg/mL of penicillin, nanopenicillin and control NSs. 
 Log10 of CFU/mL 
 Escherichia coli Pseudomonas aeruginosa 
Control 6.60 ± 1.2 7.52 ± 1.5 
Control NSs 6.70 ± 0.9 7.50 ± 1.1 
Penicillin 5.78 ± 1.7 7.51 ± 0.9 
Nanopenicillin 4.95 ± 0.9 5.26 ± 1.6 
 
5.5.4 Interaction with Bacterial Cell Membrane  
To understand the mechanism of action of the developed NSs, a Langmuir monolayer 
technique, used for mimicking bacterial membranes, was applied. This technique is 
commonly used as a supportive model to explain the interactions between different 
molecules and nanoparticulate systems with bacterial membranes even without 
considering the other constituents of the bacterial membrane. In a first assessment, 
both penicillin in solution and nanopenicillin were found to be surface active when 
analysed by Langmuir technique in the absence of phospholipid upon compression 
(Figure 5.38A). The movement of the spheres to the air-water interface indicated that 
they might be capable to interact with a membrane model and possibly with a bacterial 
membrane (Figure 5.38A right panel).  
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Figure 5.38 A) Surface pressure-area isotherms (or surface activity) and schematic 
representation of the nanospheres surface activity upon Langmuir compression; B) Surface 
pressure-area isotherm of E. coli PE monolayer (the area per molecule in X-axe refers to E. coli 
PE) in water with 0.5 µg/mL penicillin in solution, nanopenicillin and control NSs and schematic 
representation of the NSs interaction with the a Langmuir monolayer upon compression; and C) 
kinetic adsorption process resulting from the incorporation of 0.2 µg/mL (final concentration) 
penicillin, nanopenicillin and control NSs onto the air/water interface of E. coli PE monolayer at 
a surface pressure of 30 mN/m and schematic representation of the incorporation of the 
spheres in the subphase beneath the phospholipid monolayer built at 30 mN/m. 
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To prove this concept, the interaction and internalisation of nanopenicillin and 
penicillin in solution with a membrane model comprised of PE, the principal 
phospholipid extracted from E. coli was studied [367]. This technique has been 
commonly applied in our group to elucidate the interactions of antimicrobial agents with 
bacterial cell membranes at a molecular level, thus indirectly assessing their 
antimicrobial potential [147, 368]. The isotherms of E. coli PE with only water in the 
subphase presented a lift-off at molecular areas of around 300 Å2/molecule, while the 
others lifted-off at significantly higher molecular areas indicating a membrane disturbing 
effect (Figure 5.38). In fact, the same concentration of penicillin and nanopenicillin were 
able to efficiently interact with the PE membrane of E. coli, although at different extent, 
inducing a significant expansion of the monolayer at large areas per molecule of 
phospholipid (Figure 5.38B). This is mainly due to the penetration of the spheres and 
penicillin molecules within the monolayer when the molecules of phospholipids are not 
highly compressed as depicted in the right panel of Figure 5.38B (upper image). 
Regarding the control NSs, despite the fact that the effect was not as pronounced as 
the one observed for penicillin and nanopenicillin, a disturbing effect on the membrane 
model was also detected, indicating that the spherical shape and the surfactant indeed 
play an important role in the interaction with the membrane model.  
After compression, at lower phospholipid molecular areas, the isotherm of the control 
NSs merged with the isotherm of the pure monolayer (water in the subphase), which 
means that these spheres were expelled from the monolayer after full Langmuir 
compression, indicating that they produce an insignificant effect on the established 
compressed monolayer [369]. Nevertheless, this did not occur with penicillin and 
especially with nanopenicillin, as the isotherms collapsed before reaching the 
monolayer highly compressed stage, demonstrating that even at smaller areas per 
phospholipid the nanopenicillin is inserted in between the phospholipid molecules, as 
depicted in the right panel of Figure 5.38B. This effect is called penetration and occurs 
when the compounds present in the subphase emerge to the air-water interface and 
penetrates in between the phospholipid molecules [369]. Moreover, by determining the 
maximum compression modulus of the isotherms it could be observed that they all 
experienced a unique phase transition, from gaseous to liquid-expanded state, 
represented by the Cs
-1
, max around 50 mN/m (Table 5.5). The inability of the monolayer 
to reach a condensed state, commonly represented by higher values of compression 
modulus (Cs
−1), is due to the fact that the E. coli PE phospholipid is a non-pure 
compound that impedes the monolayer to organise into a more packed structure. The 
presence of nanopenicillin, in particular, induced a significant increase of the 
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monolayer fluidity, lowering the Cs
−1
max value, corroborating the observed monolayer 
disturbing effect of the spheres (Table 5.5). 
 
Table 5.5 Maximum compression modulus of E. coli PE monolayers with water, penicillin, 
nanopenicillin and control NSs in the subphase. 
 E. coli PE 
Sample Cs
-1
, max
 (mN/m) Phase transitions 
Control (H2O) 55.8 Gaseous-liquid expanded 
Penicillin 51.9 Gaseous-liquid expanded 
Nanopenicillin 26.7 Gaseous-liquid expanded 
Control NSs 48.1 Gaseous-liquid expanded 
 
By analysing the behaviour of the isotherms on Figure 5.38B at a fixed surface 
pressure of 30 mN/m, which corresponds to the lateral pressure of naturally occurring 
cell membrane, we could also infer about how these spheres interact with the bacterial 
membrane [300, 370]. We observed that at this surface pressure, nanopenicillin highly 
increased the expansion (membrane fluidity) of the monolayer as one molecule of 
phospholipid occupied ≈ 190 Å (see straight line on Figure 5.38B). On the other hand, 
the phospholipid molecules only occupied ≈ 120 Å when either penicillin in solution or 
the control NSs were present in the subphase. These results demonstrated that by 
engineering penicillin into NSs we are indeed able to improve the interaction of 
penicillin with a bacterial membrane.  
To further elucidate this behaviour, all tested compounds were also injected into the 
subphase beneath the E. coli PE monolayer, previously formed at 30 mN/m, and the 
variation in the surface tension of the monolayer was monitored as a function of time 
(Figure 5.38C). Nanopenicillin efficiently penetrated the membrane model, indicated by 
the higher increase of the surface tension in comparison to the penicillin molecules and 
control NSs inserted in the subphase. Nevertheless, the control NSs also induced a 
significant increase on the surface tension indicating that the spherical shape and 
nanosize play an important role in the interaction and penetration of nanopenicillin into 
the bacterial membrane (Figure 5.38C). The presence of the surfactant together with 
penicillin in the spheres played a key role on the interaction with the bacterial 
membrane, as suggested by the insertion capacity of the control NSs (solely comprised 
of surfactant) on the Langmuir monolayer. Indeed, surfactants such as poloxamer have 
been reported to be biomembrane active due to their relative ratio of hydrophobic 
versus hydrophilic building blocks [371]. 
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Mainly cationic NPs have been reported to efficiently kill bacteria by disrupting the 
cell membrane due to electrostatic interaction between the positively charged particles 
and the negatively charge bacterial membrane, leading to cell leakage and death - an 
effect that we have already observed for other cationic NSs [147]. The herein 
generated NSs possessed negatively charged properties and it was therefore expected 
that they would not affect significantly the bacterial membrane. Nevertheless, these 
particles were surface active and able to penetrate the membrane model, providing the 
boosting effect compared to Penicillin G in solution for killing Gram-negative bacteria. 
In fact, negatively charged particles have been reported to efficiently penetrate the 
cells, without disrupting the membrane, through nonspecific binding and clustering of 
the particles on the cationic sites of the membrane followed by internalization via 
endocytosis [372].  
 
5.5.5 Cytotoxicity with Mammalian Cells 
Since NPs and nanomaterials become highly active at nanometre scale, illustrated 
here by the enhanced bactericidal capacity of nanopenicillin, nanotoxicology studies 
should be performed to determine whether these properties might pose a threat to 
humans. We used skin fibroblasts as a model for human cells and analysed the 
cytotoxicity of nanopenicillin and penicillin at the antimicrobial-effective concentrations. 
Nanopenicillin was cytotoxic at concentration of 250 μg/mL, but at the antibacterial-
effective concentration of 125 μg/mL the antibiotic NSs were fully biocompatible (Figure 
5.39). 
 
 
 
Figure 5.39 Relative viabilities (%) of human fibroblasts exposed to 250 μg/mL and 125 μg/mL 
penicillin and nanopenicillin for 24 h.  
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5.5.6 Conclusions  
The results obtained from Langmuir monolayer studies suggested that by engineering 
penicillin G into NSs the interaction and penetration of otherwise less penetrable 
antibiotic molecules into the bacterial membrane is favoured. Since the resistance of 
Gram-negative bacteria to β-lactams is mainly due to the incapability of the penicillin 
molecules to penetrate the outer membrane and inhibit the transpeptidases in the 
periplasmic space, it is expected that nanopenicillin, in contrast, would be able to insert 
into the membrane and overcome this antibacterial-resistance mechanism (Scheme  
5.2A). Combining NPs with antibiotics has already been proved to generate a synergy 
against bacterial resistance by reducing the toxicity of both agents towards human cells 
due to the decrease on the requirement for high dosages, but also to enhance their 
bactericidal properties [373]. Herein, the same enhanced killing effect was observed, 
however, in our case the antibiotic itself was formulated into the nanoform, instead of 
being encapsulated or combined with other particles, thereby combining both 
bactericidal and nanoscale effects.  
The spherical shape and large surface area of the antibiotic NSs was further 
designated as the main reason for the successful eradication of bacterial biofilm by 
penetrating them more easily than the Penicillin G in solution and by providing better 
contact with microorganisms encased, thus allowing the eradication of Gram-negative 
biofilms and even induce a killing effect, mainly on P. aeruginosa (Scheme  5.2B). 
Treating biofilm infections remains a major challenge due to the fact that high doses of 
antimicrobial agents are required. It has also been reported that by packing the 
antibiotic into NPs increased killing of biofilm-encased bacteria could be achieved 
compared to the free antibiotic due to the protection effect that the NPs provide against 
enzymatic degradation of the antibiotic and its binding to matrix components. The 
nanoscale formulation of antibiotics could constitute a powerful tool for the treatment of 
antibiotic-resistant Gram-negative bacteria, which is particularly important due to the 
fact that this highly prevalent opportunistic pathogen is one of the most worrisome 
bacteria in clinical settings owing to its low antibiotic susceptibility, especially in the 
form of biofilms. 
 
 
 
 
 
 
 141 
 
A B 
 
 
 
Scheme  5.2 Schematic representation of the interaction of nanopenicillin and penicillin G onto: 
A) the gram-negative bacterial cell wall and B) the biofilm structure. 
 
 
6 Conclusions and Future Plans
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6.1 Final conclusions 
The accelerated emergence of drug resistant bacterial strains and their ability to form 
biofilms are one of the most serious problems of the modern medicine and the 
difficulties in finding cost-effective alternatives make it even more challenging. 
However, since the pathogenesis of implant-associated infections has become more 
clearly elucidated, the therapies and the biomaterials used to mitigate disease severity 
have also evolved. Approaches based on enzymes or antibacterial nanomaterials have 
been extensively investigated for the control of medically relevant biofilms, mainly 
because they offer the promise to decrease the need for high drug dosages and limit 
the acquisition and spread of resistance in bacteria. Based on the above, a platform of 
antibacterial and anti-biofilm nanomaterials and coatings was developed using:  
 
A. Enzymatic approaches targeting the inhibition of biofilm establishment 
rather than killing the free floating bacterial cells. These comprise: 
 
 QS inhibiting acylase in multilayer nanocoatings  
- QQ acylase within multilayers breaks down the QS signals in the 
surrounding imposing less selective pressure on the bacterial population 
for resistance occurrence. The pathogenic cells could not establish drug 
resistant biofilms on the silicone, therefore would be more susceptible to 
host immune defence and antibiotics.  
-  Acylase multilayers were stable for seven days under conditions that 
mimic the real situation during catheterisation and significantly delayed 
the QS regulated biofilm formation of Gram-negative P. aeruginosa, 
without affecting the viability of human fibroblasts.  
 QQ and matrix-degrading enzymes in hybrid LbL assemblies  
- QQ acylase and matrix-degrading amylase were assembled into stable 
and biocompatible hybrid multilayer coating able to interfere with 
bacterial QS process and degrade matrix polysaccharides. 
- The combination of both enzymes resulted in strong antibiofilm activity 
against medically relevant biofilms as a function of the enzyme position 
(acylase vs amylase) in the layers. 
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- In vitro and in vivo studies suggested the potential of these enzyme-
integrated assemblies to reduce the biofilm growth on catheter surface 
and postpone device-related infections.  
 
B. Nanomaterials aimed at controlling free floating bacterial growth and 
biofilm occurrence 
 
 Bacteria-responsive multilayer coatings comprising polycationic NSs  
- Sonochemically generated polycationic ACNSs were incorporated into 
“smart” self-defensive LbL assemblies able to counteract planktonic and 
cooperative biofilm growth of bacteria.  
- The release of highly antibacterial ACNSs in response to bacterial 
stimuli resulted in a notable inhibition of biofilm development on catheter 
surface even after seven days of catheterisation in an in vitro model of 
human bladder.  
 Covalent grafting of antibacterial ACNSs onto silicone material  
- The covalently immobilised on silicone NSs were able to counteract the 
bacterial attachment and biofilm formation, showing potential to prevent 
implant related infections. 
 Nano-sized Penicillin G for overcoming Gram-negative bacterial resistance 
- Clinically relevant antibiotic penicillin G was sonochemically transformed 
into NSs with high antibacterial efficiency against Gram-negative 
pathogens in both planktonic and biofilm forms.  
- The NSs were shown to penetrate within model cell membrane, 
confirming their capacity to interact with bacterial cell wall and cause 
membrane damage. These spheres were innocuous towards human 
fibroblasts at the antibacterial/antibiofilm-effective concentrations and 
thus are valuable alternative to combat drug resistant phenotypes.  
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6.2 Future Perspectives 
Overall, the development of materials and coatings that efficiently inhibit bacterial 
adhesion, while reducing the high incidence of antibiotic resistance, is one of the most 
difficult and challenging tasks. The results obtained during the realisation of this thesis 
demonstrated the feasibility of using enzymes and nanostructures to control bacterial 
growth and drug resistant biofilm occurrence on indwelling medical devices. The 
coatings comprising QQ and matrix degrading enzymes were able to delay biofilm 
growth on catheter surface in vitro, when inserted in a glass model of catheterised 
human bladder as well as in vivo in an animal model. A pilot study with urine collected 
from patients with UTIs is on-going at the Emergency Medicine department of George 
Washington University to validate the strategy prior to clinical trials. Furthermore, using 
simultaneously antibiotics and antibiofilm enzymes in the pilot system would provide 
the opportunity to assess the enzymes potential in enhancing the antibiotic 
effectiveness at lower therapeutic dosages. 
   The results obtained in this thesis open alternative avenues to design novel 
multifunctional nanostructured materials and coatings. The efficiency of commercially 
available and in some cases obsolete, antibiotics could be synergistically enhanced via 
the combination of the innovative approaches used herein: i) attenuation of bacterial 
virulence by enzymes interfering with bacterial QS process, ii) enzymatic degradation 
of biofilms adhesives, and iii) nanotransformation of antibiotics. The assemblies of the 
molecules into hybrid nano-sized antibacterials would improve their stability, durability 
and even increase the activity against multi-drug resistant strains and their biofilm 
phenotypes. The synergy of these innovative hybrid nanomaterials for counteracting 
biofilm formation of clinically relevant bacteria on catheters will be further investigated 
during the projects: “Hybrid nanocoatings on indwelling medical devices with enhanced 
antibacterial and antibiofilm efficiency” (MAT2015-67648-R) and “Investigating the 
mechanism of eradication of multi drug resistant bacteria by inorganic (mixed metal 
oxides), organic (antibiotic) and protein-based NPs” (AC14/00022)  
These nano-modalities could also impart antibacterial functionalities to textiles, 
wound dressings materials, contact lenses and water treatment membranes. These 
applications will be further up-scaled to a pre-commercial level for coating of medical 
devices in the project “Pre-commercial lines for production of surface nanostructured 
antimicrobial and anti-biofilm textiles, medical devices and water treatment 
membranes” (H2020-720851). Besides of human care, these nanostructures and 
nanostructures surfaces could be considered for diseases prevention, increased 
production performance and improved animal welfare.   
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